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Abstract
Microbeam Radiation Therapy (MRT) is a novel radiation therapy modality cur-
rently developed at several synchrotron sources around the world. The MRT technique
is based on the use of plane parallel arrays of microbeams produced by a multislit
collimator (MSC). The major benefit of MRT lies in the dose volume effect: a higher
radiation tolerance of the normal tissue when using micrometer scale beam size. More-
over, pre-clinical studies highlighted the detrimental effect of MRT on the tumor tissue
and demonstrated the presence of a differential effect between normal and tumor tis-
sue. One of the possible application of MRT is the treatment of inoperable paediatric
brain tumors where conventional radiotherapy presents a high level of toxicity on the
developing brain. Despite the numerous pre-clinical studies that demonstrated the
efficiency of the MRT technique over the last twenty years, efforts are still required for
the dosimetry quality assurance (QA) before being able to move from pre-clinical to
human clinical stage and are the framework of this study.
Currently, a 3rd generation synchrotron X-ray source is required to perform MRT
irradiations. Indeed, the low beam divergence allows the production of plane paral-
lel microbeams, the high dose rates ensure fast irradiation times thus avoiding any
blurring of the microbeams with cardiosynchronous motion and the energy spectrum
in the range 27-600 keV provides sharp beam penumbra. Quality Assurance (QA) is
required for MRT but remains a challenging task due to the high spatial resolution
and the radiation resistance properties required from the dosimeter.
In MRT, QA must include reference dosimetry in a reference broadbeam (i.e. no
spatial fractionation of the beam) and the dosimetry of the microbeams. Microbeam
dosimetry consists in the experimental determination of the dose in the microbeams
(i.e. peak dose), of the dose between the microbeam (i.e. valley dose), of the Peak to
Valley Dose Ratio (PVDR) and of the scatter factors. Many detectors have been inves-
tigated and led to the conclusion that ionisation chambers (IC) and Gafchromic® films
currently are the most accurate detectors for broadbeam and microbeam dosimetry
respectively. However, due to the high dose rates encountered in MRT, lack in col-
lection efficiency has been observed from the IC leading to significant uncertainties.
Moreover, despite their great spatial resolution, Gafchromic® films do not provide
sufficient dynamic range to display both peak and valley doses, they are passive de-
tectors and still present too significant reading uncertainties to be used as primary
detectors. Within this context, the aim of this study was to improve both broadbeam
and microbeam dosimetry at the ID17 biomedical beamline at the ESRF (European
Synchrotron Radiation Facility, Grenoble, France) where MRT is developed and to
propose the corresponding quality assurance procedures.
First, the lack of collection efficiency of the MRT reference IC was addressed by the
development a new method based on the measurement of the IC response at different
dose rates. This method provides correction factors to be applied to the reference IC
and results in the determination of the absolute dose with an accuracy better than
± 5%. In the context of MRT veterinary trials on the ID17 biomedical beamline, an
absorbed dose to water protocol has been established within this work.
In collaboration with ID17, the Centre for Medical Radiation Physics (University of
Wollongong, Australia) developed the X-Tream dosimetry system especially for MRT
QA applications. The system relies on a high resolution silicon Single Strip Detector
(SSD) for the microbeams acquisition. The X-Tream dosimetry system has been char-
acterised at the ESRF and a particular attention was dedicated to the study of the
radiation damage induced into the SSD as well as on the experimental determination
of the energy dependence of the device. The ability of the SSD to perform rapid and
efficient QA tests prior MRT treatment has been evaluated: in-air measurements of
1D intensity profiles of the synchrotron beam used in MRT were performed in order to
assess the alignment of the MSC. The SSD was able to detect small misalignments of
the MSC which resulted in changes in the valley shape and on the peak and valley sig-
nals. The results obtained by the SSD for the MSC alignment were in agreement with
the monitoring IC currently used for this purpose on ID17. An alignment procedure
based on the pink-beam imaging modality available at the ESRF has also been devel-
oped in order to align the SSD with the MRT beam. The SSD has then been used at
the ESRF under reference conditions in order to experimentally determine the PVDRs
and scatter factors. For the first time, an active detector has been able to measure
both valley and peak signals with the same accuracy leading to a direct determination
of the PVDRs in agreement with published results obtained using Gafchromic® films
and MC simulations. Finally, preliminary tests have been carried at the Imaging and
Medical BeamLine (IMBL) at the Australian Synchrotron (AS) where the microbeam
array have been acquired for the first time with an active detector.
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Preamble
This thesis is devided into eight chapters. First, the clinical context under which
Microbeam Radiation Therapy (MRT) technique emerged is explained as well as the
major outcomes and remaining challenges that motivated this PhD project.
Chapter 1 introduces the Microbeam Radiation Therapy principle and gives a brief
history of the technique. The major findings obtained during pre-clinical studies car-
ried to either demonstrate the technique efficiency, investigate the optimisation of
the MRT treatment or explain the underlying mecanisms are presented. A special
attention is then dedicated to the dosimetry issues encountered in the case of medi-
cal applications of a synchrotron X-ray beam. The challenges related to microbeam
dosimetry are presented and the main results obtained in previous studies investigated
different methods and/or detectors are detailed. The objectives and aims of this PhD
project are also exposed in this chapter.
Chapter 2 introduces the facilities where the experiments presented in this study
were conducted. The synchrotron principle is first explained before describing in de-
tails the instrumentation of both the ID17 biomedical beamline at the European Syn-
chrotron Radiation Facility (ESRF) in Grenoble, France, and the Imaging and Medical
Beam Line (IMBL) at the Australian Synchrotron where the MRT technique is devel-
oped.
Chapter 3 focusses on reference dosimetry that needs to be performed under broad-
beam conditions (i.e. no spatial fractionation of the beam) before MRT irradiation.
As this dosimetry procedure uses a cylindrical ionisation chamber (IC), the principle
of this detector will be explained as well as the different correction factors that needs
to be applied to the IC reading in order to measure an absolute dose. At the ESRF,
a reference dosimetry protocol has been established and is especially adapted to the
MRT technique. Indeed, due to the high dose rates encountered in MRT, this protocol
required the developement of a dedicated method for the determination of the satura-
tion correction factor to be applied to the IC reading. This method is fully described
in this chapter. A study dealing with the energy spectrum verification for two beam
conditions available at the ESRF and based on half value layer measurements is also
presented.
Chapter 4 presents the X-Tream dosimetry system especially developed by the
Centre for Medical Radiation Physics (CMRP) for microbeam dosimetry. The system
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is composed of a silicon Single Strip Detector (SSD), a pre-amplifier module, a central
data acquisition system unit (CSU) and a graphical user interface. In this chapter, the
dynamic range of the two pre-amplifier modules used for the different experiments, and
thus their suitability for MRT applications, was investigated by measuring the output
signal from each modules as a function of the input current. These measurements also
allowed the determination of the current to counts conversion factor for both modules.
As silicon-based detectors are known to be quite sensitive to radiation damage and
to exhibit a high energy dependence, these two aspects were studied in detail and are
presented in this chapter.
Chapter 5 evaluates the ability of the SSD to perform rapid and efficient QA test
prior MRT treatment. This study is based on in-air measurements of the horizontal
profiles of the microbeams X-ray field in order to determine the relative intensity of
each microbeam and assess the alignment of the MSC.
In chapter 6, the SSD has been used for microbeam dosimetry at the ESRF. The
Peak to Valley Dose Ratio (an important dosimetric parameter in MRT) was assessed
in three different dosimetric phantoms and results were compared to Monte Carlo
(MC) simulations. The scatter factors used to convert the dose measured in the MRT
reference field (i.e. 20 mm × 20 mm) to the dose in a microbeam have also been
measured using the SSD and compared to MC simulation results.
Chapter 7 presents preliminary experiments that have been carried at IMBL at
the Australian Synchrotron. These experiments consisted in broadbeam experiments
where the SSD behaviour was compared to the IC used for reference dosimetry at
IMBL. Intensity profiles of horizontal microbeams have been obtained in the MRT
hutch at IMBL (hutch 1B) for two different microbeams widths settings.
Finally, chapter 8 resumes the major findings of this thesis and gives the concluding
remarks.
Chapter 1
Introduction
1.1 Context and motivations
In 2012, brain cancer (and other CNS tumours) has been estimated to have caused
the death of 189,000 people worldwise [UK Cancer Research Website]. In 2007, brain
cancer represented 1.4% of the new cancer cases in Australia [AIHW, 2012]. However,
over the 2003-2007 period, brain cancer was the leading cause of cancer death for
adolescent and young adults (15-29 years old). Indeed, the 5 year relative survival is
only of 21.6% for brain cancer and has remained essentially unchanged for the last
30 years [AIHW, 2014]. This bears testimony to the limitations of the technologies
currently used to cure brain cancer and to the crucial need to develop new treatment
modalities.
Within this context, Microbeam Radiation Therapy (MRT) is currently under de-
velopment. MRT uses a highly brilliant synchrotron X-ray source spatially fractionated
into an array of quasi non-diverging microbeams (∼ 25 to 100 µm wide beams spaced
by a 100 to 400 µm distance). The major physical benefit of this approach lies in
the dose volume effect: a higher radiation tolerance of the normal tissue when using
micrometer scale beam size [Curtis, 1967; Zeman et al., 1961, 1959]. Such tolerance
is not observed for cancer tissue [Bouchet et al., 2010] which leads to a natural differ-
ential effect in the MRT approach. Using MRT thus implies an extraordinary sparing
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of the normal tissue and one of the possible application of MRT is the treatment of
inoperable and very radiation resistant paediatric brain tumors where conventional
radiotherapy presents a high level of toxicity on the developing brain [Laissue et al.,
2007; Ribi et al., 2005; Slatkin et al., 1992].
Over the last 20 years, many pre-clinical studies have been performed and demon-
strated the efficiency of the MRT technique [Bouchet et al., 2012; Dilmanian et al.,
2003; Laissue et al., 1998; Le Duc et al., 2011; Miura et al., 2006; Régnard et al., 2008a;
Smilowitz et al., 2006]. However, before moving from the pre-clinical to the clinical
trial stage, new and novel developments are required from the dosimetry aspect and
are the framework of this study.
1.2 Microbeam Radiation Therapy
1.2.1 Dose volume effect
Spatially fractionated beams have been used for a long time in the interest of preserving
normal tissues. In 1909, Alban Köhler introduced the use of a grid made of iron wires
in order to avoid patients skin necrosis when using medium energy photons [Köehler,
1909; Laissue et al., 2012]. Indeed, by preserving some skin cells from the direct
radiation, the skin showed a better ability to recover from the burns induced by the
radiations. With the emergence of megavoltage X-rays radiotherapy techniques and
their associated sparing of the skin tissue via the dose build up with depth in the
patient, the grid is now used occasionally in the case of advanced and/or large tumors
in order to enhance the tumor control [Laissue et al., 2012; Mohiuddin et al., 1999;
Peñagaŕıcano et al., 2010].
MRT takes advantage of the dose volume effect that occurs when micrometer scale
beams are used relying on superior repair mechanism. The dose volume effect was
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highlighted in the late 1950’s when Zeman et al. investigated the effect of cosmic
radiations on mouses’ brain using deuterium beams of different sizes. The authors
observed a much higher tissue tolerance when using smaller beam sizes: for a 1,000 µm
beam, a dose of 300 Gy was sufficient to observe a complete tissue destruction while
when using a 25 µm beam the dose had to reach 11,000 Gy prior creating a lesion
[Zeman et al., 1959].
Figure 1.1: Histological images of a mouse brain irradiated with a 22.5 MeV deuterium
beam. On the left image, the mouse brain tissue, irradiated with a 1 mm diameter
beam and an entrance dose of 280 Gy (120 days post-irradiation), is completely de-
stroyed while on the right image the tissue irradiated with a 25 µm beam and an
entrance dose of 4,000 Gy is preserved (28 days post-irradiation). Reproduced from
[Zeman et al., 1961].
A histological study was thus carried out on mouse visual cortex with high energy
particles. For a 1000 µm wide beam the dose required to produce the complete de-
struction of cells within 24 days was 140 Gy whereas, for a 25 µm large beam, a dose
of 4000 Gy only introduced the destruction of the cells within the beam path while the
tissue remained intact [Curtis, 1967; Zeman et al., 1961]. Indeed, in the case of the
larger beam sizes the authors observed tissue necrosis, circulatory disturbances and
delayed radiation damage of vessels. At the time, this extraordinary radioresistance
of the brain tissue was explained by a fast vessels repair along the microbeams path
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thus allowing the preservation of the vascular network. However, the heavy ions used
in this study are attenuated at relatively low depth (1.5 mm depth under the skin)
which prevents their use for a radiation therapy application.
In 1992, the emergence of synchrotrons X-rays sources provided the impulse for the
development of MRT. Indeed, synchrotron beam divergence is very low (∼ 0.5 mrad
and ∼ 0.02 mrad in the horizontal and vertical direction respectively at the ESRF)
compared to conventional X-ray sources (∼ 35 mrad) thus allowing the production of
plane parallel beams. Moreover, fast irradiation times are required in MRT in order
to avoid any blurring of the microbeams induced by cardiovascular or pulmonary
motions. The highly brilliant X-ray beam produced by a synchrotron source results in
large radiation dose rates enabling the dose delivery in very short times. Finally, the
kilovoltage energy range of the synchrotron beam limits the range of the secondary
electrons leading to sharp beam penumbras and edges.
MRT was first proposed and started being developed in 1992 at the Brookhaven Na-
tional Laboratory (BNL) in collaboration with the National Synchrotron Light Source
(NSLS) in Upton (USA) [Slatkin et al., 1992]. In 1994, a patent on the MRT tech-
nique was submitted [Slatkin et al., 1994] and MRT was implemented on the biomedical
beamline (ID17) of the European Synchrotron Radiation Facilty (ESRF) in France.
Since 2005, MRT experiments have been able to be performed at Spring 8 in Japan.
In 2008, the Australian Synchrotron and the Candadian Light Source (CLC) opened
their medical beamlines where MRT is also under development. Finally, in November
2013, the first MRT veterinary clinical trials was conducted at the ESRF where a cat
patient presenting a spontaneous tumor was treated.
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1.2.2 MRT technique
As mentioned previously, the MRT technique relies on the use of highly collimated,
quasi-paralell arrays of microbeams produced by a 3rd generation synchrotron source
in the kilovoltage energy range.
The spatial fractionation of the synchrotron beam is performed by a multislit col-
limator (MSC) made of tungsten carbide (WC). The MSC slits aperture can either
be fixed or tunable. In this last case, two MSCs of alternating low and high atomic
number materials are used (i.e. either aluminium/gold or air/tungsten combination)
and the microbeams width is modified by a horizontal translation of one MSC relative
to the other MSC as shown in Figure 1.2.
Figure 1.2: Illustration of the synchrotron beam collimation using two MSCs allowing
a tunable microbeam width. Reprinted from [Siegbahn et al., 2006].
The microbeam sizes are typically between 25 and 100 µm wide and spaced by a
100 to 400 µm [Bräuer-Krisch et al., 2010b]. Figure 1.3 is a schematic diagram of
the typical dose profile observed when irradiating tissue material with an array of
microbeams (extracted from [Blattmann et al., 2005]). This profile illustrates the
formation of the so-called peak and valley regions. The peak dose corresponds to the
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dose deposited in the path of the microbeams and the valley dose originates from
the photons scattered from the peaks. The valley dose is much lower than the peak
dose but remains significant for the tissue. The valley dose depends on the peak
dose, the distance between the microbeams, the microbeams width, the beam energy,
the chemical composition of the target, the number of microbeams in the array, the
irradiation field size and the point in depth of the irradiated target.
Figure 1.3: Schematic representation of a typical dose profile in MRT. Reprinted from
[Blattmann et al., 2005].
The Peak to Valley Dose Ratio (PVDR) is an important parameter in MRT. As
its name suggests, the PVDR is equal to the dose deposited in the peak divided by
the dose deposited in the valley. The distance between two microbeams is called
the center-to-center distance (c-t-c). In the context of pre-clinical studies, the term
“peak entrance dose” was introduced and corresponds to the peak dose at 3 mm depth
in tissue/water. Therefore for the pre-clinical studies, the irradiation conditions are
usually defined by the peak entrance dose, the microbeams width and the microbeams
spacing (i.e. the c-t-c distance).
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1.2.3 Pre-clinical results
The very first MRT pre-clinical trial was carried out at BNL in 1995 where the brains
of healthy rats were irradiated for different microbeams widths, heights and spacings
and for skin entrance doses ranging from 312 to 10,000 Gy. Irradiations were performed
using a single slit collimator defining either a 20 µm × 4 mm (MRT 2), 7 mm × 42
µm (MRT 4) and 37 µm × 4 mm (MRT 5) (width × height) microbeam. Parallel
slices of the rats’ brain were exposed to the microbeam after a 200 or 75 µm (MRT 2
and MRT 5) or 200 µm (MRT 4) lateral translation of the rat. 3 or 20 brain slices were
irradiated for the MRT 2 configuration. 20 and 21 slices were irradiated for the MRT
4 and MRT 5 configurations respectively. For MRT 2 and MRT 4 the space between
the slices was of 200 µm. For MRT 5, two different spaces between the slices were
investigated: either 75 or 200 µm. The rats were sacrified two weeks or one month
after the irradiation. Two of the four rats that received the maximum skin entrance
dose developed brain tissue necrosis. For the two other rats that received an entrance
dose of 10,000 Gy, all of the rats that received 5,000 Gy and some of the rats that
received an entrance dose of 2,500 or 1,250 (57% and 25% respectively), a loss of nuclei
(and their pezikarya) was observed along the microbeams path but without any brain
necrosis nor brain damage [Slatkin et al., 1995]. For 312 Gy and 625 Gy entrance
doses, the rats’ brain tissue appeared normal histologically.
After these promising results, Laissue et al. investigated the potential of MRT to
treat rats bearing cerebral 9L gliosarcomas Laissue et al. [1998]. They used either one
or two arrays of microbeams orthogonally crossed in the tumor volume. Each array
contained 101 microbeams, 25 µm wide and spaced by 100 µm c-t-c. A peak dose of
625 Gy was delivered for the single array configurations and two different peak doses
were investigated for the two orthogonal arrays configuration (312 and 625 Gy). Each
configuration gave a higher median survival time than for the unirradiated controls.
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As one can see in Figure 1.4 the longest survival time was obtained for the irradiation
performed with two orthogonal arrays of microbeams delivering a peak dose of 625 Gy
(median survival time of 139 days after tumor implementation compared to 20 days
in the case of untreated rats). Moreover, the authors observed a disappearance of the
tumor for 61% of the irradiated rats even in the case of an irradiation performed with
a single array of microbeams (observed for 4 rats over the 11 treated with a single port
using a microbeam array).
Figure 1.4: Survival curves obtained for 9L cerebral gliosarcoma bearing rats either
unirradiated (Controls), irradiated with one single array of microbeams and 625 Gy
peak dose (625-1) or irradiated with two orthoganal arrays of microbeams with a peak
dose of either 312 Gy (312-2) or 625 Gy (625-2). Reprinted from [Laissue et al., 1998].
This study highlighted for the first time the efficiency of MRT for the tumor control
without observing any macroscopic damage on the normal brain tissue. The extraor-
dinary radioresistance of the normal brain tissue was hypothesised to result from a
fast repair of the microscopic lesions by adjacent cells in the valley that have received
less dose. However, it was important to ensure that the normal brain tissue tolerance
to MRT irradiation still remained in the case of immature developing brain. Laissue
et al. [1999] thus conducted a long-term study on suckling rats where they performed
unidirectional irradiation of the normal brain using peak entrance dose of 50 or 150
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Gy, a 28 µm microbeam width and a c-t-c spacing of either 105 or 210 µm. 15 months
after the irradiation none of the rats had died or needed to be euthanised. An im-
portant weight loss coupled to neurogical and behaviour anomalies were observed but
only in the case of the rats irradiated with the highest dose and the narrowest c-t-c
spacing. For the other c-t-c spacing and peak entrance dose combinations, the rats
development remained similar to the unirradiated contol rats.
It was also necessary to demonstrate that the structure of peak and valley regions
was still preserved for larger brains. Indeed, in the tissue, the peak dose is attenuated
at a higher rate than the valley dose thus resulting in a decrease of the PVDR with
depth (this behaviour will be detailed in Section 1.3.3 and illustrated in Figure 1.17).
A long-term study was thus carried out with piglets aged between 40 and 47 days old
by Laissue et al. [2001]. This animal model was chosen because piglets neurological
development is comparable to human infants. Irradiations were conducted with skin
entrance peak doses ranging from 150 to 600 Gy and with a 1.5 cm x 1.5 cm field
composed of 25 µm large microbeams spaced by 210 µm. The animals developed
normally over at least a year and no neurological changes were observed between the
irradiated piglet and the non-irradiated ones. Histological studies performed on a
piglet brain 15 months after irradiation and that received a 300 Gy skin entrance dose
showed destroyed cells (and their nuclei) in the path of the microbeams but no signs
of hemorrhage nor necrosis was found (see Figure 1.5) [Laissue et al., 2007, 2001].
These first trials demonstrated the efficiency of MRT to treat brain tumors but also
the sparing of the normal brain tissue and led to the consideration of MRT for the
treatment of brain tumors for both adult and peadiatric patients. Indeed, the nor-
mal tissue sparing of MRT could be very beneficial for peadiatric patients for whom
conventional treatments can cause neurocognitive dysfunction [Ribi et al., 2005].
The encouraging results obtained by Laissue et al. [2001] were the starting point
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Figure 1.5: Histological images of a piglet brain 15 months after MRT irradiation with
a skin dose of 300 Gy. Reproduced from [Laissue et al., 2007].
of numerous pre-clinical studies carried out in order to optimize the MRT parameters,
increase the efficiency and understand the mecanisms responsible for the differential
effect observed between normal and tumor tissue.
1.2.4 Optimisation of the MRT irradiation parameters
Among different aims of the pre-clinical studies, some of the research was focussed
on the determination of the optimum parameters to be used in MRT in order to en-
sure both tumor control and preservation of the normal tissue and cognitive functions.
They mostly relate to the determination of the optimum microbeam size and spacing.
Microbeams inter-spacing (c-t-c distance)
Dilmanian et al. [2002] implanted fisher rats brains with 9L gliosarcoma. The rats
were then irradiated with an array of unidirectional microbeams. The microbeam
width was fixed to 27 µm and different microbeam spacings (50, 75 and 100 µm) and
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skin entrance doses (150, 250, 300 and 500 Gy) were investigated. The survival curves
obtained for the different irradiation configurations are displayed in Figure 1.6 and
compared to the one obtained for the untreated rats.
Figure 1.6: Survival curves obtained for the treatment of cerebral 9L gliosarcoma
bearing rats using different entrance peak doses and microbeams spacings. Reproduced
from [Dilmanian et al., 2002].
As one can see, for each configurations, the MRT treatment has contributed to an
increase of the survival time when compared to the unirradiated group for which the
median survival was 19 days. However, the median survival times vary between 31
and 171 days depending on the beam spacing and peak dose considered. The lowest
median survival times were observed for irradiations combining small beam spacing
with the highest peak entrance dose (i.e. 50 c-t-c with a 300 Gy peak entrance dose
and 75 c-t-c with a 500 Gy peak entrance dose). These results suggest that MRT
efficiency highly depends on the valley dose and the authors concluded that, in the
normal tissue, the valley dose must remain under the organ dose tolerance in order
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to preserve the MRT beneficial effect. Régnard et al. [2008b] treated 9L gliosarcomas
bearing rats with an unidirectional array of microbeams. The microbeam width was
fixed to 25 µm and the spacing between the microbeams was either 100 or 200 µm.
They observed a higher median survival time by using a 100 µm spacing but also
normal tissue damages. They concluded that, for the parameters used, the 200 µm
spacing was the best compromise between curing the tumor and sparing the healthy
tissue. One limitation of this study was the fact that the peak dose (around 615 Gy)
was not modified between the 200 µm and the 100 µm wide beams configurations
thus introducing a valley dose almost three times higher in the case of the 100 µm
wide microbeams than in the case of the 200 µm wide microbeams which explains the
normal tissue damages observed.
Microbeams width
Serduc et al. [2009] irradiated both healthy rats and rats implanted with 9L gliosar-
coma for different microbeam widths (25, 50 and 75 µm) and a constant beam spacing
(211 µm). The peak doses were calculated in order to produce the same valley dose
(18 Gy) for each configuration.The 50 µm microbeam width was found as the best
compromise between tumor control and normal tissue toxicity. More recently Griffin
et al. [2012] investigated the effect of the beam width (50 and 500 µm), beam spacing
(200 and 2,000 µm) and peak dose (75 or 150 Gy at 0.5 mm depth) on the tumor con-
trol in the case of mouse mammary carcinomas. The authors obtained the best tumor
control in the case of the highest peak dose and smallest beam width and spacing. For
this configuration, the valley dose was equal to 7.5 Gy at 10 mm depth. In the case of
a human U251 glioma cells, Uyama et al. [2011] also observed a better tumor growth
suppression with narrow microbeams (20 µm width, 100 µm c-t-c) rather than with
wide microbeams (100 µm width, 500 µm c-t-c).
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Results from the pre-clinical studies indicate that for a constant ratio between the
beam width and the beam spacing, the smallest beam width and spacing is more ef-
ficient in tumor control probability. Additionally, in MRT, narrow microbeams are
desirable because a larger dose would be tolerated by the normal tissue and a higher
peak dose could be delivered to the tumor. Reducing the microbeam spacing would
have the advantage of delivering a higher valley dose and increase the direct killing of
the tumour cells but such dose prescriptions are limited by the normal tissue tolerance.
The valley width thus plays an important role: enlarging the valley width would lower
the valley dose and increase the proportion of healthy tissue receiving low doses which
is expected to be instrumental for the repair mechanisms.
Multiple irradiation ports
In order to enhance the dose delivered in the tumor while ensuring normal tissue spar-
ing, irradiation configurations using multiple irradiation ports are currently explored.
The cross-firing technique consists in the delivery of two perpendicular arrays of mi-
crobeams. Usually, this method is performed using two orthogonal irradiation ports
as displayed in Figure 1.7 in order to maximise the valley dose in the tumor volume
while ensuring the normal tissue sparing in front and behind the target volume.
Figure 1.7: Cross-firing technique. Reprinted from [Serduc et al., 2008a].
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The cross-fire irradiation techniques have been applied since the early stage of
MRT pre-clinical work. In 1998, Laissue et al. treated 9L gliosarcoma bearing rats
with either a single array of microbeams or two orthogonal arrays of microbeams.
Both configurations were delivering a peak dose of 625 Gy and the highest survival
time was obtained for the rats treated with the two orthogonal arrays (median survival
time of 139 days against 24 days in the case of the single array)[Laissue et al., 1998].
Dilmanian et al. [2003] compared the efficiency of MRT cross-fire irradiation, MRT uni-
directional irradiation and broadbeam irradiation (delivered in a single fraction) for the
treatment of murine EMT-6 mammary carcinoma implanted in the hind leg of mice.
When compared to the MRT uni-directional irradiation, the cross-fire technique gave
the best compromise between tumor control and toxicity. Their results also suggested
a higher therapeutic index of the cross-fire technique than the broadbeam irradiation.
Miura et al. [2006] evaluated the efficiency of the cross-firing MRT technique to treat
aggresive murine SCCVII squamous cell carcinomas implanted in mouse leg. A better
palliation of the carcinoma was achieved when using MRT rather than a broadbeam
irradiation performed with a 100 kVp X-ray beam. Since then, the MRT cross-fire
technique has been used in many pre-clinical studies [Bouchet et al., 2012, 2013, 2010;
Le Duc et al., 2011; Schültke et al., 2008; Serduc et al., 2009].
The interspersed geometry is another irradiation technique using two arrays of
microbeams in such way that the spacing between the microbeams can be divided by
a factor of 2 in the tumor (see Figure 1.8). The aim here is to keep a low valley dose
in the normal tissue surrounding the tumor while increasing it in the tumor in order
to enhance the toxicity [Bräuer-Krisch et al., 2005b].
Finally, Serduc et al. [2010b] developed another irradiation modality where 4 mi-
crobeam arrays, each composed of 52 µm wide microbeam spaced 200 µm c-t-c, are
interlaced with a 45◦ angle in order to deliver a homogeneous dose distribution in a
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Figure 1.8: Illustration of the interspersed irradiation technique. Reprinted from
[Bräuer-Krisch et al., 2005b].
target volume (see Figure 1.9).
Figure 1.9: Interlaced irradiation technique from Serduc et al. [2010a]. (A-C) Four ar-
rays of microbeams are interlaced in order to create a region where the dose deposition
is homogeneous. (D) Gafchromic film exposed under interlaced irradiation geometry.
The red line represents the region where the dose is homogeneous and the black line, a
region that has only been exposed to one array of microbeams. (E) Comparison of the
dose profile obtained either with an unidirectional array of microbeams (black line) or
with the interlaced geometry (red line).
The development of new irradiation geometries has optimised the dose delivery
and has contributed to increase the median survival times of tumor bearing animals.
Another way to enhance the MRT therapeutic effect is to couple the technique with
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adjuvant therapies.
Combination of MRT with adjuvant therapies
One of the first combinations of MRT with an adjuvant therapy was performed by
Smilowitz et al. [2006] who coupled unidirectional MRT irradiation with gene-mediated
immunoprophylaxis. In addition to the MRT treatment, 9L gliosarcoma bearing rats
received successive subcoutaneous inoculations of radiation-disabled 9L gliosarcoma
cells transfected with the GMCSF gene (Granulocyte Macrophage Colony Stimulating
Factor). One year after therapy, 44% of the rats that received the treatment coupling
MRT and gene-mediated immunoprophylaxis were still alive compared to 20% for
those that only received the MRT treatement. In 2008, Schültke et al. used the MRT
cross-fire technique to treat rats that have been implanted with F98 or C6 gliomas.
MRT treatment was delivered alone or coupled with buthionine-SR-sulfoximine (BSO)
in order to increase the radiosensitivity of the tumor. When compared to MRT treat-
ment delivered alone, an increase in survival time was obtained for treatment coupling
MRT to BSO injections for the F98 gliomas. However, the administration of BSO was
followed by memory dysfunctions which improved with time for the tumor bearing
animals. The memory dysfunction was much less for the animals that only under-
took MRT irradiation [Schültke et al., 2008]. Bouchet et al. [2012] coupled the MRT
cross-fire irradiation with the JAI-51 chemotherapeutic agent for the treatment of
9L gliosarcoma bearing rats. The JAI-51 chemotherapeutic agent was either admin-
istrated alone or just after the MRT irradiation. The injection was repeated three
times per week for a maximum time of 20 weeks after the irradiation. The JAI-51
chemotherapeutic agent delivered alone did not increase the rats survival when com-
pared to the control rats. The median survival time with MRT delivered alone was of
35.5 days after tumor implantation and reached 48 days in the case of MRT coupled
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with the injections of the chemotherapy agent. This can be explained by the fact that
the 9L glioma has a high permeability limiting the perfusion of the JAI-51 inside the
tumor. Delivery of the MRT irradiation previous the JAI-51 injections, contributed to
the decrease of the tumor permeability which then enabled the chemotherapy agent
to perfuse the tumor resulting in the higher therapeutic effect observed.
Régnard et al. [2008a] demonstrated the potential advantage of combining the
MRT treatment with intracranial injections of gadolinium (Gd). Indeed, due to its
high atomic number (Z = 64), the Gd is used as a dose enhancer. Rats bearing 9L
glioma have thus been treated either with MRT or with MRT combined to intracranial
injection of Gd. For the rats receiving only the MRT treatment, an increase lifespan1
of 60.5% was observed when compared to untreated tumor bearing rats. In the case of
the rats that received the MRT treatment combined to intracranial Gd injections the
increase life span reached 131.6%. The principle of using a high Z element to enhance
the dose deposition in the tumor has been improved by the use of nanoparticles.
Indeed, nanoparticles are large enough to prevent their extravasation from normal
vessel and small enough to passively accumulate in the tumor. Gd nanoparticles
intravenous injections have been coupled to MRT irradiation (delivered either 5 or
20 minutes after the injection) using the cross-fire geometry for the treatment 9L
gliosarcoma implanted in rats [Le Duc et al., 2011]. For animals being irradiated 20
minutes after the Gd nanoparticles injection, the median survival time reached 90 days
whereas it is was of 34 days for MRT performed 5 minutes after the injection, 47 days
for the MRT treatment performed alone and of 19 days for the untreated animals. The
survival curves obtained for this study are displayed in Figure 1.10.
Another advantage of high Z material is that they can be clearly distinguished from
tissue matter on X-ray or MRI imaging modalities which could lead to the possibility
1Relative difference of the median survival times obtained for the treated and untreated group
(relative to the untreated group)
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Figure 1.10: Survival curves obtained for untreated rats (black dashed), rats treated
only with MRT (blue), rats irradiated with MRT 5 minutes (red) and 20 minutes
(green) after injection of Gd-based nanoparticles. Extrated from [Le Duc et al., 2011].
of performing image guided MRT in the future.
Pre-clinical trials showed that the MRT therapeutic effect could be enhanced using
different irradiations geometries or the concomitant use of drugs. However the mecan-
isms that lead to the normal tissue sparing and of the differential effect between the
normal and tumor tissue are still not fully understood and are the purpose of ongoing
pre-clinical studies.
Normal tissue tolerance
Several authors made the hypothesis that the extraordinary radioresistance of the
healthy tissue to MRT irradiation was due to a rapid repair of the microscopic lesions
enabled by the migration of the minimally irradiated cells from the valley regions to
the peak regions [Blattmann et al., 2005; Laissue et al., 1998; Slatkin et al., 1995,
1992; Zeman et al., 1961]. Blattmann et al. [2005] suggested that the rapid repair of
the irradiated normal tissue could also be attributable to two other mechanisms: an
increase in the neighboring cells surface (endothelial stitching) or to a local settlement
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of circulating stem cells. They also mentioned that the fast repair process could be a
combination of the three different mechanisms.
In 2006, a study of the early effect of the microbeam irradiation on the vascular
permeability and volume was carried out on normal mice brain [Serduc et al., 2006].
For skin entrance doses of either 312 or 1,000 Gy, the authors did not observe any
blood volume nor vascular density change in the normal tissue. In another study
carried under the same conditions, the presence of a minor and transient cellular
edema in the case of the 312 Gy exposure was observed one day after irradiation.
In the case of the 1,000 Gy exposure, the results suggested the presence of cellular
and vasogenic edema. Both edema resorbed within a week after exposure which may
attest of the normal tissue sparing in MRT [Serduc et al., 2008b]. Van Der Sanden
et al. [2010] irradiated the left hind leg of normal mice with an array of 26 microbeams
(50 µm width spaced by 400 µm) and investigated the influence of MRT irradiation on
arteries for two different peak doses (312 and 2,000 Gy). Despite a slight modification
of the walls of the arteries in the path of the microbeams, no oclusion was observed
nor damage in the valley region.
The preservation of the vascular network might explain the extraordinary radiore-
sistance of the normal tissue to MRT irradiation. However, as mentioned before,
normal brain sparing is only ensured for a valley dose remaining below the normal
tissue tolerance Dilmanian et al. [2002].
MRT differential effect and mechanisms
In 2011, Sabatasso et al. [2011] highlighted the differential effect that exists between the
mature and immature vascular network. They studied the response of chick chorioal-
lantoic membrane (CAM) to a single array of microbeams (25 µm width, 200 µm
c-t-c distance) at different stages of maturation and observed that more damage was
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induced in the case of the immature CAM. Consequently, the results implied that
an immature vasculature, like the tumor one, would be less capable of repairing the
lesions induced by MRT irradiation than a mature vasculature like the normal tissue.
In order to understand the mecanisms responsible for the differential effect of MRT
between the tumor and the normal tissue, Serduc et al. [2008a] irradiated nude mice
brain implanted with 9L gliosarcoma with two orthogonal arrays each made up of
28 microbeams (25 µm width, 211 µm spacing and 500 Gy peak entrance dose) and
studied the short-term response of the tumor and its vasculature. As the authors
did not observed significant change in both the apparent diffusion coefficient and in
the blood volume on the magnetic resonance images, they stated that the increased
survival time observed for the MRT irradiated rats bearing 9L gliomas was mostly due
to a cytoreduction (i.e. a reduction of the tumor volume) rather than an early effect
of the radiations on the blood vessels . Bouchet et al. [2010] investigated the effect of
MRT on the normal and tumor tissue. Rats implanted with the 9L tumor model in
the brain were irradiated using two orthogonal arrays of microbeams intersecting in
the tumor region. In the tumor, a loss of endothelial cells was observed and followed
by a decrease of the blood volume and vessel diameter. No damage was reported
in the normal tissue thus demonstrating the differential effect of the cross-fire MRT
irradiation geometry on tumor and normal tissue. In 2013, Bouchet et al. studied the
effect of cross-fire MRT irradiation on the oxygenation of 9L gliosarcomas implanted
in rats brain. A significant decrease of oxygenation was observed in the tumor leading
to hypoxia. On the contrary, the normal tissue exposed to MRT remained perfused
enough to avoid hypoxia [Bouchet et al., 2013].
In 2014, Bouchet et al. tested the expression of 28,000 transcripts before and after
unidirectional MRT irradiation. In the tumor, the authors observed changes in the
expression of some genes after MRT which were either in favor or disfavor of the
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tumor palliation [Bouchet et al., 2014]. The identification of these genes could allow
the developement of molecular therapy enhancing or reducing these genes expression
in order to further improve the MRT therapeutic index.
Pre-clinical studies have demonstrated the existance of a differential effect in MRT
between the normal and tumor tissue vasculature and pointed out the influence of
vascular network maturity on the tissue damage. However, differential effects have
also been observed at the cellular and molecular level and could partially explain the
mechanisms responsible for the MRT differential effect.
1.3 Dosimetry
1.3.1 Fundamentals
Reference dosimetry consists in the determination of the absorbed dose to water un-
der reference conditions. The notion of absorbed dose has been introduced in order
to predict the effect of radiations on tissue. The absorbed dose corresponds to the
quantity of energy deposited by charged particles per unit of mass:
D =
∆E
∆m
(1.1)
The dose SI unit is the gray (Gy) which corresponds to one joule per kilogram (J.kg−1).
As photons are uncharged particles, a photon source is an indirect radiation source.
The dose is actually deposited by secondary electrons produced by the interaction of
the primary photons with the matter. Once those electrons are created they will lose
their energy via inelastic collisions and contribute to the dose. There are three main
ways for the primary photons to interact with matter: photoelectric effect, Compton
scattering and pair production.
For the photoelectric effect, the incoming photon transfers all its energy to an
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electron within the medium of interest. In the case of electrons bound to the atoms
making up the medium, if the transferred energy is higher than the binding energy of
the electron, the electron is ejected from the bound shell and becomes a photo-electron
with kinetic energy (Ee−) equal to the energy transfered by the photon (hν, with h the
Planck’s constant and ν the frequency of electromagnetic radiation) minus the binding
energy (Eb) (see equation 1.2).
Ee− = hν − Eb (1.2)
In the case of Compton scattering, the incoming photon is scattered from its origi-
nal direction by an angle θ and transfers part of its energy to the electron. The electron
thus acquires kinetic energy and is referred to as a recoil electron. The energy of the
deflected photon is expressed by:
hν ′ =
hν
1 + hν
m0c2
(1− cos θ)
(1.3)
with m0c
2 the mass energy of an electron at rest (0.511 MeV).
The pair production process occurs only if the incoming photon energy is higher
than twice the rest mass of an electron (1.02 MeV). The photon energy is used to
produce an electron-positron pair and the energy is equally shared between the two
created particles. The positron will eventually go through an annihilation process with
another electron. This will result in the creation of two annihilation photons emitted
in two opposite directions (at 180◦ from each other) if the positron is at rest when it
annihilates.
The predominance of one interaction process to another depends on the energy
of the incoming photon and on the material atomic number (Z) (see Figure 1.11).
The photoelectric effect is predominant for low energies and is highly dependent of
the Z number of the material: the probability of observing the photoelectric effect is
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Figure 1.11: Photon interactions probability as a function of the photon energy and
the material atomic number.
proportional to ZN where N is between 4 and 5. For the Compton scattering, this
probability is linear with Z. For the pair production interaction the threshold energy
of the incoming photon is 1.02 MeV and the probability increases with Z2 and the
photon energy.
Due to the photons energy range encountered in MRT, the photons interact with
matter primarily through the photoelectric effect and Compton effect.
1.3.2 Dosimetry of homogeneous synchrotron beam dedicated
to medical applications
Reference dosimetry is part of the QA to be performed in radiotherapy in order to
ensure a correct dose delivery. Instructions are provided by the IAEA TRS 398 protocol
[IAEA, 2000] for different sources and beam qualities. However there is currently no
code of practice available for radiation therapy modalities using synchrotron sources.
In 2011, Prezado et al. published a dosimetry protocol dedicated to Synchrotron
Stereotactic Radiation Therapy (SSRT) in the context of the upcoming clinical trials
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at the ESRF [Prezado et al., 2011a]. SSRT is an irradiation modality dedicated to
the treatment of brain tumors. The technique involves injection of an iodine contrast
agent in order to enhance the dose deposition in the tumor followed by a stereotactic
irradiation with a monochromatic synchrotron X-ray beam tuned to 80 keV [Adam
et al., 2008; Boudou et al., 2005]. The dosimetry protocol developed by Prezado
et al. remains as close as possible to the TRS 398 guidelines for medium energy X-
rays. However a few reference conditions had to be adapted to the specificities of the
synchrotron source. In SSRT, the beam dimensions at the patient stage are limited to
3 mm in height and 150 mm in width. In order to perform irradiation at a clinically
relevant height, the patient is scanned through the beam at a constant speed. Prezado
et al. demonstrated in their protocol the equivalence of the scanning technique to an
uniform irradiation field and showed that the dose measured by an ionisation chamber
(IC) centered into the irradiation field (as presented in Figure 1.12) was equal to:
D =
zbeam · Ḋ
vz
=
zbeam · Ḋscaled
I · vz
(1.4)
Where D is the measured absorbed dose (Gy), Ḋ the dose rate (Gy.s−1) , zbeam the
beam height (mm), v the scan speed (mm.s−1), I the current in the synchrotron storage
ring (SR) and Ḋscaled the dose rate scaled by the SR current (Gy.s
−1.mA−1). Ḋscaled
can then be deduced from the measured dose and allows the determination of the scan
speed to be used in order to deliver the correct dose during the irradiation. Indeed, as
the SR current is decaying at the ESRF, the scan speed needs to be adapted depending
on the desired dose and the current in the machine at the time of the irradiation.
As recommended by the TRS 398 code of pratice, the absolute dosimetry in SSRT
is performed using a cylindrical ionisation chamber (IC) (Semiflex 31010, PTW). Once
the uncertainties relative to the IC positioning, calibration factor and correction factors
are taken into account, the global uncertainty on the measured dose is as good as 2%
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Figure 1.12: Schematic illustration of the dosimetry configuration in SSRT. Extracted
from [Prezado et al., 2011a].
under the SSRT reference conditions.
At the ESRF, the synchrotron beam dimensions are more limited in MRT as they
can only reach a maximum of 2.5 mm in height and 41 mm in width. As in SSRT, a
scanning method is employed to reach larger field sizes and the dose given by equa-
tion 1.4 is measured with an IC. The Pinpoint 31014 (PTW) IC has been chosen as
reference dosimeter for MRT due to its smaller sensitive volume (0.015 cm3) intended
to minimize the saturation effect when performing measurements at very high dose
rates. Indeed the dose rate in MRT can reach 20 kGy.s−1 while the average dose
rate in SSRT is around 1 Gy.s−1. This is much higher than the dose rates encoun-
tered in conventional radiation therapy which remain below 2400 MU.min−1 (i.e. ∼24
Gy.min−1 depending on the monitor chambers calibration). In MRT, a significant lack
in collection efficiency is the main challenge to etablish an absolute dosimetry protocol
and to evaluate the uncertainty on the measured dose.
In order to determine the absolute dose rate at the Imaging and Medical Beamline
(IMBL) at the Australian Synchrotron, graphite calorimetry was performed in collabo-
ration with ARPANSA (Australian Radiation Protection And Nuclear Safety Agency)
[Harty et al., 2014]. Graphite calorimetry relies on the measurement of the tempera-
ture increase induced by the radiations which is directly proportional to the absorbed
dose. The ARPANSA graphite calorimeter consists of a core suspended by microbeads
inside a 150 × 150 mm2 piece of graphite (see Figure 1.13). The core consists in a
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disc of graphite including two thermistors. In order to thermally insulate the sys-
tem from ambiant temperature, the graphite assembly is surrounded by 35 mm of
polystyrene and thin aluminised Mylar sheet. Thermistors are calibrated in such a
way that when performing an irradiation, the change in the measured resistance can
be directly converted into a change in temperature. An example of the temperature
changes observed at IMBL after (a) one single or (b) multiple exposures of 10 sec is
displayed in Figure 1.14.
Figure 1.13: Schematic representation of the ARPANSA graphite calorimeter used for
the absolute dose measurements at IMBL. Extracted from [Harty et al., 2014].
The change in temperature ∆T is then converted into dose rate Ḋ using the following
equation:
Ḋ =
∆Tcg
t
· Acore
Abeam
(1.5)
where cg is the heat capacity of the graphite core, t the irradiation time, Abeam the
cross-sectional area of the beam, and Acore the cross-sectional area of the core. Con-
version factors calculated by Monte Carlo (MC) simulations are then applied in order
to transpose the absorbed dose in the graphite into absorbed dose to water. Measure-
ments were performed at three different depths, two filtering conditions and compared
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Figure 1.14: Example on the temperature change observed after (a) one single or (b)
multiple exposure of 10 sec. Extracted from [Harty et al., 2014].
to the results obtained with a free-air chamber. Measurements performed in depths
agreed within 1% while those performed at the surface were within an agreement of
3%. However, these measurements were performed at dose rates much lower (maxi-
mum of 50 Gy.s−1) than those commonly used in MRT. This was a necessary condition
in order to avoid the saturation of the free-air chamber. Experiment under MRT dose
rate conditions are thus foreseen in the near future at IMBL.
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1.3.3 Microbeam dosimetry
In order to switch from the broadbeam to the microbeams irradiation configuration,
a multislit collimator (MSC) is inserted in the synchrotron beam path. Figure 1.15
displays an example of a lateral dose profile at 3 mm depth in water (obtained by
the superposition of a single microbeam calculated by Monte Carlo (MC) simulation
[Bräuer-Krisch et al., 2005a]).
Figure 1.15: Lateral dose profile of an array of 51 parallel 50 µm wide X-ray mi-
crobeams for a centre-to-centre distance of 400 µm obtained by PSI GEANT MC
simulation at 3 mm depth in a water phantom. Reproduced from [Bräuer-Krisch
et al., 2005a].
To perform an MRT irradiation, the speed of the goniometer is adjusted in order to
achieve the desired peak entrance dose using equation 1.6 bellow:
vz =
zbeam
D3mm
· Ḋscaled · I · f (1.6)
vz is the scan speed of the goniometer, zbeam the beam height, D3mm the desired
peak entrance dose at 3 mm depth, Ḋscaled the dose rate scaled to the beam current
(Gy.mA−1.s−1) obtained from reference dosimetry and I the current in the machine
at the time of the irradiation. f is the output factor that scales the measured dose
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rate scaled to the beam current to the desired peak entrance dose. This factor takes
into account the microbeam width, the field size, the depth and the contribution of
the scattering coming laterally from the peaks depending of the c-t-c distance.
In order to predict the peak, valley and PVDR for a MRT irradiation, MC simu-
lations are required and need to be experimentally benchmarked.
Monte Carlo based microbeam dosimetry studies
Many authors have investigated the dose distribution in MRT using MC simulation
methods [Orion et al., 2000; Siegbahn et al., 2005, 2006; Slatkin et al., 1992; Stepanek
et al., 2000]. Different codes have been investigated such as Geant4 [Bartzsch et al.,
2014; Cornelius et al., 2014; Stepanek et al., 2000], EGS4 [De Felici et al., 2007; Orion
et al., 2000], EGS5 [Hugtenburg et al., 2010] and PENELOPE [Mart́ınez-Rovira et al.,
2012; Siegbahn et al., 2005, 2006]. De Felici et al. [2008] compared five MC codes
(EGS4, PENELOPE, GEANT4, EGSnrc, and MCNPX) under identical irradiation
conditions and scoring geometries. The authors stated that for simple geometries and
material composition, the results given by the different codes agreed together within ±
20% . The differences between the different codes were observed in the regions outside
the primary beam and were therefore attributed to the electron transport modeling
used in the MC code. The MCNPX code showed the highest disagreement.
Siegbahn et al. [2006] showed that the deposited dose in MRT was mainly coming
from the Compton scattering and that the valley dose was due to the lower energy
photons scattered out of the primary beams. Consequently when increasing the c-t-c
distance, the PVDR increases as the valley dose becomes lower due to a less impor-
tant contribution of the scattered photons. From their MC calculations, Siegbahn
et al. showed that the valley dose was produced by two different types of scattering.
Nearby the microbeam, the main contribution to the valley dose is due to the photo-
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electrons scattered from the primary microbeam field while at larger distances from
the microbeam, the valley dose is mainly coming from Compton scattered photons
and electrons (see Figure 1.16.)
Figure 1.16: Effect of different interaction
processes on the lateral dose deposition
of a 1 cm × 25 µm microbeam (obtained
by MC calculation, by scoring the energy
deposition between 7 and 8 cm depth).
Diagram extracted from Siegbahn et al.
[2006].
Figure 1.17: Peak and valley doses vari-
ation with depth in the center of a pla-
nar microbeam array for two different
microbeam spacings (100 and 200 µm)
and calculated for a 3 × 3 cm2 array
of 25 µm wide microbeams. Reprinted
from [Siegbahn et al., 2006]
Siegbahn et al. [2006] also simulated the variation of peak and valley doses with
depth in a water phantom for a 3 × 3 cm2 array of 25 µm wide microbeams and two
different microbeam spacings (100 and 200 µm). The results (presented in Figure 1.17)
are normalised to the maximum peak dose for the 100 µm spacing. One can observe
a dose buildup in the valley which is due to the scattered photons. In the case of the
peak dose, the build-up is reached before 1 mm depth and is not visible on the graph.
Finally, Siegbahn et al. demonstrated the relevance of Output Factors (OF) as the
study showed a dose decrease of 14% within a single 25 µm wide microbeam compared
to a 75 µm wide microbeam (dose calculated within a 1 cm slice located at 7-8 cm
depth in water for a 1 cm high beam).
The ESRF’s ID17 biomedical beamline has been modeled by Mart́ınez-Rovira et al.
[2012] using the PENELOPE MC code and includes the current intrumentation for
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the pre-clinical beam conditions from the wiggler source down to the sample to be
irradiated. The state variables of the simulated photons are stored into a phase-space
file (PSF) just before the MSC location. The PSF was generated for three different
field sizes (1 cm × 1 cm, 2 cm × 2 cm and 3 cm × 3 cm) and used as input to
generate the photon beam model. PVDRs have then been calculated for these three
field sizes and for the default microbeam width and spacing on ID17 (50 µm width,
400 µm c-t-c). The PSF produced by Mart́ınez-Rovira et al. [2012] was the basis for
the development of the MRT treatment planning system (TPS).
The TPS is a software that takes as an input the patient medical images (obtained
from computed tomography, MRI or positron emission tomography) and simulates the
treatment using radiation transport simulations. TPS thus allows the visualisation of
the irradiation geometry and the relative dose deposition. TPS using convolution-
based algorithms provides much faster computation times than TPS based on MC
simulations. For conventional radiation therapy using medium energy X-rays, TPS
based on convolution algorithms are usually not able to provide a sufficient accuracy.
Indeed, in the case of medium energy photons, a greater focus needs to be dedicated to
the photolectric dose deposition and to the scattered photons energy transport. In or-
der to meet these requirements in the specific case of MRT, Bartzsch and Oelfke [2013]
proposed a new method based on analytical dose kernels. The accuracy obtained on
the dose calculation using this approach was comparable to MC simulations. This
algorithm was implanted in the MRT TPS and can provide a treatment plan within a
few minutes while sereval days are required when running MC simulations. Bartzsch
et al. [2014] then developed a simplified version of the MC code allowing faster dose
calculations and more accurate dose determination. The main parameters influenc-
ing the dose distribution in MRT were first identified by analysing the information
of the phase space developed by Mart́ınez-Rovira et al. [2012]. They found that the
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important features to consider were the flux profile across the broadbeam, the in-
sufficient absorption of the MSC material, and the geometrical change of the beam
width due to inclined incidence outside the beam axis. Thus they developed a source
model of parallel microbeams and included the appropriate corrections required for
the features identified. The PVDRs obtained with the so-called semiadjoint MC code
at different depths and for two different field sizes were compared to those published
by Mart́ınez-Rovira et al. [2012] and a good agreement was observed (see Figure 1.18).
Figure 1.18: PVDRs with depth calculated with the adjoint MC simulation using
the model developed by Bartzsch et al. [2014] (solid line) for a 20 × 20 and a 30
× 30 mm2 field in water compared to the results obtained by Mart́ınez-Rovira et al.
[2012] with Gafchromic® film measurements (circles) and MC simulations (dashed
line). Reproduced from [Bartzsch et al., 2014].
As one can see in Figure 1.18, the PVDR first decreases rapidly with depth. This is
due the build-up observed in the valley dose. Once the valley dose starts decreasing, the
PVDR becomes almost flat since the valley dose decreases at almost the same rate than
the peak dose. Bartzsch et al. [2014] also investigated the effect of the synchrotrom
radiation polarisation on the delivered dose for broadbeam geometry. They showed
that the polarisation influence was the most important in the off-field region where
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they observed dose differences up to 40%. Nonetheless, the beam polarisation does
not have an important impact for MRT dose calculations and could even be neglected
for PVDRs and valley dose calculations. Cornelius et al. [2014] developed a GEANT4
MC model of the ID17 beamline in order to be used for an independent verification of
the TPS. Moreover, the code is adapted for the dose calculations under the veterinary
clinical trials conditions. The veterinary conditions differ from the pre-clinical condi-
tions by the introduction of a Krypton gas filter and additional monitoring chambers
(the instrumentation relative to pre-clinical and veterinary beam configurations will
be detailed in section 2.2). In this paper Cornelius et al. also assessed the issue of the
synchrotron beam polarisation. They showed that ignoring the resulting asymmetry
in the out-of-field dose profiles could lead to errors of up to 150% and therefore stated
that the effect of beam polarisation on out of field doses should be included in the
TPS.
Both Bartzsch et al. [2014] and Cornelius et al. [2014] mentioned the lack of more
precise experimental dosimetry data. Bartzsch et al. stated that due to the limitations
of current experimental techniques it was still not feasible to conclude on the influence
of the possible photon scattering from the inside surfaces of the MSC on the dose dis-
tribution nor on the possible total external reflection that could be induced by photons
with an incidence angle below the critical angle. Cornelius et al. recommended more
precise dosimetry system coupled to refining theoritical models of Compton scattering
in order to reach a very high accuracy in the out-of-field dose calculations.
Exprimental dosimetry
The experimental dosimetry of the microbeams is a challenging task given the require-
ments that the detector has to satisfy. The detectors should ideally meet the following
criteria:
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• Micrometer-scale spatial resolution
• Ability to withstand dose rates up to 20 kGy.s−1
• Large dynamic range in order to measure both peak and valley doses with the
same accuracy
• Waterproof properties for QA in water
• Real time readout
• Made of water equivalent material
Solid state detectors and in particular MOSFET (metaloxide semiconductor field-
effect transistor) were among the first devices investigated for microbeam dosimetry.
Indeed MOSFET detectors provide a high spatial resolution because of their very
small radiation sensitive area defined by the thickness of the oxide film. The ability
of MOSFETs to scan a 200 µm wide microbeam was first demonstrated by Rosenfeld
et al. [1999] during measurements performed at NSLS, BNL. When used in edge-on, the
beam profile obtained with the MOSFET detector was similar to the one obtained with
Gafchromic® films [Kaplan et al., 2000; Rosenfeld et al., 1999]. The spatial resolution
of the MOSFET was estimated to be 1 µm. Orion et al. [2000] compared the relative
lateral dose fall-off of a single microbeam measured with a MOSFET detector at BNL
to MC simulations and the agreement observed was a very encouraging result at the
time of the study (see Figure 1.19).
Vertical profiles of a 30 µm wide microbeam were acquired at the ESRF using the
MOSFET detector [Rosenfeld et al., 2001]. The FHWM of the acquired profiles was
actually of 35 µm but the analysis of the measurements revealed a misalignment of
5.7◦. The MOSFET detector has also been used for the measurement of the absolute
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Figure 1.19: Microbeam profile obtained experimentally with the MOSFET compared
to the absorbed dose simulated using MC calculations. The profiles are compared
after normalizing the results to the maximal dose point. Reprinted from [Orion et al.,
2000].
peak and valley doses [Bräuer-Krisch et al., 2003]. The experimental results obtained
were approximately 20% less than the MC predicted values.
In 2009, Siegbahn et al. reported PVDRs obtained by MC simulations up to 50%
higher than the experimental PVDR measured with a MOSFET detector. These dis-
crepancies were mainly attributed to the energy dependence of the detector [Siegbahn
et al., 2009]. The MOSFET significant energy dependence was also highlighted in the
work of Kron et al. [1998], De Felici et al. [2005] and Cheung et al. [2009]. Moreover,
Rosenfeld et al. [2005] observed a lateral distortion in the microbeam profile measured
with the MOSFET detector. This distortion was attributed to a lateral dose enhance-
ment induced by the interaction of the microbeam with substrate adjacent to one side
of the sensitive volume. Finally the major drawback of the MOSFET detector relies on
its low tolerance to high dose rates. Indeed, Siegbahn et al. [2009] observed that after
an approximate accumulated absorbed dose of 1000 Gy, the MOSFET was saturated
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and had to be replaced. This was a major limitation as it prevents the detector from
being used under the MRT standard operation mode at the ESRF.
PVDR have also been measured at the ESRF using 2D LiF:Mg,Cu,P (MCP-N)-
based thermoluminescence (TL) detectors. Three different beam widths (25, 50 and
75 µm) and two c-t-c distances (200 and 400 µm) were considered. The measured
PVDRs were between 11% and 17% smaller than MC predicted values [Ptaszkiewicz
et al., 2008].
Very high resolution measurements have been performed at the ESRF using Fluo-
rescence Nuclear Track Detectors based on Al2O3:C,Mg single crystals detectors [Bartz
et al., 2011]. Microbeams profiles have been acquired for peak doses of 3, 10, 30, 50
and 100 Gy. For peak doses above 50 Gy, the detector was saturated and the dose was
under-estimated. The authors also observed an underestimation of the measured peak
dose at 3 and 10 Gy. This was attributed to the combined uncertainty relative to the
background substraction and the fluctuation of the detector sensitivity. One major
advantage of this detector is that it allows 3D representation of the dose as shown in
Figure 1.20. FNTDs could be an interesting tool for the TPS benchmarking once the
uncertainties of measurement could be reduced to 5%.
Gafchromic® films currently are the most widely used detectors for microbeam
dosimetry in MRT. Indeed, these detectors have a high spatial resolution and do not
require the intervention of an external lab or company: storage, calibration and reading
can be realised on the beamline. Moreover, Gafchromic® films dedicated to high dose
measurements have a dynamic range large enough to obtain the calibration curve
for MRT applications (i.e. optical density of films as a function of delivered dose).
Indeed, HD-810 and HD-V2 films from ISP (Nuclear Associates) are usually used over
a dose range from approximately 10 to 400 Gy and from 10 Gy to 1.0 kGy respectively.
Gafchromic® film have thus been used in numerous studies for the determination of the
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Figure 1.20: 3D distribution of fluorescence from an FNTD irradiated with 10 Gy
using an array of microbeams. Reprinted from Bartz et al. [2011].
peak dose, valley dose and PVDRs [Bartzsch et al., 2015; Bräuer-Krisch et al., 2009b;
Crosbie et al., 2008; Mart́ınez-Rovira et al., 2012; Nariyama et al., 2009]. However,
Gafchromic® films dynamic range does not allow to read both peak and valley dose
on the same film; either the peak dose saturates the films or the valley dose is too low
to be read on Gafchromic® films dedicated to high doses measurements. Therefore,
for MRT applications, it is recommended to irradiate two films separately: one for the
peak dose and the other one for the valley dose determination in order to remain in
the most linear range of the calibration films. To measure the valley dose, the user can
either use films dedicated to a lower dose range (EBT films for example) or increase
the peak dose by a known factor in order to be able to observe the valley dose on a
Gafchromic® film dedicated to high dose measurements (such as HD-810 or HD-V2).
In the study from Crosbie et al. [2008], the authors chose to use films of different
sensitivity to measure either peak or valley dose (HD-810 or EBT respectively). An
example of a HD-810 films irradiated with an array of 5 microbeams as well as the cor-
responding relative dose profile are displayed in Figure 1.21. Crosbie et al. compared
the experimental PVDRs values obtained to MC results published by different authors
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[Bräuer-Krisch et al., 2005b; De Felici et al., 2005; Siegbahn et al., 2006; Slatkin et al.,
1992; Stepanek et al., 2000] who considered the same microbeam width and spacing
(25 µm and 200 µm respectively). The PVDRs values reported by Crosbie et al. were
higher than those obtained in the different MC studies. Indeed, Crosbie et al. obtained
a maximum PVDR of 144 ± 29% at 1 mm depth in water and a minimum PVDR of
60 ± 29% at 50 mm depth while MC studies from Slatkin et al. , Stepanek et al.,
De Felici et al., and Siegbahn et al. report PVDRs closer to 30. The discrepancies
observed were attributed to the fact that, in the MC studies considered, the full beam
line instrumentation was not included in the simulations especially the MSC.
Figure 1.21: Top: scan of a HD-810 film irradiated with a 5 microbeam array and an
entrance peak dose of 160 Gy. Bottom: corresponding relative dose profile. Extracted
from [Crosbie et al., 2008]
In 2009, Nariyama et al. [2009] used HD-810 Gafchromic® films and obtained a
good agreement of the measured peak dose with MC simulation while the measured
valley was higher than therotical values. Bräuer-Krisch et al. [2009b] compared the
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valley dose measured using HD-810 Gafchromic® films and obtained a good agreement
with the MC simulations within the uncertainty bars.
PVDRs values obtained from the complete simulation of the ID17 beamline per-
formed by Mart́ınez-Rovira et al. [2012] were compared to HD-810 Gafchromic® mea-
surements and a good agreement was obtained.
Bartzsch et al. [2015] investigated the feasibility of performing radiochromic film
dosimetry using a microscope to validate peak and valley doses in MRT. In this study,
the authors compare the performance of HD-810 and HD-V2 films. Indeed, until now
the HD-810 films exhibited the best performance in terms of sensitivity and resolution
in MRT but these films are not available any more and have been substituted by HD-
V2 films. Peak and valley doses measurements were performed at the ESRF using both
HD-810 and HD-V2 films in a solid water phantom for a 20×20 mm2 microbeam field.
The microbeam width and the c-t-c distance were 50 µm and 400 µm respectively.
Results are presented in Figure 1.22 and are compared to MC calculations.
The peak and valley doses measured with the films agree with MC calculations
within the uncertainties. Bartzsch et al. reported that the peak dose was deter-
mined with an accuracy better than 5% and the valley dose with an accuracy between
10% and 15%. The uncertainties are related to the statistical noise, the film inho-
mogeneities, and the calibration errors. Despite the good agreement obtained with
the MC calculations, a systematic difference between HD-V2 and HD-810 films was
observed: valley doses were higher on HD-810 films and peak doses were higher on
HD-V2 films. This difference was attributed to the different film sensitivities at low
photon energies. Indeed, the performance evaluation of the films showed that the HD-
810 films exhibit a higher energy dependence at low photon energies than the HD-V2.
However, a higher statistical noise was observed in the case of the HD-V2 films. The
authors concluded that both films could be used for dosimetry in MRT.
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Figure 1.22: A. MRT dose profile obtained using Gafchromic® films. In order to
remain within the films dynamic range a combination of two measurements was used:
the peak regions were measured with a low peak entrance dose and the valley regions
with a high peak entrance dose. B. Peak dose as a function of depth in the solid
water phantom. C. Valley dose as a function of depth in the solid water phantom. D.
Resulting PVDRs. Figures have been extracted from Bartzsch et al. [2015].
Gafchromic® films are an interesting tool for MRT applications but still exhibits
some limitations. As mentioned before, films dedicated to high dose measurements
have a logarithmic response with dose and a limited dynamic range that prevents the
reading of peak and valley signal on the same film. Moreover, according to a Task
Group report (TG55) by the American Association of Medical Physicists (AAPM) one
should wait between 24 to 48 hours after the exposure before reading the films. This
time is necessary for the polymerisation process to stabilise [Niroomand-Rad et al.,
1998] which makes impossible the dosimetry check before a patient treatment. Finally,
results obtained with Gafchromic® films have a significant uncertainty. Crosbie et al.
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[2008] reported an error of ± 29% on their experimental PVDR, Bräuer-Krisch et al.
[2009b] mentioned an error of 10% on the absolute dose measurement and the uncer-
tainty on the experimental PVDR obtained by Mart́ınez-Rovira et al. [2012] are up to
23% (at 2 σ). Finally, the sensitivity of Gafchromic® film is not homogeneous over
one sheet of film. Bräuer-Krisch et al. [2010b] reported that this effect affected the
dose reading by 8%. These uncertainties are higher than the maximum uncertainty
tolerated on the dose delivery to the planning target volume (PTV) during the treat-
ment (i.e. 5%) [Thwaites et al., 2005]. Gafchromic® films can therefore not be used
for reference dosimetry but remain one of the best candidate for relative dosimetry
and have been successfully used for the TPS benchmarking at the ESRF [Bartzsch,
2014; Bartzsch et al., 2015].
Bräuer-Krisch et al. [2010a] gave a general overview of the main experimental de-
vices investigated for MRT dosimetry and summarised detectors specifications in a
table. This table, reprinted from Bräuer-Krisch et al. [2010a] is displayed in Fig-
ure 1.23.
Other techniques have recently emerged and are currently investigated for absolute
and relative dosimetry in MRT such as 3D dosimetry using solid radiochromic plas-
tic PRESAGE® [Doran et al., 2010, 2013], thermoluminescent Ge-doped silica fibres
[Rahman et al., 2010], erasable samarium doped glass (based on the reduction of Sm3+
to Sm2+ with irradiation) [Martin et al., 2013; Morrell et al., 2014; Okada et al., 2011,
2014] and optical fibers [Belley et al., 2015; Sporea et al., 2014].
Ackerly et al. [2011] demonstrated the proof-of-concept of a dosimetry method
based on reference image topography (RIT) combined with particle image velocimetry.
This method consists in the mapping of the rate of change of the water refractive index
induced by the temperature increase from which the absolute dose deposition can be
determined. However, because of the thermal diffusion, the authors reported than in
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Figure 1.23: High resolution detectors tested for MRT applications. Pinpoint 31014
ionisation chamber and alanine are suitable for broadbeam dosimetry only. Repro-
duced from [Bräuer-Krisch et al., 2010a].
the case of MRT, the measured PVDR would be equal to 76% of its initial value.
Many detectors and techniques have been investigated for the task of microbeam
dosimetry. Some of them such as Gafchromic® films gave very satisfying results but
are not suitable for pre-treatment QA mostly due to their lack of real-time readout
and accuracy. The Centre for Medical Radiation Physics (CMRP, University of Wol-
longong, Australia) has developed the X-Tream dosimetry system based on a high
resolution silicon strip detector (SSD) especially for MRT applications. The charac-
teristics and properties of the detector will be given in Section 4.1.
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1.4 Thesis aims and objectives
MRT is a novel radiation therapy technique allowing the preservation of the normal
tissue surrounding the tumor because of the spatial fractionnation of the incoming
beam into an array of microbeams. Moreover, pre-clinical studies highlighted the
detrimental effect of MRT on the tumor tissue and demonstrated the presence of a
differential effect between normal and tumor tissue. MRT therapeutic index could
be further enhanced by optimising the irradiation parameters and coupling the MRT
treatment to adjuvant therapies.
As for conventional radiation therapy modalities, dosimetry QA is required for
MRT and this development is a mandatory step to reach the MRT clinical stage. QA
includes reference dosimetry in a reference broadbeam, check of the beam geometry and
shape, and accurate experimental determination of the peak and valley dose. Many
detectors have been investigated for this purpose and led to the conclusion that IC
and Gafchromic® films currently are the most accurate detectors for broadbeam and
microbeam dosimetry respectively. However, due to high dose rates encountered in
MRT, lack in collection efficiency has been observed from the IC leading to significant
uncertainties. Moreover, despite their great spatial resolution, Gafchromic® films do
not provide sufficient dynamic range to display both peak and valley doses, they are
passive detectors and still present too significant reading uncertainties to be used as
primary detectors. Within this context, our aim was to improve both broadbeam and
microbeam dosimetry and to propose the corresponding quality assurance procedures.
First, the Pinpoint IC lack of collection efficiency was addressed by the development
a new method based on the measurement of the IC response at different dose rates.
This method provides correction factors to be applied to Pinpoint IC and results in
the determination of the absolute dose with an accuracy better than ± 5%. In the
context of MRT veterinary clinical trials on ID17, an absorbed dose to water protocol
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has been established within this work.
The X-Tream dosimetry system developed by the Centre for Medical Radiation
Physics has been characterised at the ESRF. Particular attention was payed to the
evaluation of the radiation damage induced in the SSD as well as on the experimental
determination of the energy dependence of the device.
The ability of the SSD to perform rapid and efficient Quality Assurance test prior
MRT treatment has been evaluated. In-air measurements of 1D profiles of the syn-
chrotron beam used in MRT were performed in order to assess the alignment of the
MSC. The SSD was able to detect small misalignments of the MSC which resulted in
changes in the valley shape and on the peak and valley signals. The results obtained
by the SSD for the MSC alignment were in agreement with the monitoring IC cur-
rently used for this purpose on ID17. Moreover, an alignment procedure based on the
pink-beam imaging modality available at the ESRF has been developed in order to
align the SSD with the MRT beam within half an hour.
The SSD was used at the ESRF under reference conditions in order to determine
experimentally the PVDRs and scatter factors. For the first time, an active detector
was able to measure both valley and peak signals with the same accuracy leading to
a direct determination of the PVDRs in agreement with published results obtained
using Gafchromic® films and MC simulations.
Finally, preliminary tests have been performed at the Imaging and Medical Beam-
Line (IMBL) at the Australian Synchrotron (AS).
Chapter 2
Facilities
2.1 Synchrotrons
A synchrotron with an electron storage ring provides an extremely brilliant source of
X-rays generated by the change in direction of electrons moving nearly at a relativistic
speed. If a charged particle is deviated by a magnetic field from its uniform direction,
the particle will loose energy in form of electromagnetic radiation. In the case of
non-relativist electrons, the radiation field is displayed in an isotropic way around the
particle (Figure 2.1 (A)) but in the case of a relativist electron, the radiation field
will take the form of a cone and be emitted tangentially to the electron direction
(Figure 2.1 (B)).
Figure 2.1: Distribution of the radiation field emitted by a non-relativistic (A) and
relativistic electron (B) following a non-uniform direction.
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The work presented in this thesis took place at both the ID17 biomedical beamline
at the ESRF and at the Imaging and Medical BeamLine (IMBL) at the AS. Both
ESRF and AS are 3rd generation synchrotrons. At such facilities the electrons are
generated by a Linac (linear accelerator) by heating a cathode in an electron gun.
The electrons are then extracted by a strong electric field before being packed into
bunches and accelerated to 200 MeV at the ESRF and to 100 MeV at the AS.
In the booster synchrotron, electrons are accelerated to their final energy (6 GeV
at the ESRF and 3 GeV at the AS) before being injected into the storage ring. At the
ESRF, the booster is only used a few times a day to refill the storage ring. At the AS,
the continuous top-up operation mode is used in order to maintain a constant current
in the storage ring (200 ± 0.5 mA). This operation mode consists in a periodical
injection of small amounts of currents in the storage ring. The ESRF is planning to
switch to the top-up operation mode in the near future.
Figure 2.2: Main structures of a synchrotron facility.
In the storage ring electrons circulate under vacuum. Quadrupoles and sextupoles
are used as focusing magnets in order to maintain the electron beam orbit. Bending
magnets (BM) are dipole magnets that are used to force the circular trajectory of the
electrons. BMs can also be used to create synchrotron radiation (see Figure 2.3). 3rd
generation synchrotrons such as the ESRF and the AS, use insertion devices (ID) (see
Figure 2.4) on top of the BMs to produce synchrotron radiation of higher intensity.
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Figure 2.3: Representation of a bend-
ing magnet.
Figure 2.4: Representation of an inser-
tion device.
There are two types of IDs: the undulators and the wigglers. They consist of
two parallel arrays of magnets between which the electron beam is traversing and
periodically deflect the electrons direction. Depending on the ID used, the electron
beam will either undulate or wiggle and create a much more brilliant photon source
than the one created by a BM. The gap between the array of magnets (wiggler or
undulator gap) can be tuned to adjust both the energy spectrum and the fluence
of the created photon source. In the case of the ID17 beamline or the IMBL, the
photon source is generated by a wiggler. On the ID17 beamline, the photon source
is produced by a 15 cm period wiggler (w150) while IMBL uses a superconducting
multipole wiggler (SCMPW). The parameters of both insertion devices are given in
Table 2.1.
Table 2.1: Comparison of the wiggler IDs used on ID17 and on IMBL for the generation
of the photon source.
ID parameters ID17 (w150) IMBL (SCMPW)
Magnetic field period (cm) 15 4.8
Number of period 11 31
Magnetic field strengh (T) 1.592 4.17
Deflection parameter 22.30 18.7
Critical energy (keV) 38.6 25
Total Power (kW) 19.3 29.5
In order to compensate for the energy loss caused by the generation of synchrotron
radiation, radiofrequency (RF) cavities are used to re-accelerate the electrons in the
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storage ring.
2.2 ESRF ID17 Biomedical Beamline
ID17 is the medical beamline of the ESRF. The main areas of research on ID17 are
medical imaging, radiation biology and radiation therapy. MRT and SSRT are the two
radiation therapy modalities under development at the beamline. SSRT and MRT are
performed in two different experimental hutches; the MRT hutch is located 40 m from
the source in the experimental hall while the SSRT hutch is located 150 m from the
source in a satellite building (see Figure 2.5).
Figure 2.5: ID17 beamline. The optical hutch and the MRT experimental hutch are
located in the experimental hall. A tunnel connects the MRT hutch to the the satellite
building where one can find the Monochromator hutch and the SSRT experimental
hutch.
In MRT the photon source is produced by a 15 cm period wiggler (w150). When
working in the SSRT hutch, a second wiggler (w125) with a 12.5 cm period can be
used in order to further increase the monochromatic photon flux.
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MRT optical hutch
A representation of the MRT optical hutch is displayed in Figure 2.6.
Figure 2.6: MRT optical hutch.
From the wiggler, the beam travels inside a long stainless steel pipe under vacuum.
Different valves and Beryllium (Be) windows (300 to 500 µm thick) provide isolation
between the different vacuum sections. At 21.6 m from the source, a diaphragm
limits the beam dimensions to 2.4 cm in the horizontal direction and to 0.5 cm in the
vertical direction in order to minimise the heat load of the downstream instrumentation
devices. The maximum beam dimensions at the sample stage can therefore not exceed
41 × 2.5 mm2. The primary slits, made of oxygen free copper blocks, are situated at
29.3 m from the source and define the so-called primary horizontal and vertical gaps.
The photon beam is filtered by a combination of different water cooled attenuators in
order to remove energies below 30 keV from the energy spectrum. The typical MRT
filter combination is as follows: 1.42 mm of C, 0.28 mm + 1.24 mm of Al and 0.35
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mm + 0.69 mm of Cu. In the study of Mart́ınez-Rovira et al. [2012] spectra have
been obtained by MC simulations at different locations on the ID17 beamline and are
presented in Figure 2.7. At the sample/patient location, the energy spectrum ranges
from 27 to 600 keV with a mean energy at 99 keV. The fraction of photons with
energies higher than 300 keV is equal to 0.1%.
Figure 2.7: Integrated spectrum obtained by MC simulation at different beamline
locations. The primary slits aperture was set in order to produce a 2×0.1 cm2 field size
at the patient position. The 500 µm aperture of the vertical slit was used. Extracted
from [Mart́ınez-Rovira et al., 2012].
Due to the extremely high dose rates encountered in MRT, the exposure time must
be accurately controlled. A fast shutter has therefore being developed at the ESRF
allowing closing times below 5 ms [Renier et al., 2002]. The fast shutter is composed of
two 15 mm thick blades made of tungsten carbide (WC) , each coupled to an actuator
magnet (see Figure 2.8). In the rest position, the blade (1) (upstream) is under the
beam axis and the blade (2) (downstream) is blocking the beam. Before an irradiation,
the system is armed, i.e. the blade (2) goes above the beam and the blade (1) goes
in the beam by the activation of the electromagnets. When the irradiation starts, the
supply of the blade (1) electromagnet is cut which accelerates its motion back to rest
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position. Once the irradiation is performed, the blade (2) goes back to its rest position
also by cutting the supply of its electromagnet. In order to limit the heating of blade
(2), a photon absorber made of a 15 mm thick cooled copper block, follows blade (2)
motion but with a longer reaction time (around 1 sec). A diagram summarizing the
fast shutter and photon absorber sequence is displayed in Figure 2.9 (extracted from
[Renier et al., 2002]).
Figure 2.8: Mechanical design of the
fast shutter. Extracted from [Renier
et al., 2002]
Figure 2.9: Sequence of the fast shutter
and photon absorber. Extracted from
[Renier et al., 2002]
A Laue type monochromator consisting in a double-Si (111) crystal is available in
the optical hutch but is only used for imaging purposes. The MRT slits are former
slits that used to define the field size at the patient/sample position and clean up the
beam. They are no longer in use. The safety shutter finishes the beamline and is
protected from heat load by a photon absorber. A last Be window protected by an Al
foil makes the transition between the optical and the MRT experimental hutch, i.e.
between the vaccum and in-air section. When entering the MRT experimental hutch,
the total thickness of Be attenuators is equal to 2.3 mm.
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In the context of the veterinary clinical trials, additional elements have been in-
serted in the beam path for patient safety leading to two different beams filtering
conditions: the pre-clinical and the veterinary configurations.
In the optical hutch, the veterinary configuration differs from the pre-clinical config-
uration by the insertion of an additional gas beam attenuator and of a beam monitoring
chamber (IC0). The gas attenuator consists of a 2.2 m long krypton (Kr) gas pipe
maintained at an effective pressure of 85 mbar and is inserted upstream the primary
slits. This gas filter provides a beam filtration like the downstream mechanical filters
cutting the energies below 30 keV [Requardt et al., 2013]. The purpose of the Kr gas
filter is twofold. First, it will prevent any patient overexposure in the unlikely event of
multiple mechanical filter failure (sudden cracking). Second, as the Kr gas pressure is
monitored, any change in the pressure can be detected and such a signal can be used
safely to intervene in due time to shut down the beam if necessary.
IC0 has been especially developed by the ESRF to suit the synchrotron intense
beam. IC0 consists in two redundant in vacuo Compton counters made of two parallel
Al plates. In order to prevent the device from radiation damage, the Al plates are
coated with ∼ 100 µm of Au [Berkvens et al., 2013]. The relative dose measurements
provided by IC0 are linked to the MRT Patient Safety System (PASS) and are core-
lated to the absolute dose measured under reference conditions the day before the
patient treatment.
MRT experimental hutch
A layout of the MRT experimental hutch is displayed in Figure 2.10. An ionisation
chamber (IC1) monitores the beam right after the optical hutch. PMMA attenuators
and a rotary shutter are available for imaging purposes. IC1, the PMMA attenuators
and the rotary shutter are kept out of the beam for pre-clinical MRT irradiations. In
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order to select only the central homogeneous part of the synchrotron beam, vertical
slits are used. Four different apertures are available with nominally 50, 100, 500 and
800 µm. Horizontal slits can be inserted in the beam in order to define beam width
below 1 mm. Both the horizontal and vertical slits are made of tungsten carbide (WC).
Figure 2.10: Technical drawing of the MRT instrumentation in the experimental hutch.
(Courtesy of Michel Renier from ID17). Right top: photo of the optical table in MRT.
For the MRT veterinary clinical trials at the ESRF, a dedicated collimator with a
fixed beam aperture and spacing has been manufactured in order to ensure treatment
reproducibility and more reliability in the Monte-Carlo based treatment planning sys-
tem [Bräuer-Krisch et al., 2009a]. A microbeam width of 50 µm was chosen since it
was the best compromise between the biological data provided by the pre-clinical stud-
ies, the available mechanical performance to manufacture the MSC and an acceptable
uncertainty in the Output Factors determination. The microbeam spacing was fixed
to 400 µm in order to ensure a high enough PVDR for potentially therapeutic peak
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entrance dose values. The MSC is made of a 8 mm thick block of WC inside which
the slits have been grooved thanks to a high precision wire cutting technique [Bräuer-
Krisch et al., 2009a]. A schematic drawing of the MSC is displayed in Figure 2.11.
Figure 2.11: Technical drawing of the MSC with a fixed aperture of 50 µm spaced by
400 µm. Reprinted from Bräuer-Krisch et al. [2009a].
The MSC is embedded in a dedicated Al box and cooled thanks to a nitrogen gas
flushing. The nitrogen gas also prevents the MSC carbide surface from oxydation that
could arise at the surface of the MSC from the ozone production and the temperature
increase induced by the irradiation. The patient, sample or dosimetry phantom is set
on the a 3-axis Kappa-type high precision goniometer (Huber, Germany) located at
40.5 m from the wiggler X-ray source center.
For the veterinary trials configuration two additional redundant in-air monitoring
ionisation chambers (Bragg Peak ionisation chambers 34070, PTW), with an equivalent
PMMA thickness of 19 mm (PTW private communication), are set between the MSC
and the goniometer. Those chambers, linked with the MRT PASS, integrate and verify
the dose at each 500 µm vertical displacement of the goniometer. If the integrated
dose measured exceeds a pre-defined threshold value, the PASS system interrupts the
exposure.
At around 4 m from the goniometer stage, an ionisation chamber (IC2) is used
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for beam monitoring and beam alignment. Downstream the IC2 chamber, a two di-
mensional X-ray detector is available for imaging purposes. The detector consists in a
Fast-Readout Low-Noise (FReLoN) CCD camera designed and developed at the ESRF
[Labiche et al., 2007]. When performing imaging in MRT, the fast shutter and the
photon absorber in the optical hutch are fixed opened (i.e. kept out of the beam).
The beam delivery is then controlled by the rotary shutter located in the experimental
hutch.
Monochromator hutch
A 100 m long in vacuo pipe links the MRT experimental hutch to the monochromator
hutch in the satellite building. Water cooled attenuators are located just after the
long pipe and before the secondary slits defining the beam dimensions. A layout of
the monochromator hutch is displayed in Figure 2.12.
There are three different monochromators in the hutch; the multilayer, the com-
puted tomography (CT) monochromator and the angiography monochromator. The
multilayer is a fixed exit double multilayer mirror monochromator. The first set of
mirrors delivers energies ranging from 30 to 60 keV. The multilayer provides a beam
with a broader bandpass than the CT monochromator but with a smaller beam height
(∼ 1 mm). The second set of mirrors is designed to deliver energies ranging from 18 to
35 keV but is currently not in use at the beamline. The CT monochromator consists
in two cylindrically bent Si crystals in the Laue geometry and operates at energies
between 25 to 150 keV. The angiography monochromator is a K-edge substraction
monochromator that operates at beam energies ranging from 17 to 100 keV. It uses a
single Si (111) crystal thats is bent to vertically focus the beam on the target. In the
case of K-edge substraction imaging, a contrast agent is injected and two images are
simultaneously acquired with two monochromatic beams of different energies: one just
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Figure 2.12: SSRT optical hutch.
below and one just above the K-edge energy of the constrast agent. This method al-
lows the determination of the contrast agent concentration and is used for a wide range
of applications on ID17 (coronary angiography [Bertrand et al., 2005], bronchography
[Bayat et al., 2009; Porra et al., 2010, 2011] study of nanoparticles biodistribution
[Alric et al., 2008], brain and spinal cord perfusion [Balvay et al., 2009; Kelly et al.,
2007; Schültke et al., 2010] etc.). In order to obtain the two monochromatic beams, a
tungsten splitter is used to block the central part of the beam and two monochromatic
beams at slightly different energies (typically separated by ∼ 300 eV) can be obtained.
The monochromators are under oxygen free helium flow at atmospheric pressure
and are separated from the vacuum section by a 500 µm thick Be window. Right after
the monochromators comes an optic bench supporting Plexiglass attenuator, clean-up
slits and beam monitors. This bench can move up and down and be tilted up to
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13◦ in order to align different optical elements with the monochromatic beam. As in
the MRT optical hutch, a fast shutter is used in order to obtain fast beam opening
and closing times. For imaging purposes, a rotating chopper is also available. The
chopper is synchronised with the FReLoN camera located in the SSRT experimental
hutch in order to avoid the camera exposure during read out times [Renier et al., 2005].
SSRT experimental hutch
At the start of the SSRT experimental hutch, cerrobend masks can be used in order
to define the field size at the patient stage. Since the irradiations can be performed
from different ports, sereval masks corresponding to the different ports are individually
manufactured. The masks are set on a rail in order to be switched when moving from
one irradiation port to another. Two redundant transmission ionisation chambers
monitor the beam and as in MRT, are linked to the PASS.
Under SSRT irradiation conditions, the beam height is limited to 2 mm at the
patient/sample stage which requires a vertical scanning of the stage through the beam
in order to irradiate clinically relevant field sizes. A dedicated patient chair has been
developed and allows 5 degres of freedom (see Figure 2.13). The patient can therefore
be accurately positioned, the relevant field sizes can be reached and the chair rota-
tion permits to perform computed tomography (CT) images of the patient before the
irradiation for positioning purposes.
Finally, after the patient/sample stage comes the detectors stage where two differ-
ent imaging detectors are permanently installed: a Germanium (Ge) detector and a
FReLoN camera with taper. The Ge detector is 2 mm thick and composed of two lines
of 432 parallel strips spaced by 350 µm. This detector is often used for bronchography,
in-vivo brain perfusion studies, K-edge substraction imaging and also to determine the
iodine concentration in the brain for SSRT patients. The FReLoN camera has a 93
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Figure 2.13: At the entrance of the SSRT experimental hutch, cerrobend masks define
the field size at the patient stage and the beam is then monitored by two redundant
plate ionisation chambers.(Courtesy of Michel Renier from ID17).
×93 mm2 field of view, a 46 µm pixel size and is principally used for microtomography
experiments.
2.3 Australian Synchrotron Imaging and Medical
Beamline (IMBL)
The Australian Synchrotron (AS) is a 3rd generation synchrotron working at an energy
of 3 GeV. The storage ring operates under the top-up mode resulting in a more stable
beam. Nine different beamlines are availabe at the AS including the Imaging and
Medical BeamLine (IMBL) where MRT is currently under development.
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The continuous top-up mode confers an advantage for MRT as the irradiation
parameters, such as scan speed, would be able to remain identical for dosimetry and
patient irradiation. This is also an advantage for dosimetry measurements that don’t
need to be normalised to the beam current as it is the case at the ESRF. At the time of
the experiments presented in this study, there was no motorised stage able to perform
vertical motion during the irradiation. MRT was thus performed in the so-called static
mode (i.e. no vertical motion) or in step and shoot mode where the sample is vertically
moved between two consecutive static exposures.
IMBL first saw synchrotron light in December 2008 and since then, the beamline
has undergone many improvements and some developments are still in progress. A
general overview of the current state of the beamline instrumentation is provided here.
At IMBL, a superconducting multipole wiggler is used as a photon source. The
wiggler is located at the exit of the storage ring in the front end section and is followed
by two different sets of masks, a diamond window that removes low energy compo-
nents from the beam, and a photon stop (see Figure 2.14). The front end section is
terminated by a safety shutter.
Figure 2.14: Front End section of the IMBL. (Courtesy of Jayde Livingstone from
IMBL).
After the front end starts the hutch 1A (optical hutch, see Figure 2.15) where all the
intrumentation is under vacuum. Water cooled vertical and horizontal tungsten made
slits are used to optimise the synchrotron beam size in order to minimise unnecessary
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heat load of the downstream elements. Different mechanical filters (C, Al and Cu) are
available in the filter vessel. In MRT mode, the filter combination is chosen in order to
remove the photons with an energy lower than 30 keV and to protect the downstream
components and decrease the skin entrance dose. During normal beamline operation,
the first three filters are fixed to 0.45 mm of C + 5 mm of high density C + 10 mm
of high density C. A double Laue monochromator is also available but is not used
for MRT applications. A diagnostic cross is used for beam monitoring. It consists in
measuring signal from a Be foil (white beam intensity monitor), a Be wire (monitoring
of white beam vertical position) or a W wire (monitoring of monoenergetic beam
vertical position). The MRT shutter is located in vacuum. It is composed of 2 blades
used together so that the gradient in the vertical direction resulting from the use of
one blade alone is counteracted by the second blade. This shutter allows fast opening
and closing time (down to 30 ms as of the writing of this thesis). The beamline finishes
with a safety shutter. A photon stop is located upstream the shutters to prevent them
from overheating.
Three different operating modes are available on IMBL. Mode 1 takes place in
the experimental hutch 1B (20 meters from the source) and is dedicated to high dose
rate, step and shoot MRT. At this distance from the source the maximum beam
dimensions are limited to 30 × 2 mm in horizontal and vertical direction respectively.
Beam defining slits are located in vacuum and He flushed Be window protected by
an Al foil makes the transition between the vacuum and in-air sections. The MRT
table includes two beam monitors (ionisation chambers located before and after the
multislit collimator) and a sample stage. The multislit collimator is actually composed
of two separated collimators superimposed in order to change the microbeams width
by vertically translating the collimators. The two available microbeam widths are 25
and 50 µm. For both configurations the c-t-c distance is 200 µm. The collimators
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Figure 2.15: Diagram of the optical and experimental hutches in mode 1. (Courtesy
of Jayde Livingstone from IMBL).
are composed of W plates between which thin sheets of kapton are sandwiched. The
incident beam is thus attenuated by the W plates and goes through the thin apertures
defined by the kapton areas. A manual mode shutter made of lead ends the hutch.
In hutch 2A, downstream the beam defining slits (“Mamma Bear”), two beam
shutters are available: an imaging rotary shutter and a MRT shutter (see Figure 2.16).
They are both set on the same rail in order to use one or another depending on the
purpose of the irradiation performed in hutch 2B (either imaging or MRT). A beam
monitoring ionisation chamber is located right after the MRT shutter. Slits, shutters
and beam monitor chamber are positioned within an air path of 0.6 m isolated from
the vacuum sections by Be windows.
A new MRT shutter has been installed in hutch 2A in June 2015 and is currently
being tested. This shutter is working using the same principle as the MRT shutter
located in hutch 1A except it is operating in-air. Depending on the operation mode,
i.e. mode 1 or mode 2, this new shutter is meant to be installed in hutch 1B or 1A
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respectively. During our experiment, the new in-air MRT shutter was not in place and
only the in-vacuum MRT shutter in hutch 1A was used.
Figure 2.16: Diagram of the optical and experimental hutches in mode 2. In green,
the removable components. In red, the components under developement. (Courtesy
of Jayde Livingstone from IMBL).
In operating mode 2, a long vacuum pipe is going through the entire hutch 1B
and imaging and fast computed tomography of small objects are performed in the
hutch 2B located at 32 m from the source. Hutch 2B is also currently used for the
development of dynamic MRT. Dynamic MRT consists in performing vertical motion
of the patient/sample during the irradiation, i.e. as MRT irradiations are delivered at
the ESRF since 1995.
The dynamic MRT instrumentation is located on the so-called Dynamic MRT
(DynMRT) table. It is composed of beam defining apertures, tungsten-carbide made
MSC and a sample stage. The beam defining aperture is a removable component which
provides three beam heights (0.5, 1 and 2 mm) all of the same width (30 mm). The
MSC generates vertical microbeams with a fixed width (50 µm) and spacing (400 µm
c-t-c). Two silicon (Si) diodes, located upstream and downstream the MSC, monitor
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the dose rate. If the dose rate appears to be sufficient in hutch 2B to perform MRT,
then DynMRT will be performed in this same hutch. Otherwise, the DynMRT setup
will be moved to hutch 1B. A computed tomography (CT) table is located after the
DynMRT table and holds the sample to be imaged.
Two imaging detectors are available in hutch 2B: Diamond and Ruby2. Diamond
is a very high spatial resolution X-ray detector, able to image with sub-micron pixel
sizes (image pixel size down to 0.64 µm). Two Ruby detectors are actually available
on the IMBL: Ruby is located in hutch 3B and Ruby2 in hutch 2B. Ruby is a custom
designed detector based on a photo sensitive device coupled by a bright lens to a
suitable X-ray sensitive scintillator. It produces images at a lower resolution than the
Diamond detector (minimum image pixel size of 6.35 µm) but provides a larger field of
view (up to 70 mm). More detailed information about Diamond and Ruby detectors
can be found elsewhere [Hall et al., 2013].
A Manual mode shutter finishes this section of the beamline. After the hutch 2B,
the beam leaves the main building and is transported to the two hutches in the satellite
building in a long vacuum pipe called “beam transfer line”.
The hutch 3B is located in a satellite building at 140 m from the source and
is dedicated to imaging and computed tomography of large objects (Figure 2.17).
Indeed, in this hutch, due to the beam divergence, beam dimensions reach 120 × 40
mm [Harty et al., 2014].
In addition to Ruby, the Argus commercial detector (Teledyne Dalsa) is available
in hutch 3B. Argus is a CCD imager that provides a lower spatial resolution (27 µm
pixel size) but a wider field of view (22 cm) than Ruby. Beam defining slits (“Papa
Bear”) and a beam monitoring are located upstream the sample stage. Because of
the lower flux and higher field sizes available, the set up can be modified to perform
detector characterisation experiments.
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Figure 2.17: Diagram of the optical and experimental hutches in mode 3.(Courtesy of
Jayde Livingstone from IMBL).
At different locations accross the beamline several valves and pumps maintain the
vacuum.
Chapter 3
Reference dosimetry in MRT
At the ESRF, the MRT irradiation is delivered for a prescribed peak dose. Reference
dosimetry is performed using a homogeneous radiation field and an output factor is
applied in order to convert the reference dose to the dose within a microbeam at 3 mm
depth. The reference dosimetry is therefore a crucial step for the accurate delivery of
the treatment dose. Furthermore, the establishment of a reference dosimetry protocol
allows the internal calibration of dose monitors within the MRT patient safety system
as well as the calibration of high spatial resolution detectors dedicated to the quality
assurance of the microbeam field to be used for the actual MRT treatment.
This chapter presents the MRT reference dosimetry protocol to be performed before
a MRT irradiation at the ID17 biomedical beamline at the ESRF1. First the principle
of the ionisation chamber based dosimetry is presented. Within the establishment of
the MRT dosimetry protocol, a special attention is paid to the determination of the
correction factors to be applied to the ionisation chamber reading accounting for the
effect of the MRT beam quality and of the ion recombination occuring in the air cavity
of the ionisation chamber.
1Part of the work presented in this chapter has been published in the journal of Physics in Medicine
and Biology [Fournier et al., 2016b].
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3.1 Ionisation chambers
3.1.1 Description and Principle
Ionisation Chambers (ICs) are the gold standard dosimeter in conventional radiation
therapy. Cylindrical ICs are recommended for medium energy kilovoltage X-ray beam
[IAEA, 2000] and are therefore the reference dosimeter for the radiotherapy modalities
on ID17 and IMBL. Hereafter the operational principle of ICs is presented as well as
the different correction factors to consider when using such detectors. Finally, the
Pinpoint 31014 and Semiflex 31010 ionisation chambers used for reference dosimetry
in MRT and SSRT respectively are introduced.
Cylindrical ICs consist of an air cavity inside which ions are created from the inter-
action of incident radiations with the air. The inner conductive wall of the IC cavity
serves as the external electrode and the collection electrode is located at the centre of
the air cavity. A polarisation voltage in the order of a few hundred volts is applied
between the two electrodes in order to induce the motion of charges created after ioni-
sation, collect them so as to avoid their recombination. Electrodes are generally made
of low Z material such as Al, C or conductive plastic. When a positive polarisation
voltage is applied to the external electrode, the central electrode (i.e. the collecting
electrode) detects the positive ions. A guard electrode prevents the signal electrode
from detecting leakage current and parisitic signals coming from regions with distorted
electric field [Seco et al., 2014]. The IC measures the quantity of charge collected in
Coulombs (C) which is directely proportional to the absorbed dose. The IC signal is
read with an electrometer. UNIDOSwebline Dosemeter electrometers (PTW, Freiburg)
are used in MRT and SSRT.
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3.1.2 Ionisation chamber based absolute dosimetry
According to the TRS 398 code of practice [IAEA, 2000], the absorbed dose to water
Dw,Q is given by:
Dw,Q = MQ ×ND,w,Q0 × kQ,Q0 (3.1)
ND,w,Q0 is the IC calibration factor in gray per nano coulomb (Gy.nC
−1) that is applied
to the IC readings in order to convert the measured current into an absorbed dose.
ND,w,Q0 is dosimeter specific and is provided by a metrology lab in terms of absorbed
dose in water at the reference beam quality Q0.
If the IC is used at a beam quality Q that differs from the reference beam quality
Q0, a beam quality correction factor kQ,Q0 needs to be applied. kQ,Q0 is equal to:
kQ,Q0 =
ND,w,Q
ND,w,Q0
(3.2)
If the path of the secondary electrons is larger than the detector volume, the Bragg-
Gray theory [Ma and Nahum, 1991] can be applied and kQ,Q0 can be determined using
the following equation:
kQ,Q0 =
(sw,air)Q
(sw,air)Q0
(Wair)Q
(Wair)Q0
pQ
pQ0
(3.3)
Where sw,air is the Spencer-Attix water/air stopping power ratios, Wair the mean
energy expended in air per ion pair formed and pQ the perturbation factors. The
kQ,Q0 factors can be obtained by measurements or provided by a metrology lab for a
specific beam quality. MQ is the raw IC reading Mraw corrected for different influence
quantities ki (see equation 3.4). These influence quantities are described hereafter in
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Section 3.1.3.
MQ = Mraw × ki (3.4)
3.1.3 Correction for influence quantities
In order to measure the absolute dose with an IC, several correction factors, needs to
be applied to the IC reading.
Temperature and Pressure
The mass of air contained in the cavity and thus the ionisation current measured
is dependent on the atmospheric conditions at the time of the measurement. As
atmopheric conditions at the time of the calibration may be different from those during
the measurements, a correction factor kT,P accounts for this effect:
kT,P =
P0T
T0P
(3.5)
T0 and P0 respectively are the temperature and the air pressure at the time of the
calibration while T and P are the temperature and the air pressure at the time of
the measurement. In the case where the measurement is performed within a water
phantom, T has to be the water temperature. Both T0 and T have to be expressed
Kelvin.
Polarity effect
kpol corrects for the differences that can occur in the dosimeter reading depending
whether the polarisation voltage is positive or negative. The polarity effect can be
caused by a parasitic radiation-induced current arising from secondary electrons pro-
duced by the Compton effect in the wall and electrodes of the IC. A potential difference
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between the guard and the central electrode can also have an influence on the polarity
effect as this could distort the electric field and cause polarity asymmetry [Kim et al.,
2005]. Parasitic current can also occur from the irradiation of the IC cable and induce
polarisation effects.
kpol is determined from M+ and M−, the electrometer readings for an applied volt-
age of +V and −V respectively. M is the current measured with the usual operating
voltage.
kpol =
|M+|+ |M−|
2M
(3.6)
Ion recombination
If the applied voltage of the IC is not high enough, the current measured during an
irradiation will be dependent on the applied voltage. Indeed, if the applied voltage is
not high enough, the ions created inside the air cavity will recombine before reaching
the electrode thus resulting an underestimation of the dose. By increasing the polar-
isation voltage, the ions are collected more rapidly and the recombination process is
reduced. The measured current will stabilise with the applied voltage when the IC will
enter the so-called saturation regime where all the charges are collected. ICs therefore
need to be used in this regime where the ion recombination is expected to be small.
However, the IC readings still need to be corrected for this effect by applying the ion
recombination correction factor ks.
There are two different types of ion recombination processes: the initial and general
(or volume) recombination [IAEA, 2000]. The initial recombination is coming from
the recombination of one single particle track and is independent on the dose rate. On
the other hand, the general recombination is due to the recombination of ions created
by different particle tracks and is dependent on the dose rate. Both effects are depen-
dent on the IC geometry and on the voltage applied to the IC. Volume recombination
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is considered as the one having the highest influence and the ion recombination cor-
rection factor is determined using the so-called ”two-voltage” method. In the case of
synchrotrons sources, the beam is pulsed but the frequency is so high (352 MHz at the
ESRF), compared to the charge collection process in the ionisation chamber, that it
can be considered as a continuous beam. According to the TRS 398 code of practice
[IAEA, 2000], in the case of a continuous beam, ks is estimated as follows:
ks =
(V1/V2)
2 − 1
(V1/V2)2 − (M1/M2)
(3.7)
Where M1 and M2 are the signals measured by the electrometer at the polarising volt-
ages V1 and V2 respectively with V1 the IC operating voltage and V2 chosen in order
to obtained a ratio V1/V2 ideally equal or larger than 3.
Other correction factor to take into account
Other correction factors need to be applied to the IC reading in order to perform
absolute dosmietry. kelec is the correction factor for the electrometer calibration. This
factor is determined by the metrology lab when the IC and the electrometer are sent
for calibration.
3.1.4 Reference ionisation chambers on ID17 and IMBL
The Semiflex 31010 (PTW) has a sensitive volume of 0.125 cm3 and is the reference
chamber for SSRT. This IC has also been considered in a dosimetry protocol published
by Prezado et al. [2011a] in the context of pre-clinical trials in minibeam radiation
therapy on the ID17 beamline.
For the purpose of MRT reference dosimetry a PinPoint 31014 IC (sensitive volume
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Figure 3.1: Top: Semiflex 31010 reference ionisation chamber for SSRT. Bottom:
PinPoint 31014 reference ionisation chamber for MRT.
Figure 3.2: Top: Technical drawing of the Semiflex 31010. Bottom: Technical drawing
of the PinPoint 31014.
of 0.015 cm3) from PTW has been chosen because of its suitability for measurements
in field sizes down to 2 cm × 2 cm. Furthermore, from theory it is known that the
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recombination in ICs is proportional to the dose rate and to the electrode spacing
[Boag, 1966, 1987; Swanson, 1979]. With the PinPoint effective electrode separation
(considering both the spherical and cylindrical parts of the sensitive volume) being
less than for the Semiflex, the PinPoint can be clearly identified as more appropriate
dosimeter for reference dosimetry in MRT. The PinPoint 31014 IC is thus the reference
IC for MRT reference broadbeam dosimetry at both ID17 at the ESRF and IMBL at
the AS.
3.2 Establishment of a dosimetry protocol for ref-
erence dosimetry on ID17
3.2.1 Introduction
The MRT reference dosimetry protocol is intended to be applied in the context of
veterinary trials, and therefore requires reference conditions that remain as close as
possible to the irradiation conditions used during the MRT treatment. The exper-
imental validation of the energy spectrum in both pre-clinical and veterinary beam
filtering conditions helped us to decide under which beam quality the PinPoint had to
be calibrated and therefore led to the determination of the kQ,Q0 correction factor to
be applied to the PinPoint dose readings. The MRT irradiation conditions also imply
that special care needs to be dedicated to the determination of the ion recombination
correction factor. Indeed, in the particular case of synchrotron X-ray beam spectrum
ks is by far the most challenging correction factor to determine, due to the very high
dose rates involved [Crosbie et al., 2013; Nariyama, 2006]. Since no international rec-
ommendations are available for synchrotron medical beam dosimetry at such high dose
rates, a storage ring current ramping method was investigated.
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3.2.2 MRT irradiation technique and reference dosimetry con-
ditions
The MRT energy spectrum ranges from ∼ 30 to 600 keV with less than 1% of the pho-
tons with energies higher than 300 keV and a mean energy around 100 keV [Crosbie
et al., 2015; Mart́ınez-Rovira et al., 2012; Siegbahn et al., 2006]. The dosimetry proto-
col presented here remains as close as possible to the international recommendations
of the TRS 398 code of practice for medium energy kilovoltage X-ray beam whenever
technically possible.
Reference dosimetry takes place under broad beam conditions; the MSC is kept
out of the beam path so there is no spatial fractionation of the beam. At the ID17
beamline, the maximum synchrotron beam dimensions at the sample stage are 41 mm
× 2.5 mm in the horizontal and vertical directions respectively. The primary horizontal
slits and the vertical slits are used to select a part of the synchrotron beam having a
homogeneous intensity distribution in both vertical and horizontal directions. At the
sample stage, the MRT field is thus reduced to 520 µm height and 3.5 cm width.
As detailed in subsection 1.3.2, in order to cover treatment field sizes of a clini-
cally relevant height, a scanning method is employed; the target is positioned on a
goniometer stage and vertically translated at constant speed (including pre-calculated
acceleration and deceleration times). Target irradiation is done via the shutter device
that opens and closes at the vertical position of the goniometer to deliver the desired
dose over the pre-selected target field size [Renier et al., 2002].
For medium energy kilovoltage X-ray beams the TRS 398 protocol recommends per-
forming the dosimetry at 2 cm depth in water under a 10 cm × 10 cm field size. Since
the synchrotron beam propagates in the horizontal direction, our reference dosimetry
uses the MP3-P water tank from PTW (Freiburg, Germany) allowing irradiation from
the side. The water tank is thus mounted on the goniometer located 40.5 m down-
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stream of the X-ray source. Because of the high attenuation of the MRT beam in
water equivalent material the initial entrance window of 5 mm PMMA was replaced
by thin kapton window (around 70 µm thick). The resulting window limits the ref-
erence field size to 2 cm × 2 cm. This field size allows a homogeneous irradiation as
well as a negligible error in case of small misalignment of the IC with the beam (∼
1 mm). Moreover the lateral electronic equilibrium is ensured as the electron CSDA
(continuous slowing down approximation) range at 100 keV is around 150 µm in water
[Berger, 1992]. Therefore, a 2 cm × 2 cm field size has been adopted for reference
dosimetry in MRT.
A 20 mm.s−1 vertical scan speed was chosen as the reference speed because it is
close to a typical treatment speed. Reference conditions for reference dosimetry in
MRT are summarised in Table 3.1 and compared to those recommended by the TRS
398 protocol for medium energy photons.
Table 3.1: Reference dosimetry conditions used in MRT compared to those recom-
mended by the TRS 398 protocol for medium energy X-rays
Parameter of interest TRS 398 MRT
Phantom Material water water
Ionisation chamber type cylindrical cylindrical
Measurement depth (zref ) 2 g.cm
−2 2 g.cm−2
Reference point Central axis, Central axis,
of chamber volume at the centre of the cavity at the centre of the cavity
Reference position zref zref
Field size 10 cm×10 cm 2 cm×2 cm
Vertical slit size N.A. 500 µm
Scan speed N.A. 20 mm.s−1
3.2.3 Determination of kQ,Q0
As presented in Section 3.1.2, kQ,Q0 is a factor that corrects for the difference between
the beam quality Q0 used for the calibration and the beam quality Q under which the
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measurements are performed. At the ESRF, the PinPoint 31014 is calibrated in terms
of dose to water towards the 60Co beam quality. The most appropriate beam quality
for the PinPoint 31014 calibration in order to perform reference dosimetry in both
pre-clinical and veterinary beam filtering conditions thus needs to be determined.
Figure 3.3 represents the dose rate scaled to the storage beam current (Ḋscaled)
obtained from PinPoint 31014 IC measurements at different depths in water in both
pre-clinical and veterinary configurations. Only the kT,P correction factor was applied
to the IC readings.
Figure 3.3: Depth dose measurements performed in water using the PinPoint 31014
IC for both pre-clinical and veterinary beam filtering conditions. Only the kT,P cor-
rection factor was applied to the IC readings. Error bars correspond to two standard
deviations.
The switch from pre-clinical to veterinary beam filtering configuration introduces
a beam intensity attenuation of 41% at 20 mm depth. In order to see if any spectral
change occurs between the two configurations, percentage depth dose (PDD) curves
has been deduced from results reported in Figure 3.3 and are displayed in Figure 3.4.
The introduction of the additional components in the beam doesn’t seem to affect the
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energy spectrum as no significant change can be observed on the PDD curves obtained
for both configurations.
Figure 3.4: Percentage depth dose obtained from depth dose measurements in both
pre-clinical and veterinary beam filtering conditions (Figure 3.3). Depth dose mea-
surements have been performed in water and are normalised to 100% at 20 mm depth.
Error bars correspond to two standard deviations.
In order to validate the pre-clinical and veterinary beam spectrum, Crosbie et al.
[2015] calculated them using the SPECTRA program (version 9.0) [Tanaka and Kita-
mura, 2001] and the XOP program (version 2.3) [del Rio and Dejus, 2004]. The calcu-
lations were validated experimentally by transmission measurements through different
thicknesses of high-purity copper sheets (Gammex 116 HVL attenuator set; Gammex
Inc., Middleton, WI, USA) in order to determined the first to third half value layer
(HVL) of each beam. HVL is defined as the material thickness (Cu or Al) required
to attenuate a X-ray beam intensity by 50%. The first, second and third HVL thus
correspond to the thickness of copper that attenuates the original beam intensity by
50, 75 and 87.5% respectively. The transmission measurements were performed in air
using the PinPoint 31014 IC.
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From the energy spectra calculated by the Spectra program, a MATLAB-based
computer program called Dose4IMBL was used to extract information of dosimetric
interest such as the HVLs and the mean energy. The HVLs measured for the two
different MRT beam configurations were then compared to the calculated ones. In the
pre-clinical conditions, the first HVL measured was 1.754 mm and 1.763 mm for the
calculated one. In veterinary conditions, a HVL of 1.962 mm was measured compared
to 1.984 mm with theoritical calculations. The calculated mean energies were 105 keV
and 110 keV for the pre-clinical and veterinary configuration respectively.
Knowing the value of the 1st HVLs the MRT spectra, one can determine the most
suitable beam quality toward which calibrate the PinPoint 31014 IC. The filtration
and the copper 1st HVL of the two MRT spectra are compared to three beam qualities
available at PTW for beam calibration in terms of absorbed dose in water in Table 3.2.
Table 3.2: Comparison of the MRT spectrum mean energy and 1st Cu HVL to those
of the closest beam quality available at PTW for calibration.
Beam Quality Mean Energy (keV) 1st Cu HVL (mm)
MRT pre-clinical 105a 1.754±0.035
MRT veterinary 110a 1.962±0.039
TH 140 65.7b 0.43
TH 200 109b 1.67
TH 280 163b 3.40
a Fluence.
b Air kerma.
At PTW, the TH 200 beam quality is obtained from an X-ray generator operating
under a 200 kV tube voltage filtrated with 4.0 mm of aluminium and 1.0 mm of copper.
This results in an energy spectrum with a mean energy of 109 keV (air kerma). As one
can see from Table 3.2, the TH 200 beam quality is the closest to the MRT spectrum
for both pre-clinical and veterinary beam filtering conditions. Consequently, when the
PinPoint IC is calibrated in terms of absorbed dose to water for the reference 60Co
beam quality, PTW now provides us with a kQ value for the TH 200 beam quality.
3.2. Establishment of a dosimetry protocol for reference dosimetry on ID17 78
3.2.4 Determination of ks
For medium energy kilovoltage X-ray beams, the TRS 398 protocol recommends to
use the Two-Voltage method for the determination of ks. This method is based on
the linear dependence of the ion recombination with the polarisation voltage applied
to the IC. The ks value obtained with this method therefore depends on the dose rate
and should be determined at the different dose rates available on the machine.
At the ESRF the current in the SR is constantly decreasing with time leading
to a significant change in dose rate. This decreasing current prevents to use the
conventional Two-Voltage method for MRT reference dosimetry measurement because
the dose rate will be different between the measurements performed at the normal IC
polarisation voltage and those performed at the lower polarisation voltage. For MRT
dosimetry, the ks correction factor should be determined as a function of the dose rate.
The current ramping method is based on the measurement of Ḋscaled at different SR
currents.
The initial recombination is generally less than 0.2% for beams except for heavy
ions [IAEA, 2000]. Therefore, in the present study, the initial recombination was
assumed to be negligible and the study only focussed on the general recombination.
Measurements of Ḋscaled using the PinPoint IC at different dose rates were performed
in order to observe the effect on the chamber collection efficiency. However, a constant
energy spectrum over the range of dose rates investigated was required. As such the
use of beam attenuators to modify the dose rate was not possible. Since the dose rate
is directly proportional to the beam current in the SR, it represents the only parameter
that can be changed without influencing the energy spectrum and dose measurements
were performed at SR currents ranging from 20 to 200 mA. The irradiations were done
under reference conditions (2 cm depth in water, 2 cm × 2 cm field size, 520 µm beam
height, 20 mm.s−1 scan speed) and under the pre-clinical filtering conditions.
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From the dose measurements performed at the different SR currents, the corre-
sponding dose rates scaled for the SR current (Ḋscaled) were determined using equa-
tion 1.4. The resulting values of Ḋscaled obtained at the different beam currents under
pre-clinical filtering conditions are presented in Figure 3.5. Only the kT,P correction
factor was applied to the measurements and five data points were acquired at each
ring current. The error bars are equal to one standard deviation (σ). The uncertainty
in the beam current was assumed to be negligible.
Figure 3.5: Dose rate scaled by the current measured with the Pinpoint 31014 IC at
different storage ring currents (Ramping method measurements).
As Ḋscaled corresponds to the dose rate divided by the current in the SR, no change
should be observed on its value as long as the IC efficiency remains constant. Due to
the ion recombination occurring in the air cavity of the PinPoint chamber, Ḋscaled is
linearly decreasing with the current from 20 to 200 mA. The experimental data points
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were fitted using the following linear equation:
Ḋscaled = (−1.69× 10−2 × I) + 75.81 [Gy. mA−1. s−1] (3.8)
In this approach, it was assumed that no ion recombination occurs at very low
current (i.e. very low dose rate). The dose rate scaled for the SR current for a 100%
collection efficiency was thus assumed to correspond to the value obtained for a 0 mA
SR current using equation 3.8 i.e., 75.81 Gy.mA−1.s−1. The ks factor to be applied to
the IC reading as a function of the current in the SR can thus be determined using
equation 3.9.
ks(I) =
Ḋscaled(I = 0mA)
Ḋscaled(I)
=
1
1− (2.23× 10−4 × I)
(3.9)
In order to evaluate the error on the determination of ks using equation 3.9, the
extreme possible fits of the experimental data have been determined using the gradient
method. In order to determine those fits the two extreme experimental data points
were considered (i.e. those obtained at 20 and 200 mA). The curve with the maximum
slope intercepts the points of coordinates (20 mA; Ḋscaled(I = 20mA)+∆Ḋscaled(I=20mA))
and (200 mA; Ḋscaled(I = 200mA)−∆Ḋscaled(I=200mA)). Conversely the curve with the
minimum slope intercepts the points of coordinates (20 mA; Ḋscaled(I = 20mA) −
∆Ḋscaled(I=20mA)) and (200 mA; Ḋscaled(I = 200mA) + ∆Ḋscaled(I=200mA)). The resulting
curves and their corresponding fitting equations are displayed on Figure 3.6. For each
current, the extreme possible values of ks (i.e. ks,min and ks,max) can thus be calculated
as follows:
ks,min(I) =
1
1− (1.94× 10−4 × I)
(3.10)
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ks,min(I) =
1
1− (2.51× 10−4 × I)
(3.11)
Figure 3.6: Determination of the maximum (Red) and minimum (Green) slope fitting
curves using the gradient method.
From equation 3.9, ks is calculated for the different current values investigated
during the experiment and results are displayed in Figure 3.7. The absolute difference
between ks and ks,max is higher than between ks and ks,min. In order to remain con-
servative, the error on ks (i.e. ∆ks) displayed on Figure 3.7 is equal to the absolute
difference between ks and ks,max.
From Figure 3.7 and equation 3.9 the ks factor to be applied to the Pinpoint IC reading
can be determined as a function of the SR current at the time of the measurement. At
the maximum SR current, the ks factor was found equal to 1.047 ± 0.006. However,
this determination as a function of the SR current is only valid if the filtering conditions
are identical to those used in the ramping experiment. If the beam filtering conditions
are changed, then the dose rate at a given SR current may need to be modified leading
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Figure 3.7: ks as a function of the storage ring current in the machine.
to a different ks factor. For example, under MRT veterinary filtering conditions,
the normalised dose rate measured at a SR current of 200 mA decreased to around
40 Gy.mA1.s1. However, as showed in the Material and Method section, the spectral
mean energy shift between the pre-clinical and the veterinary beam filtering conditions
is only of a few electron volts. Assuming that ks is proportional to the dose rate, ks is
expected to be around 1.025 at 200 mA under veterinary beam filtering conditions.
3.2.5 Evaluation of the uncertainty in MRT reference dosime-
try
The relative uncertainty of our reference dosimetry technique applied to MRT was
determined by summing in quadrature, all the uncertainties on all correction factors
applied to the PinPoint chamber reading.
On the PinPoint calibration certificate from PTW, the uncertainty on kelec is given
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equal to 0.5% and the uncertainty on kQ, for the TH 200 beam quality, is given equal
to 3.7%. The polarisation effect correction factor (kpol) is reported to be <1.0%. In
order to remain conservative, an uncertainty of ± 1% was considered for kpol. Our
thermometer has an accuracy of ± 1% and the barometer ± 1.0 hPa + one digit.
The error on the kT,P will therefore be dependent on the temperature and pressure
measured. The uncertainty on kT,P was evaluated not being higher than ± 0.3%.
The calibration certificates provide uncertainties at the 2σ level so we have extended
our uncertainty to 2σ for our experimentally determined ks values. The relative un-
certainty in ks increases with the dose rate, so we calculate the uncertainty at the
maximum dose rate reached during the ramping experiment (i.e. when the SR current
was 200 mA) and this uncertainty is ±1.2%. Finally, an error in the PinPoint ion
chamber alignment on the x axis (i.e. beam axis) was introduced. From the measured
broad beam depth dose curves, we deduced that for both pre-clinical and veterinary
beam spectra, a misalignment of ±1 mm at the reference depth induces a change in
the dose reading of ±1.6%.
σD
D
=
√
(
σkq
kq
)2 + (
σkpol
kpol
)2 + (
σkelec
kelec
)2 + (
σkTP
kTP
)2 + (
σks
ks
)2 + (
σposition
D
)2
=
√
(2.3)2 + (1)2 + (0.5)2 + (0.3)2 + (1.2)2 + (1.6)2
= 4.4%
(3.12)
Using the propagation of uncertainties of the independent variables by summing
in quadrature, as shown in equation 3.12, we obtain an overall percentage uncertainty
of ±4.4%.
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3.2.6 Conclusion
We have presented a method for MRT reference dosimetry at the ID17 biomedical
beamline of the ESRF, Grenoble, France. In developing our new method we have
tried to remain as close as possible to the recommendations of the TRS 398 code of
practice for medium energy kilovoltage X-ray beams. Some of the reference dosime-
try conditions (such as the reference dosimeter and the reference field size) had to be
adapted to the ESRF specific synchrotron X-ray source, instrumentation and irradia-
tion technique. Previous work on the MRT beam energy spectra [Crosbie et al., 2015]
allowed us to determine the best beam quality for our reference dosimeter calibration.
A limitation of the current ramping technique is that it requires dedicated SR
shifts which has a significant impact on all the other beamline stations around the
synchrotron facility. Indeed, as a modulation of the SR current impacts all the beam-
lines at the same time, these experiments can be logistically difficult to organise at
a facility such as the ESRF. However, such measurements only need to be performed
each time a new reference chamber is purchased or calibrated at a reference beam
quality in a metrology laboratory (i.e. every two to three years).
From the measurements presented here we do not expect the change from pre-
clinical to veterinary beam filtering conditions to significantly affect the energy spec-
trum. The major effect observed being a substantial decrease in the average measured
dose rate (from ∼70 Gy.mA1s1 down to ∼ 40 Gy.mA1s1). For this reason, the esti-
mation of the ks correction factor from the ramping experiment presented here should
be suitable for reference dosimetry in the context of veterinary trials. However, the
ramping method should at one point be performed under the veterinary beam filtering
conditions which is technically not feasible on ID17 at the moment. Indeed moving
from pre-clinical to veterinary beam filtering configuration includes the insertion of a
krypton gas filter. The fact of progressively increasing the SR current from 20 to 200
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mA induces a strong local temperature and pressure gradient across the krypton gas
pipe. The high temperature along the X-ray beam path leads to a local reduction of
the gas density which, combined with the partial ionisation of the krypton, decreases
the density of electrons available to absorb the beam and causes a decrease of the beam
attenuation. This effect thus prevents us to perform dose ramping measurements with
the krypton gas filter in place unless such effects can be accurately modelled. This
will be the focus of a study in the future.
Calorimetry is another possible technique to be investigated for absolute dosimetry
in broadbeam radiation fields with a similar quality to that used in MRT [Harty et al.,
2014]. However, for a routine protocol, the use of a small volume IC remains the best
compromise between detailed dosimetry measurements incorporating radiation trans-
port Monte Carlo correction factors and a routine clinical dosimetry protocol such
as that used in daily quality assurance of clinical radiotherapy. This protocol also
provides the basis to correctly scale the dose values from the MRT treatment plan-
ning system (TPS) [Bartzsch, 2014] to the spatially fractionated dose distribution in
the animal to be treated, based on the previously acquired CT data. Furthermore,
such reference dosimetry protocol is of high importance for internal calibration of dose
monitors within the MRT patient safety system and for calibration of high spatial
resolution solid state detectors used to perform verification of the spatially fractioned
beam for the actual MRT treatment [Bräuer-Krisch et al., 2010a; Lerch et al., 2011;
Petasecca et al., 2012; Povoli et al., 2015]. In the case of the applied ramping method,
the determination of the ion-recombination correction factor may not result in exactly
the same values applying a uniform irradiation or a scanning method. However, since
the scanning conditions at ID17 are unique, any hypothesis cannot be experimentally
verified. The important point remains that the introduction of a reliable dosimetry
protocol for MRT at such high dose rates is essential. In the case of the spatially frac-
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tionated dose delivery in MRT, the physical dose may not result in the same biological
effects when compared with broad beam irradiations and it may be of higher impor-
tance to determine a biologically equivalent dose (BED) in MRT. This is the focus
of much current research internationally and beyond the scope of the work presented
here.
This reference dosimetry protocol demonstrates the ability of performing reference
absorbed dose to water measurements in a high dose rate synchrotron-generated X-
ray beam with an acceptable precision. This protocol will therefore be used for future
MRT pre-clinical studies and veterinary trials at the ID17 beamline. The precision
could be further improved in the future by calibrating the MRT reference IC directly
at the TH 200 beam quality and by performing the current ramping experiment using
this calibration.
The very high dose rates associated with synchrotron X-ray sources requires care-
ful consideration of how to correct IC readings for ion recombination effects. This
study therefore provides a method, the current ramping method, dedicated to the
determination of the ion recombination correction factor for a small volume ionisa-
tion chambers exposed to highly brilliant synchrotron radiation sources. This current
ramping method allows the direct determination of the ion recombination correction
factor using the reference dosimeter (PinPoint) in the reference dosimetry conditions
and in the pre-clinical beam filtering configuration. Using the data presented in Fig-
ure 3.7, we are able to predict a value of ks for a given SR current. The maximum
value of ks factor was found to be 1.047 ± 0.006. Under veterinary beam filtering
conditions, ks is expected to be around 1.025. It should be noted that no uncertainty
was considered on the SR current as this value is provided with a 0.05% precision at
the ESRF.
Chapter 4
X-Tream Dosimetry System
Characterisation
4.1 X-Tream dosimetry system
The X-Tream dosimetry unit has been developed by the CMRP in consultation with
the ESRF biomedical beamline. The aim was to design a new dosimetry system able to
cope with the challenging MRT dosimetry specifications [Lerch et al., 2011; Petasecca
et al., 2012]. The system is composed of a silicon Single Strip Detector (SSD), a pre-
amplifier module, a central data acquisition system unit (CSU) and a graphical user
interface (see Figure 4.1).
Figure 4.1: The different elements composing the X-Tream dosimetry system.
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4.1.1 Silicon Strip Detector (SSD)
The SSD consists in a microstrip diode fabricated via ion implantation on a p-type
epitaxial substrate. The single strip dimensions are 900 × 10 µm2. The 100 Ω-cm
p-type epitaxial layer is grown on top of a 370 µm thick substrate of lower resistivity
(0.001 Ω-cm) [Lerch et al., 2011; Petasecca et al., 2012]. A silicon oxide (SiO2) layer
surrounds the silicon detector in order to protect the bulk silicon (from dust, oil, grit,
etc.) and avoid the generation of surface leakage currents that would otherwise de-
grade the overall performance of the device. The SSD structure also incorporates a
n-type guard ring limiting the width of the sensitive area to approximately 30 µm for
an applied bias of -50V [Petasecca et al., 2012]. A cross-sectional view of the detector
sensor is displayed in Figure 4.2.
Figure 4.2: Cross-sectional view of the SSD chip. Reprinted from [Petasecca et al.,
2012].
The sensitive volume (SV) of the SSD depends on the applied (reverse) bias. In-
teraction of the incident radiation within the SV of the SSD leads to the generation
of electron-hole (e-h) pairs that separate under the influence of the electric field and
induce a photocurrent (proportional to the dose rate) in an external circuit.
The SSD can be either used in passive mode or active mode, i.e. with or without
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Figure 4.3: (A): Waterproof flexible carrier with USB interface connection to pre-
amplifier, (B): detail of the SSD chip mounted in the end of the flexible carrier using
the CMRP patented ”drop-in” technology, (C): detail of the chip mounted in the
flexible carrier, (D): Scanning Electron Microscopy (SEM) image of the SSD chip
where the 900 µm × 10 µm sensitive volume (SV) is indicated.
applying a polarisation voltage. For MRT applications, the SSD is working in active
mode by appling a voltage of between -50 and -70 V. Pictures of the SSD for differ-
ent magnifications as well as an image of the SSD acquired using scanning electron
microscopy are displayed in Figure 4.3.
Very high resolution dosimetry can be achieved using the SSD in “edge-on” mode
(see Figure 4.4) and in active mode using the above operating voltage range. When
using the “edge-on” orientation, the depletion region in the epitaxial growth direction
defines the intrinsic width of the SV. Because of the low resistivity of the silicon, this
length can be as low as 10-12 µm at a -30 V polarising voltage [Petasecca et al., 2012].
In addition to this, the effect of the guard ring design allows further reduction in the
depletion width as it acts as sucking electrode to collect a proportion of the charge
created directly under the strip electrode. Two orientations of the SV are available:
so called “90◦” orientation, with the long axis of the SV strip parallel with the beam
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Figure 4.4: Different possible orientations of the SSD.
direction, and so called “straight”, with the long axis orthogonal to the beam in the
vertical dimension. Figure 4.4 summarises the different possible orientations of the
SSD.
4.1.2 Pre-amplifier module
The pre-amplifier is directly connected to the SSD probe via a USB connector and
to the Central data acquisition System Unit (CSU) via a long cable (see Figure 4.1).
The pre-amplifier needs to provide a dynamic range sufficiently large to allow the mea-
surements of the peak and valley signals with the same accuracy. A linear sensitivity
over the entire dynamic range is also a requirement of the pre-amplifier. For MRT
applications, a low-gain amplifier is used and another pre-amplifier called “high-gain”
amplifier has been engineered for applications at lower dose rates. A schematic of the
pre-amplifier module is displayed in Figure4.5.
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4.1.3 Central data acquisition system
The CSU provides the voltage bias to the SSD. The system sampled the generated
photocurrent at 1 MHz and proceeds to its digital conversion. The CSU also provides
a communication between a remote personal computer used to operate the system via
a USB cable.
4.1.4 RADPLOT Graphical user interface
The custom software RADPLOT is an user interface that displays the photocurrent
generated (in ADC counts) as a function of time. An example of a signal acquired
with the X-Tream system on the RADPLOT interface is showed in Figure 4.6.
Figure 4.6: Signal acquired by the SSD on the ID17 beamline for a 2 cm ×2 cm field
size at 2 cm depth in solid water phantom (50 mm.s−1 scan speed)
Cursors are used to select an area of interest under which the integrated counts
is measured. A first set of cursors is used to sample a region where the beam is off
in order to quantify the baseline counts associated with the dark current of the SSD
detector at its operating voltage. A second set of cursors is used afterwards to select
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the area of interest (i.e. when the beam is on). The baseline is then subtracted in
the calculation of the integrated counts over this area of interest. To speed up the
visualisation of the data in the GUI the data file is sampled every 10,000th point and
displayed. All calculations and data manipulations are performed on the whole data
file with the result being displayed as necessary.
4.2 Characterisation of the X-Tream pre-amplifier
modules
The gain of the X-Tream pre-amplifier depends on the capacitor and feedback resistor
(referred as C1 and R1 respectively in Figure 4.5). The linearity response of both
the high and low pre-amplifier modules as well as their dynamic range have been
investigated in order to test their suitability for MRT quality assurance purposes.
These measurements also allowed the determination of the current to counts conversion
factor for both modules.
Resistances of 200 kΩ, 21.94 MΩ and 101.8 MΩ were used as an input of the
considered pre-amplifier and different polarisation voltages were applied across the
device in order to generate a current source ranging from 9.82 nA to 154 µA. The
output was acquired by the ADC level signal with the Radplot software.
Figure 4.7 shows the high gain pre-amplifier response as a function of the input
current. The high-gain pre-amplifier exhibits a linear behaviour between 10−7 A and
10−5 A. For larger input currents the ADC count value stabilises because of the sat-
uration of the ADC at 60,000 counts. From these results, the dynamic range of the
high gain pre-amplifier can be deduced as being around 102. This dynamic range
does not suit the MRT requirements as a dynamic range of at least 103 is desirable.
However, this pre-amplifier can be used for experiments performed at lower dose rates
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Figure 4.7: Response linearity of X-Tream high gain pre-amplifer module as a function
of the input current.
than MRT, like in SSRT for example. From the slope of the linear fit in Figure 4.7,
the current to counts conversion factor was found to be 5.332 counts/nA for the high
gain pre-amplifier.
The low gain pre-amplifier response as a function of the input current is displayed
in Figure 4.8. The low gain pre-amplifier response was found to be linear from 10−7 A
to 10−4 A. Similarly to the high gain pre-amplifier, for larger input currents, the ADC
reaches the 60,000 counts and saturates. The ADC counts to nano-Ampere conversion
factor was determined to be 0.606 counts/nA for this amplifier. The dynamic range
of the high gain amplifier was found to be equal to 103 which is suitable for MRT
applications.
The low level of around 300 and 100 ADC counts observed for the high gain and
low gain pre-amplifier respectively depends on the offset of the low pass band filter
of the ADC. This level can be adjusted to compensate for the offset generated by
the leakage current of the detector. In theory it could be compensated to zero ADC
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Figure 4.8: Response linearity of X-Tream low gain pre-amplifer module as a function
of the input current.
counts by nulling the input leakage current but, in practice, it is typically set to 100
ADC counts to make sure that there is a baseline to be subtracted. Consequently, if
required, the dynamic range could be further increased by adjusting the offset of the
low pass band filter and thus by reducing the baseline signal.
4.3 Radiation Damage
4.3.1 SSD pre-irradiation
Silicon-based detectors exposed to radiations are known to experience radiation dam-
ages leading to a decrease of their sensitivity [Rikner and Grusell, 1987]. Radiation
damages induced by X-rays in silicon-based detectors are generated by the electrons
with energy higher than 260 keV and that have enough energy to dislocate an atom
(i.e. point defect) from the silicon lattice [Flicker et al., 1962]. This atom vacancy
acts as a generation-recombination centre which can trap or release a carrier. Elec-
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trons mostly generate point defects which define extra energy levels in the forbidden
bandgap of the semiconductor band structure. The defects acting as traps are the ones
responsible for the decrease of charge collection efficiency [Lindström et al., 1999]. In
both n and p type substrates, the carrier lifetime (τ) is inversely proportional to the
concentration of deep-level defects and is thus responsible for the deterioration of the
sensitivity of the sensor with the accumulated dose [Rosenfeld, 2006].
Silicon-based detectors sensitivity also depends on their resistivity and whether the
detector is n-type ot p-type. Indeed, p-type radiation detectors are known to be more
radiation hard [Lozano et al., 2005]. This is the reason for this material type being
chosen for the SSD.
The knowledge of the SSD response behaviour as a function of the accumulated
dose is thus of the highest importance as response reproducibility is required from
the detector in order to be used for quality assurance in MRT. The SSD response
was measured as a function of the pre-irradiation dose at the ESRF and results are
reported in Figure 4.9.
Figure 4.9: SSD response as a function of the accumulated dose.
First, a slight rise in response with pre-irradiation dose is observed which is related
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to the generation of an accumulation layer of negative charge in p-Si below the Si-SiO2
due to a buildup of the positive charge in the SiO2 induced by the X-ray radiations.
This effect increases the length of depletion region in the lateral direction and thus the
detector’s SV. The charge collection and hence the signal are increased accordingly.
Then the response of the SSD decreases with the delivered dose before stabilising
at around 40 kGy. At this pre-irradiation dose the initial response of the SSD has been
reduced by 84%. This decrease in response is likely to be coming from the combination
of two effects. First, as explained before, the X-ray radiations induces point defects
in the silicon bulk that lead to a degradation of the carrier lifetime and thus to a
reduction of the response. Moreover the accumulation of trapped charges in the oxide
layer surrounding the silicon detector reduces the electric field slightly which degrades
the effective charge collection efficiency.
Above 40 kGy the reduction in response is ∼1% per 1000 Gy. Since the peak en-
trance dose (measured at 3 mm depth) is usually below 1000 Gy, 40 kGy was therefore
chosen as the recommended pre-irradiation dose for normal MRT QA for in-phantom
measurements in order to maximise the useful operational lifetime of the SSD without
too much decrease in overall response with dose.
4.3.2 SSD Initial Over-response Mechanisms
After demonstrating the mandatory pre-irradiation of the SSD in order to stabilise its
response, an investigation into the underlying mechanisms responsible for this initial
change in response was required. Several line scans of the synchrotron X-ray broad
beam were performed over a SSD with a straight orientation of the SV oriented face-
on (see schematic drawing in Figure 4.10) in order to look at the detector response
as a function of line position for different accumulated radiation doses. The resulting
recorded photocurrent as a function of the lateral location are displayed in Figure 4.11.
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Figure 4.10: Drawing of the
SSD chip representing the detec-
tor guard ring, the microstrip and
its pad and the p+ substrate con-
nector pad.
Figure 4.11: SSD recorded current from
the line scans performed for different pre-
irradiation doses.
As expected from the pre-irradiation results obtained in subsection 4.3.1, the area
below the resulting curves is decreasing with the pre-irradiation dose and stabilises once
the accumulated dose reaches 37 kGy. The initial increase in overall SSD response (or
charge collection) observed in Figure 4.9 is not directly noticeable in the line scan
presented in Figure 4.11 as the increment in dose was too large.
In Figure 4.11 it can be seen that the response in the area under the microstrip
stabilises very quickly. This stability is indicated by the flat plateau region in the
line scan which is ∼900 µm long (corresponding to length of the microstrip) and that
does not decrease after 5 kGy of total irradiation dose. This stable component of
the response is due to the presence of the n+ junction under the collecting electrode
which is able to maintain a strong and constant electric field so as to allow a consistent
amount of photogenerated charge drift and collection when the SSD is exposed to the
same irradiation conditions. The experimentally observed decrease in overall response
of the SSD up to a 37 kGy pre-irradiation dose is therefore primarily due to the decrease
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in the otherwise undesired photogenerated charge collection from the area around the
wire bonding pad of the SSD and inside the guard ring indicated in Figure 4.10.
On the line scans acquired, from a 2 kGy accumulated dose, the small over-response
peak on the left-hand side of the plateau in Figure 4.11 corresponds to a charge col-
lection under the microstrip. This peak continues to decrease in intensity with total
irradiation dose and is primary responsible for the associated decrease in the overall
radiation response of the SSD observed experimentally. This peak is associated with
charge collection from the region located between the detector pad and the microstrip.
This finding is an undesired behaviour as the response of the SSD would ideally be
constant over all the SV of the detector. A 2D scan of an unirradiated SSD was per-
formed at the ID17 beamline in order to study the charge collection behaviour across
the device. The SSD was face-on oriented and irradiated with a 50 µm × 50 µm beam
spot at different horizontal and vertical locations via a raster scanning technique. The
SSD was reverse biased at -30 V. The resulting response as a function of the vertical
and horizontal beam position on the SSD chip was established and is represented in
Figure 4.12. In order to ease the interpretation of the results, the map obtained from
the SSD 2D scan has been superimposed on the SSD chip technical drawing.
In Figure 4.12 a strong over-response (indicated by the red region associated with
large charge collection) is observed in the region between the microstrip and the im-
mediately adjacent wire bonding pad. This is due to the (undesired) charge collection
which almost doubles the sensitive area of the detector. This explains the massive
broad peak observed in Figure 4.11 when irradiating a non pre-irradiated SSD face-on
oriented.
The charge collection region is also present in the area between the guard-ring pad
and the microstrip pad. A residual charge collection (i.e. of lower intensity) is also
spreading underneath the p+ junction around the guard ring which makes the charge
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Figure 4.12: 2D scan of an unirradiated SSD chip using a 50 µm × 50 µm beam
spot. The color scale is in ADC counts. An over-response of the device is particularly
highlighted in the region between the pad and the microstrip.
collection region very wide. However, after the first two steps of pre-irradiation the
charges are exclusively collected from the microstrip and the area delimited by the
guard ring and the response of the detector starts stabilising.
In order to improve the SSD charge collection behaviour, a 3D model of the de-
vice was developed by Marco Petasecca (CMRP, University of Wollongong) using the
Synopsys TCAD simulation software package. The electric field, total current density
and electrostatic potential of the SSD were simulated for bias voltages ranging from
0 to -100 V. Simulations showed no breakdown in the electric field meaning that the
charge collection efficiency of the SSD increases with the amplitude of the reverse bias
voltage applied. A significant increase in both the electrostatic potential and current
density in the region between the microstrip and the pad was observed and was seen
to increase with the amplitude of the applied bias. It was concluded that the over-
response observed in the region between the pad and the microstrip was introduced by
the fact that the guard ring is positioned (unavoidably) around the wire bonding pad
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(see Figure 4.10). Indeed, the distance being larger between the guard ring and the
pad than between the guard ring and the microstrip, charge collection is allowed from
the metal-oxide-semiconductor (MOS) capacitor generated by the Al pad, the silicon
oxide layer under the wire bonding pad and the silicon substrate.
The carrier lifetime is constant in the silicon substrate and sufficiently long to allow
the electrons to diffuse from under the wire bonding pad (but inside the guard ring)
into the drift region of the microstrip where they can be collected. This effect will also
contribute to the over-response observed in unirradiated SSDs.
All these contributions to the charge collection efficiency clearly reduce significantly
once the detector is pre-irradiated: only a small over-response is observed in the final
profile presented in Figure 4.11 and the SSD response remains quite stable above 40
kGy.
4.4 X-Ray Photon Energy Dependence of the SSD
4.4.1 Introduction
Silicon based dosimeters are known to over-respond to low energy X-ray photons com-
pared to water-equivalent dosimeters. This energy dependence is due to the higher
atomic number Z of the silicon compared to water which enhances the number of pho-
ton interactions in the material and thus the energy deposition. The energy depen-
dence of silicon based detectors therefore strongly depends on the presence of high-Z
materials in the dosimeter packaging [Rosenfeld et al., 1995]. The importance of this
over-response also depends on the energy spectrum.
For MOSFETs, the over-response introduced by the detector energy dependence
has been determined experimentally to be as high as a factor of 3 for an X-ray source
of 50 kVp [Cheung et al., 2009]. In MRT, as the photon energy spectrum ranges from
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30-300 keV with a mean energy around 100 keV, the over-response of silicon based
detectors is expected to be considerable and to vary with depth in water due to beam
hardening. This energy dependence could lead to an over-response in valley dose due
to the dominance of lower-energy photons scattered out of the primary beam [Siegbahn
et al., 2006]. In the study of Siegbahn et al. [2009] the discrepancies observed between
the experimental and MC calculated PVDRs were attributed to the energy dependence
of the MOSFET detector.
An experimental study was conducted at the ESRF to investigate the energy de-
pendence of the SSD. Measurements were performed at four different beam energies
(35.3, 60, 80 and 100 keV) using the SSD. On top of the SSD response behaviour with
the beam energy, the SSD linearity with dose was investigated for each beam energy.
The influence of both the SSD and SV orientation was studied for both the linearity
and energy dependence studies.
4.4.2 Material and Methods
The study to experimentally determine the energy dependence of the SSD was per-
formed in the SSRT hutch of the ID17 beamline using monochromatic beams. For these
experiments, a Laue monochromator was used, producing monochromatic beams with
energies ranging from 25 keV up to 150 keV.
Two SSDs were tested: a first one with a 90◦ orientation of the SV and a second
one with a straight orientation of the SV. Each detector was irradiated in both face-on
and edge-on orientation. The aim was to study the possible influence of the orientation
of both the detector and their SV on the device response.
Before starting measurements at a given energy, one needs to exactly know the
amount of dose delivered to the detector. Consequently, dosimetry measurements
using a reference dosimeter were required before performing SSD acquisitions at a
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given energy.
During an SSRT irradiation, the delivered dose is monitored by two redundant
plane parallel ICs located upstream the sample stage. Before an SSRT treatment,
those chambers are calibrated towards the SSRT reference Semiflex 31010 IC fixed
at 2 cm depth in a solid water phantom for the different irradiation masks about to
be used for the treatment. This calibration allows to correlate the plane parallel ICs
recorded signal to the dose delivered at 2 cm depth in the phantom. In the context of
the energy dependence experiments, three different masks were used for the calibration.
These masks defined squared field size of dimensions 2 cm × 2 cm, 3 cm × 3 cm and
5 cm × 5 cm. The measurements were performed in the Easy Cube cubic solid water
phantom produced by Euromechanics.
Once the calibration is performed, a given dose can be delivered at 2 cm depth
using one of the available masks via a user graphical interface. The irradiation is then
monitored by the two plan parallel ICs and stopped once their signal reach the value
corresponding to the desired dose.
For each beam energy investigated, the Semiflex 31010 SSRT reference IC was
used for dosimetry. This chamber has a calibration factor for a TH200 beam quality
delivered by PTB (Physikalisch-Technische Bundesanstalt) in Germany. kQ correction
factors are also provided for different beam qualities. The different beam qualities
under which the kQ correction factor is known for the Semiflex 31010 IC are reported
in Table 4.1. In order to have a reference dosimetry as accurate as possible, the aim
was to perform our energy dependence study at energies as close as possible to the
beam qualities reported in Table 4.1. From the 1st Cu HVL provided by PTB to
define each beam quality, it is possible to estimate the closest beam energy to this
beam quality. Indeed, as the 1st Cu HVL corresponds the copper thickness required
to obtain a photon beam intensity I1/2 equal to half of the intensity of the primary
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beam I0, I1/2 can be written:
I1/2(E) =
I0(E)
2
= I0(E)e
−µCu(E)x1/2 (4.1)
with E the beam energy, µCu(E) the copper energy attenuation coefficient and
x1/2, the 1
st Cu HVL. From Eq. 4.1, it is possible to determine the copper energy
attenuation coefficient. Then, by dividing the µCu(E) coefficient by the copper density,
the Cu mass energy attenuation coefficient is obtained. From this value, one is able
to determine the beam energy by using the NIST database providing the mass energy
total attenuation coefficient with coherent scattering as a function of the beam energy
Berger et al. [2010]. The energies obtained using this method for the different beam
qualities are reported in Table 4.1.
Table 4.1: Beam qualities available at PTB for the Semiflex IC calibration. Beam
qualities are defined by the 1st Cu HVL. For each of them, the correction factor kQ
is provided in order to perform absolute dosimetry measurements at different beam
qualities. From the 1st Cu HVLs, the corresponding beam energy has been calcu-
lated using the NIST database providing the energy total attenuation coefficient (with
coherent scattering) [Berger et al., 2010]
Beam Quality 1st Cu HVL (mm) kQ Calculated Beam Energy (keV)
T70 0.1 0.985 34
T100 0.18 0.983 42
T140 0.46 0.986 59
T150 0.82 0.989 73
T200 1.59 1 97
The kQ values provided by PTB are plotted as a function of the calculated energy
beam in Figure 4.13. For practical and technical reasons, the experiments had to be
performed at the following beam energies: 35.3, 60, 80 and 100 keV. When possible,
the kQ factor was thus estimated using a linear interpolation between the two closest
beam energies for which the kQ factor was known. For the 100 keV beam energy, a
kQ factor equal to 1 was used as this energy is very close to the mean energy of the
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T200 beam quality. The kQ values finally used for the dosimetry measurements at the
different beam energies are displayed in Figure 4.13.
Figure 4.13: kQ determination for the PTW Semiflex 31010 at different beam energies
investigated in the energy dependence study.
Figure 4.14: SSD edge-on oriented at 2 cm depth in the Easy Cube phantom for the
energy dependence study.
As the dosimetry was performed at 2 cm depth in the Easy Cube phantom, the
SSD was set at the same depth in the same phantom. The SSD was fixed in a gammex
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plate where a dedicated groove was created to hold the SSD either in face-on or edge-
on orientation. Figure 4.14 shows the SSD set up for irradiations performed in edge-on
mode. In SSRT, the dose rate under reference conditions (i.e. at 2 cm depth in the
Easy Cube phantom and using a 5 cm × 5 cm field size), the dose rate is ranging
between 14 and 18 Gy/min [Prezado et al., 2011b]. As the dose rate is much lower
than the one encountered in MRT, the high gain amplifier of the X-Tream dosimetry
system was used for the experiments in order to maintain a good Signal to Noise
Ratio (SNR). Three different doses were delivered to the detectors: 0.25, 0.5 and 1
Gy. During the irradiation, the dose delivery was monitored by the two redundant
plane parallel ICs upstream the Easy Cube phantom. All the measurements were
performed within a 2 cm × 2 cm field size and the beam height was 2 mm.
4.4.3 Results
Figure 4.15 represents the signal acquired by the SSDs as a function of the delivered
dose and for the four different beam energies investigated. The anotations “90◦”
and “straight” stand for the SSD with a “90◦” or “straight” orientation of the SV
respectively.
For both detectors, the acquired signal is linear with dose for the different energies
investigated in both face-on and edge-on orientations. Experimental results have been
fitted with linear curves. Depending on the beam quality, different slopes are observed
because of the energy dependence of the SSD. The difference in terms of ADC counts
values between both detector is most likely due to the total irradiation dose being
significantly different for each detector. This means that the sensitivity of each detector
cannot be compared directly.
Using the detector in edge-on or face-on orientation doesn’t seem like having a sig-
nificant effect on the measurements. The slight difference in terms of recorded counts
4.4. X-Ray Photon Energy Dependence of the SSD 107
Figure 4.15: Investigation of the SSD linear behaviour with dose at different beam
energies. Two orientations of the SSD have been tested (face-on and edge-on), both
for the two possible orientations of the SV (straight and 90◦).
sometimes observed is most likely coming from a lack in position accuracy of the detec-
tor between the different sets of measurements. Also, additional measurements have
been performed separately where the response of the ”straight” SSD in edge-on mode
was compared with the response of the same SSD but rotated by 90 degrees. In this
case the response of the SSD varied by less than 10% [Lerch ”private communication”].
Currently, the only way to obtain a dose value from the SSD is to calibrate the
detector relative to a reference IC and to convert the integrated counts recorded into
a dose value. As evident from Figure 4.15, this calibration will depend on the beam
quality. Therefore, from the measurements performed, it is difficult to accurately
quantify the detector response as a function of the beam energy as only a relative
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difference in the SSD response can be extracted from the results. For example, for the
results obtained in the “90◦, Face-On” detector configuration, one can only state that
the SSD response obtained at 35.3 keV is around 4 times higher that the response
obtained at 100 keV. The only way to provide a more precise analysis of the SSD
response variation as a function of the beam energy is to compare our experimental
results to what is expected from theory.
The dose deposited by a monoenergetic photon beam of energy E into a Si medium
is equal to:
DSi = Ψ(E)×
µen(E)
ρ
∣∣∣∣
Si
(4.2)
with Ψ(E) the energetic fluence (J.cm−2), µen(E)
ρ
∣∣∣
Si
the mass energy-absorption coef-
ficient of silicon (cm2.g−1) at the energy E. Conversely, the absorbed dose in water
delivered by a monoenergetic photon beam of energy E of similar energetic fluence
Ψ(E) is equal to:
DH2O = Ψ(E)×
µen(E)
ρ
∣∣∣∣
H2O
(4.3)
Therefore, the ratio of DSi over DH2O as a function of the photons energy should have
a trend close to the response of the SSD as a function of the beam energy. For an
identical energetic fluence, the ratio of DSi over DH2O becomes:
DSi
DH2O
=
Ψ(E)× µen(E)
ρ
∣∣∣
Si
Ψ(E)× µen(E)
ρ
∣∣∣
H2O
=
µen(E)
ρ
∣∣∣
Si
µen(E)
ρ
∣∣∣
H2O
(4.4)
The SSD signal was thus normalised to the ratio of Si to H20 mass energy-absorption
coefficients (extracted from the NIST database [Berger et al., 2010])for a 100 keV
energy. Figure 4.16 represents the resulting response of the two different SSDs for
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both face-on and edge-on orientations as well as the Si to H20 mass energy-absorption
coefficients ratio as a function of the beam energy.
Figure 4.16: Experimental determination of the energy dependence of the SSD for two
detector orientations (face-on and edge-on) as well as for the two possible orientations
of the SV (straight and 90◦). Results have been normalised to the ratio of Si to H20
mass energy-absorption coefficients at 100 keV.
Due to time constraints, it was not possible to repeat sereval times the measure-
ments for each doses. Consequently, for the energy dependence investigation, the
signal obtained for the 0.25 and the 0.5 Gy delivery were respectively multiplied by
4 and 2 in order to be compared to the signal obtained for the 1 Gy delivery and to
get a higher statistics on the results. The uncertainty bars represent two standard
deviations (2 σ). The experimental results are consistent with the variation in the
absorption coefficient ratio, with differences most likely associated with the impact of
scattered photons from the surrounding phantom material. Detailed MC calculations
are now required in order to validate this experimental work but are beyond the scope
of this thesis. The results represent a worst case scenario as in reality the photon
energy used in MRT at the sample stage is “pink” (see Figure 2.7), not monoener-
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getic and with no component in the primary spectrum less than 30 keV. Additional
measurements could be performed in the future with different pink beam spectra (i.e.
varying peak beam energies) which would provide a more realistic impact of the SSD’s
silicon energy dependence on the calculated doses in MRT.
The SSD energy dependence may be critical for the experimental determination of
the PVDRs. Indeed, as previously described by Siegbahn et al. [2009], as the valley
dose is due to the photons scattered from the microbeams, the energy spectrum in the
valley region is softer than in the peak.
Figure 4.17: Peak and Valley energy spectra at 1, 10 and 20 mm depth in water
simulated with a Geant4 MC code. Made by Dr. Stefan Bartzsch.
Considering the energy dependence of silicon-based detector, this could introduce
an under-estimation of the PVDR. Energy spectrum in both the peak and valley
regions at different depths in water have been simulated by Dr. Stefan Bartzsch
(postdoctoral training fellow at the Institute of Cancer Research, London) using a
Geant4 MC simulation code. The simulation has been run in a 20 mm × 20 mm field
size and for 50 µm FWHM microbeams spaced by 400 µm. Figure 4.17 represents
the valley and peak spectrum at different depths in water. The variation of the mean
4.4. X-Ray Photon Energy Dependence of the SSD 111
energy of both spectra with depth is presented in Figure 4.18.
A 30 keV offset between the peak and valley mean energy is observed at narrow
depths and decreases progressively with depth. The main reason for the difference in
mean energy is due to the higher contribution of Compton scattered photons at lower
energy in the valley. As the valley dose is directly correlated to the peak dose (i.e.
generated by the photons scattered out of the microbeams), the valley mean energy
increases accordingly. At the reference depth (i.e. 20 mm depth), the mean energy is
equal to 97 keV and 77 keV in the peak and in the valley respectively. In addition, the
lack of backscattered photons at depth (no scattering medium present beyond 50 mm
in the simulations) further adds to the shift of the valley spectrum to high energy.
Considering the energy dependence results obtained for the SSD, one can thus
expect this offset to have a significant impact on the PVDRs measurements.
Figure 4.18: Variation of both peak and valley energy spectra mean energy with depth
in water. Simulations were performed using a Geant4 MC code by Dr. Stefan Bartzsch.
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4.5 Conclusion
In this chapter experimental measurements have been performed in order to charac-
terise the SSD response to total irradiation dose as part of a radiation damage inves-
tigation. First, the SSD response as a function of the accumulated dose was studied.
An initial slight rise in response with pre-irradiation dose was observed and has been
attributed to the positive charge buildup in SiO2 induced by the X-ray radiations.
This effect was already observed in the study of Aldosari et al. [2013] where the au-
thors characterised p-type epitaxial diode used as sensitive elements of the MagicPlate
detector [Wong et al., 2012]. Then the SSD response decreased by around 84% before
stabilising once a 40 kGy accumulated dose was reached (see Figure 4.9).
Line scans were performed on the SSD for different pre-irradiation doses in an at-
tempt to isolate and therefore better explain the radiation damage mecanisms, and
a similar behaviour was observed: the signal stabilises after a pre-irradiation dose
of 37 kGy (see Figure 4.11). However, the SSD response with vertical scans exhib-
ited a plateau corresponding to the signal measured from charge collected under the
microstrip which remains stable from a 5 kGy accumulated dose. After the 5 kGy
pre-irradiation dose, the SSD response reduction is most likely due to the charge ac-
cumulation in the oxide layer surrounding the silicon detector which decreases the
electric field and the effective charge collection efficiency.
In Figure 4.11, an over-response in the region between the microstrip and its pad
was noticed. A 2D response mapping of a non pre-irradiated was thus performed
at the ESRF with a 50 × 50 µm beam spot. As expected, a strong over-response
was observed in the region between the microstrip and the detector pad which is
coming from the metal-oxyde-semiconductor (MOS) capacitor generated by the pad
and the silicon oxide underneath it which allows charges collection from the pad in
unirradiated SSD devices. A charge collection region has also been noticed in the
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area between the guard-ring pad and the microstrip pad as well as a residual charge
collection spreading underneath the p+ junction around the guard ring thus resulting
in a very wide sensitive region. But, as demonstrated by the line scans, after the first
two steps of pre-irradiation the charges are exclusively collected from the strip-guard
ring area and the response of the detector starts stabilising.
During the pre-irradiation process, once the concentration of the point defects
generated reach approximately the same concentration as the generation centres, the
carriers recombine before reaching the electrodes. There is then no more signal asso-
ciated with the charge generated underneath the pad. As the dimension of the pad is
around 200 µm × 200 µm, the pre-irradiation process is thus of major importance in
order to limit the charge collection to the microstrip and improve the spatial resolu-
tion of the detector. After, an accumulated dose of around 40 kGy, the change in SSD
response is ∼1% per 1000 Gy. As a peak dose of a few hundreds grays are usually de-
livered for a MRT treatment, the SSD should be quite suitable for MRT as the change
in SSD response is acceptable. However for clinical applications one needs to either
recalibrate or model the decrease in response with total accumulated dose. Between
70 and 80 kGy the overall response of the device is extremely stable so for very high
precision dosimetry (future clinical work for example) a 70 kGy pre-irradiation dose
is recommended for such dosimetry conditions.
In the future, it would be ideal to extend the pre-irradiation precedure on different
SSDs until an effective deterioration of their response is reached in order to evaluate
the SSD lifetime. This would allow the establishment of standard operating procedures
in order to ensure the most accurate and reproducible results from the SSD. Additional
simulations are also required in order to validate the experimental results obtained.
Finally, each batch of detectors should be characterised in order to correct for the slight
decrease observed in SSD response above 40 kGy. This will contribute to extend the
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effective radiation lifetime of the SSD which may be useful in the clinical application
of the SSD.
The energy dependence of the silicon single strip detector was experimentally de-
termined at the ID17 beamline at the ESRF. Measurements were performed in the
SSRT experimental hutch at four energies in the range of the MRT energy spectrum.
The monoenergetic beams were delivered by a Laue monochromator. Two different
SSDs presenting different orientations of the SV (i.e. straight or 90◦) were tested in
both edge-on and face-on configurations. The SSDs linearity with dose was studied at
the different beam qualities by delivering three different known doses to the detectors.
For all configurations investigated, the SSDs showed a linear behaviour with the deliv-
ered dose. A decrease of the slope of the linear fits with the beam energy was observed
due to the over-response of the SSD at low energies. Indeed, as demonstrated in Fig-
ure 4.16, all the SSD configurations investigated exhibit a strong energy dependence
below 100 keV.The influence of the SV orientation and the SSD setup configuration
(i.e. face-on or edge-on configuration) on the SSD response with beam energy needs
to be further investigated. The energy dependence is a major limitation of the SSD as
it would make absolute dose measurements in MRT a complex task. Indeed, despite
the possibility of calibrating the detector under reference conditions, this calibration
will be lost as soon as the experimental conditions differ from the reference ones. For
example, change of detector depth in a dosimetric phantom will affect the detector
response due to the hardening of the energy spectrum with depth. Change in the ir-
radiation geometry may also induce difference in the SSD response as this will modify
the amount of scattered radiations.
MC simulation results show a difference of mean energy about 20 keV between the
valley and peak energy spectra at 20 mm depth in water. Given the energy dependence
of the SSD, this offset could lead to an under-estimation of the PVDR measured with
4.5. Conclusion 115
the SSD. This issue was assessed in the context of a MOSFET dosimeter by Siegbahn
et al. [2009] where the photon energy spectrum in both the valley and peak regions was
calculated using MC simulations. From the acquired spectra, Siegbahn et al. [2009]
estimated that the PVDRs measured with the MOSFET detector had to be multiplied
by a factor of 1.7 in order to compensate for the energy dependence of the detector.
In the near future, additonal measurements could be performed at higher energies
(at 150, 200 and 250 keV) in order to verify that the SSD energy dependence is
stabilising from 200 keV. This would also allow the establishment of an experimental
set of data for energies ranging over the entire MRT spectrum. These measurements
were not feasible at the time of the experiments as the maximum reachable beam
energy was limited to 150 keV. They might though be complicated to perform because
of the reduced photon flux at those energies. MC simulations are also required in
order to confirm the experimental results. These simulations should also include an
investigation of the SSD response in both microbeam and valley spectra in order to
predict the influence of the SSD energy dependence on the PVDRs measurements.
In a longer term approach, the design of the SSD could be improved in order to
mitigate for the energy dependence effect. To this end, thinning the Si substrate and
adding a water equivalent material (PMMA) encapsulation around the device could
be considered.
Chapter 5
MRT Beam Quality Assurance at ESRF
The quality of MRT treatment demands reproducible and precise spatial fractionation
of the incoming synchrotron beam. The intensity profile of the microbeams must also
be quickly and quantitatively characterised prior to each treatment for comparison
with that used for input to the dose planning calculations. In this chapter, the ability
of the SSD to perform rapid and efficient QA test prior to each MRT treatment is
evaluated. This study is based on in-air measurements of the horizontal profile of the
intrinsic microbeam X-ray field in order to determine the relative intensity of each
microbeam and also assess the alignment of the MSC1.
5.1 Methods
5.1.1 Instrumentation
The experiments were performed at the ID17 MRT beamline at the ESRF. The fil-
tering conditions consisted in the pre-clinical configuration with two additional beam
modifiers inserted in the beam; the krypton gas filter and the IC0 beam monitoring
ionisation chamber as they are both planned to be used in the context of the veteri-
nary clinical trials for patient safety purposes. At a 24.8 mm wiggler gap, insertion of
1Part of the work presented in this chapter has been published in the Journal of Synchrotron
Radiation [Fournier et al., 2016a].
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these additional elements shifts the mean energy from 105 to 108 keV. In the current
study, the most relevant beamline components are the beam defining vertical slits,
horizontal slits, the high-precision multi-slit collimator (MSC), and the goniometer.
The horizontal slits were used to limit the horizontal field to 20 mm at the sample
stage. The vertical slits aperture was set to the reference height of 500 µm, resulting
in a beam height of 520 µm at the patient position due to beam divergence. The MSC
was used to produce the 50 µm FWHM microbeams separated by a center-to-center
(c-t-c) distance of 400 µm.
5.1.2 Detectors and Readout
A single strip detector was used for this study. For measurements performed in-air,
the X-rays interacting in the silicon wafer and device packaging generate secondary
electrons which in turn create electron hole (e-h) pairs in the sensitive volume. These
e-h pairs, moving under the influence of the electric field in the device, induce a current
in an external circuit. This current was sampled and recorded using the X-Tream fast
data acquisition system presented in section 4.1. The RADPLOT software was used
to configure the data acquisition system, acquire data, and display the ADC counts
against time profile. By careful alignment of the device with the central axis of the
synchrotron radiation beam, and by scanning the device in the horizontal directions,
one is able to measure the energy deposition in silicon in the array of microbeams. To
facilitate rapid installation, alignment, and scanning, the device was mounted directly
on the goniometer stage (see Figure 5.1).
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Figure 5.1: Photograph of the setup used for the in-air experiment. 1. SSD edge-on
oriented, 2. Pre-amplifier module, 3. Goniometer stage.
5.1.3 Rapid detector alignment with pink beam imaging
An imaging modality known as ’pink-beam’ imaging [Serduc et al., 2010a] was used to
align the device with the beam axis. Currently, the pink-beam is obtained by opening
the wiggler gap from 24.8 mm to 100 mm and removing the MSC from the beam path.
Under pre-clinical beam filtering conditions, moving from the irradiation to imaging
modality decreases the beam intensity by 99.99% and shifts the mean energy from
the initial 105 keV to 50 keV. The imaging system is comprised of a two dimensional
X-ray detector located at around 4.3 m downstream of the goniometer stage. The
detector consists of a fast-readout low-noise CCD camera (FReLoN) developed at the
ESRF [Labiche et al., 2007]. A characterisation of the FReLoN camera can be found
in [Coan et al., 2006]. The aim is to benefit from the small pixel size (23.26 µm ×
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23.26 µm at the sample stage) of the FReLoN camera to image the SSD chip in order
to align it with the beam. When shifting from irradiation to imaging mode, the beam
defining slits can be removed from the beam path leading to a beam height around
2 mm at the goniometer stage. For large samples, in order to avoid the limitation of
the image dimension in the vertical direction, a vertical scan is performed using the
goniometer and images are acquired at different vertical offsets. The acquired frames
are piled-up together to obtain a complete image of the sample [Serduc et al., 2010a].
During the beam alignment procedure, the pixel of the FReLoN camera corre-
sponding to the central part of the beam is defined as the central pixel. When the
MSC is inserted in the beam, the plane of the resulting X-ray microbeams is parallel
with the vertical plane of the FReLoN camera (see Figure 5.2). The clear roll-off of the
intensity of the microbeams is clearly visible in the FReLoN image which is a direct
result of the wide wiggler gap used. The MSC is aligned in the beam in order to make
the centroid of the central microbeam match with the central pixel of the camera.
Figure 5.2: Image of the 2 cm × 520 µm parallel array of microbeams obtained with
the FReLoN camera.
To proceed to the SSD imaging, the detector was set-up on the goniometer stage
and the MSC removed from the beam path. One frame image of the SSD was ac-
quired by exposing the detector during 0.1 s. On the resulting image, the vertical and
horizontal offset between the current position of the centre of the SSD chip and the
central pixel position can be quantified. The detector was thus moved to the central
position using the goniometer vertical and horizontal motion motors. A second image
is usually acquired to verify its correct alignment.
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5.1.4 Quality Assurance of multi-slit collimator alignment
At the ID17 biomedical beamline at the ESRF, the MSC is aligned by the monitoring
of the output of a beam monitor IC whilst rotating the MSC about the vertical axis
(z) perpendicular to beam direction (x). The MSC is rotated through small angles,
typically ranging from 0.1◦ to -0.1◦ in increments of 0.01◦. During alignment, the
wiggler gap is set to a nominal setting of 40 mm in order to minimise beam fluence and
associated ozone accumulation in the experimental hutch. In order to benchmark SSD
measurements against the IC, the measurements with the SSD were also performed
for a wiggler gap of 40 mm. For the beam filtering conditions considered during the
experiments, moving the wiggler gap from 24.8 to 40 mm led to a 62% photon flux
decrease and moved the mean energy from 108 to 90 keV.
A SSD with a straight orientation of the SV was used and the detector was edge-on
oriented. The straight orientation of the SV was chosen to minimize the misalignment
of the SV with the microbeams. The MSC rotation angle was moved between 0.05◦
and -0.05◦. For each angle, the SSD was horizontally scanned through the 2 cm large
array of microbeams at a constant speed (2 mm.s−1). As the measurements were
performed in-air, the notion of PVDR is irrelevant in the context of the present study.
The notion of Peak to Valley Intensity Ratio (PVIR) corresponding to the ratio of
peak signal and valley signal measured by the SSD was thus introduced. The effect of
the MSC rotation on the peak and valley signal, PVIR and shape of the microbeams
was investigated.
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5.2 Results
5.2.1 Rapid detector alignment with pink-beam imaging
The images acquired during the alignment process for both face-on and edge-on ori-
ented detector are displayed in Figure 5.3. These images consist in one single frame
acquisition (i.e. the SSD was not moved through the beam during the image acquisi-
tion, only one image was acquired at a given vertical position of the detector). The
pink-beam imaging of the detector is very fast as a 0.1 s exposure per frame was
sufficient to acquire the image of the detector with a satisfying image quality. There-
fore, the total time to set-up the detector and align it in the centre of the beam was
approximately 30 minutes.
Figure 5.3: Images of the detector chip acquired with the FReLoN camera, in (A) face-
on and (B) egde-on orientation, with one single frame and 0.1 s exposure. The red
area on the image represents the dimensions of the MRT beam used for the experiment
(i.e. 520 µm high at the goniometer stage).
In clinical practice a pre-aligned SSD could be mounted permanently in air. The
imaging procedure would thus merely confirm that no misaligment of the detector,
with respect to the microbeams, had occurred immediately prior to exposing the SSD
to the full intensity X-ray microbeams to characterise the intrinsic MRT field profile.
The red area on the image represents the dimensions of the reference MRT beam
(i.e. 20 mm × 520 µm) used for the experiments. One can notice that only a part
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of the detector is exposed the beam as the sensitive volume of the SSD (900 µm) is
longer than the beam height.
5.2.2 Quality Control of the multi-slit collimator alignment
The RADPLOT software records the ADC counts as a function of time. Knowing the
scan speed of the motor used to perform the acquisition of the microbeams horizontal
profile, one is able to convert the time variable into a distance value. The detector
response profile of a 2 cm wide array of X-ray microbeams obtained for a 0◦ angle of
the MSC is displayed in Figure 5.4.
Figure 5.4: 2 cm wide array of microbeams acquired in air with the SSD (after sub-
straction of the baseline) for a wiggler gap of 40 mm. MSC rotation angle = 0◦.
On this figure, the RADPLOT data have been averaged by a factor equal to 500
and the baseline signal has been subtracted. During the experiment, the baseline noise
of X-Tream with the SSD was better than ± 1.3 ADC counts (1 standard deviation)
with no averaging applied. On Figure 5.4 one can verify the dimension of the lateral
field size and that all the 49 microbeams are present. The peak signal is defined as the
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maximum signal in the microbeam and is represented by the red crosses (Figure 5.4).
Figure 5.5 presents a focus on the five central microbeams of the array presented
in Figure 5.4. As a logarithm scale is used on the ordinate axis, one can notice
that the valley is not stable and the lowest value is not necessary in the middle of
two consecutive microbeams. Therefore, in order to determine the valley signal, the
signal has been averaged over a region of interest of 100 µm centered in the middle of
two consecutive microbeams. The resulting valley is presented by the blue crosses in
Figure 5.4 and Figure 5.5.
Figure 5.5: Focus on the five central microbeams of the 2 cm wide array of microbeams
acquired in air with the SSD for a wiggler gap of 40 mm. MSC rotation angle = 0◦.
Figure 5.6 represents the central microbeam profile obtained for 0.0◦, 0.02◦ and
0.04◦ rotation angle of the MSC about the z-axis. One can see that the intensity
of the central microbeam is decreasing with the MSC angle because of the reduced
aperture resulting from the MSC misalignment.
With the change of the MSC rotation angle, one would expect the Full Width
Half Maximum (FWHM) of the central microbeam to decrease as the effective slit
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Figure 5.6: Central microbeam signal for three different rotation angles of the MSC
(0◦, 0.02◦ and 0.04◦).
aperture is decreasing. Consequently, one possible way to check the MSC alignment
would be to measure the FWHM of the central microbeam for the different angles
of rotation investigated. The highest FWHM should then be obtained for a rotation
angle corresponding to the optimum alignment of the MSC. For the different angles of
rotation investigated, the lateral profile of the central microbeam has thus been fitted
with a gaussian (not shown here) in order to extract the FWHM and FW10%M (Full
Width at 10% Maximum) values from the fitting equation. The resulting FWHM and
FW10%M values are reported in Figure 5.11. Only a 1.6% decrease is observed between
the highest and lowest FWHM and FW10%M values which highlights the advantage
of using an intensity method to determine the optimum MSC rotation angle rather
than this method.
At the ESRF, the readings from a monitoring IC are used for MSC alignment pur-
poses by acquiring the IC signal while rotating the MSC. The maximum integrated
air kerma (proportional to the total fluence) measured by the IC is considered to
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Figure 5.7: FWHM and FW10%M of the central microbeam as a function of the MSC
angle. Only a 1.6% decrease is observed between the highest and lowest FWHM and
FW10%M values.
correspond to the optimum MSC alignment with the beam. From the horizontal pro-
files obtained in-air with the SSD, the integrated counts over the resulting microbeam
arrays have been extracted for each MSC rotation angle investigated. Figure 5.8 com-
pares the monitoring IC signal recorded for MSC rotation angles ranging from -0.1◦ to
0.1◦ to the integrated counts values extracted from the SSD measurements performed
at the different MSC rotation angles investigated. Each set of data is normalised to 1
for their respective maximum recorded value. A good correlation can be established
between the two detectors as they both agree on a maximum signal reached for 0◦. Of
course, such a scan to check the alignment of the MSC immediately prior to a patient
treatment would be enough to verify the MSC alignment. However the current MRT
treatment protocol demands that power to all such motors is switched off to minimise
the risk of accidental and undesired change in MSC angle or position. Therefore such
a measurement is impossible immediately prior to a patient treatment.
From Figure 5.7 on can see that for a 0.0◦ rotation of the MSC, the FWHM of the
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Figure 5.8: Total silicon SSD counts integrated over the microbeam array for the differ-
ent angles investigated and comparison to the results obtained by the beam monitoring
IC.
central microbeams is around 78 µm. At the goniometer stage, the microbeam FWHM
is expected to be equal to 51.5 µm due to the beam divergence. The over-estimation
of the microbeam width is due to misalignment of the SV of the detector. Indeed,
the SV length should be parallel to the microbeams but, as one can see in Figure 5.3
(B), the SSD chip is slightly tilted in the vertical direction (∼ 7◦) which degrades the
effective spatial resolution and leads to an overestimate of the microbeam FWHM as
seen in the microbeam profile.
A lateral profile containing 49 microbeams has been acquired with the SSD fixed at
2 cm depth in a phantom made of water equivalent material. For these measurements,
the krypton gas filter and the two redundant Compton chambers were kept out of the
beam leading to an increase of 25% of the beam intensity compared to the previous
experiments. The wiggler gap was set to 40 mm. The three central microbeams of the
resulting array are displayed in Figure 5.9 and the central microbeam is fitted with a
gaussian. As the SSD was rigidly mounted in the edge-on orientation in the phantom,
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Figure 5.9: Central microbeams signal obtained at 2 cm depth in a water equivalent
phantom. The krypton gas filter and the two redundant Compton chambers were out
of the beam. The wiggler gap was set to 40 mm.
it was thus less sensitive to motion and its alignment could be performed with a
higher accuracy. Indeed Figure 5.10 shows the pink-beam image acquired during the
SSD alignment within the water equivalent phantom and one can clearly notice that
the tilt of the SSD chip (∼ 3◦) has been reduced compared to the in-air configuration.
Figure 5.10: Image of the SSD rigidly fixed in the edge-on orientation within a water
equivalent phantom acquired with the FReLoN camera. The red area on the image
represents the dimensions of the MRT beam used for the experiments (i.e. 20 mm ×
520 µm at the goniometer stage).
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The spatial resolution has thus been improved accordingly: on Figure 5.9 the
FWHM of the central microbeam, deduced from the gaussian fitting equation, is equal
to 61 µm. It should be noted that all FWHM values reported in this study include
the intrinsic dimensions of the SSD.
Concerning the c-t-c distance, a value of 412 ± 2 µm was measured in the water
equivalent phantom and 413 ± 2 µm in air. These values are in close agreement
with the 412.2 ± 3.2 µm c-t-c distance reported by Bräuer-Krisch et al. [2009a] from
Gafchromic® films measurements.
5.2.3 Effect of the MSC rotation angle on the intensity dis-
tribution of microbeams
When performing measurements for the QA of the MSC alignment, satellite peaks
were observed on the edge of the microbeams array for small rotation angles of the
MSC. Figure 5.12 and 5.11 compare the SSD response profile on the field edge for
3 different angles: 0.0◦, -0.02◦ and -0.04◦; satellites peak only appear on the right
edge of the microbeams array when the MSC is misaligned. Conversely, for positive
rotation angles (Figure 5.13 and 5.14), satellite peaks only appear on the left edge
of the microbeams array (see Figure 5.10). As the satellite peaks are only observed
on one side of the array and as this side is dependent on the rotation direction of
the MSC, they are likely to be related to total external reflection of the photons on
the side walls of the MSC. This represents an important finding, as the detection of
satellite peaks suggests a dose deposition outside of the irradiation field and must be
minimised.
As the effect of the misalignment of the MSC was observed on the edges of the
microbeams array, Figure 5.15 shows the effect induced on the central microbeams
for the following MSC rotation angles: -0.02◦, 0◦ and 0.02◦. One can see that the
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Figure 5.11: Left edge of the mi-
crobeams array profile for 0◦, -0.02◦ and
-0.04◦ rotation angles of the MSC.
Figure 5.12: Right edge of the mi-
crobeams array profile for 0◦, -0.02◦
and -0.04◦ rotation angles of the MSC.
Satellite peaks appear when the MSC
is misaligned.
Figure 5.13: Left edge of the mi-
crobeams array profile for 0◦, 0.02◦ and
0.04◦ rotation angles of the MSC. Satel-
lite peaks appear when the MSC is mis-
aligned.
Figure 5.14: Right edge of the mi-
crobeams array profile for 0◦, 0.02◦ and
0.04◦ rotation angles of the MSC.
MSC rotation angle has a strong influence on the valley signal. Once again, photon
reflections may occur on the side walls of the MSC and modify the valley signal.
Figure 5.16 displays the average of the 48 peaks and 48 valleys signals measured
over the microbeams array as a function of the MSC angle. The uncertainty bars
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Figure 5.15: Central microbeams obtained for three different rotation angles of the
MSC (-0.02◦, 0◦ and 0.02◦).
represent the standard deviation of the mean σmean defined as:
σmean =
σ√
N
=
1√
N
√√√√ 1
N − 1
×
N∑
i=1
(xi − x̄)2 (5.1)
where N is the number of peaks or valleys measured in one array of microbeams (48
in the present case) and x̄ either is the peak or valley mean value over the array of
microbeams. The valley signal first increases with rotation angle of the MSC, from
15 counts at 0◦ to around 17 counts at ± 0.02◦. For larger angles, the signal in the
valley decreases due to the higher effective thickness of the MSC with misalignment
thus attenuating even more the primary beam. For the peaks, the signal decreases
constantly with the MSC angle as previously observed in Figure 5.6.
As measurements were performed in-air, the SSD should ideally only be sensitive
to the photon flux. At the centre of the microbeam the flux is not expected to change
significantly for such small MRT collimator angles since the air-scatter contribution
to the photon flux here is negligible. The immediate decrease in response with angle
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Figure 5.16: Average peak and valley signals obtained for the full range of angles
investigated.
demonstrates that the SSD is sampling the intensity across a significant proportion of
the width of the microbeam. This result is consistent with the SSD effective spatial
resolution degradation observed when the SSD is misaligned.
The 48 PVIR values deduced from the peak and valley signals measurements over
the microbeam array have been averaged and are presented in Figure 5.17 as a function
of the MSC rotation angle. The error bars represent the standard deviation of the
mean. For rotation angles between 0 and ± 0.02◦, the PVIR decreases as the peak
signal is decreasing while the valley signal is increasing. For larger angles, the PVIR
increases again as the valley signal decreases at a higher rate than the peak signal.
The QA results presented here highlight the importance of precise alignment of
the MSC relative to the X-ray beam. Even in what may be considered a worst case
scenario for the SSD (poorly aligned), the system is still able to confirm that the MSC
is aligned appropriately. However in order to precisely determine the relative peak
intensity of each microbeam for input into the dose planning system the SSD should
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Figure 5.17: Average PVIRs obtained for the full range of angles investigated.
be optimally aligned.
5.3 Discussion and Conclusion
A single silicon based strip detector was used for the acquisition of 1D profiles of the
synchrotron beam used in MRT. The SSD was used to measure the horizontal profiles
of a 2 cm wide microbeam array. The detector was able to detect small misalignments
of the MSC which resulted in changes in the valley shape but also in modifications of
the peak, valley and PVIR values. The rotation of the MSC did not have a significant
impact on the FWHM and FW10%M values extracted from the gaussian fit of the
central microbeam of the array under the measurements conditions presently used.
The significance may increase if the detector had a spatial resolution of 1 µm and was
perfectly aligned with the X-ray microbeams. Such a detector is under development
and will therefore be investigated in the future. Consequently, the MSC alignment was
performed by calculating the integrated counts recorded over the array of microbeams
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by the SSD for the different rotation angles of the MSC. The results were in agreement
with the monitoring IC currently used for the MSC alignment on ID17.
The SSD provided a complete view of the microbeam array enabling rapid verifi-
cation of the lateral field size as well as the correct shape and number of microbeams.
Similar measurements using ionisation chambers or films is impossible. As the align-
ment of such a small device can be tedious, an alignment procedure based on the
pink-beam imaging modality available at the ESRF was developed, allowing an align-
ment of the SSD within half an hour for a completely dismantled SSD.
Using the SSD, satellite peaks have been detected outside of the defined irradiation
field for a misalignment angle of the MSC as small as -0.02◦. The presence of such
peaks suggests a dose deposition outside of the irradiation field. These satellite peaks
may originate from photons that have undergone total external reflection from the
inner surface of the MSC. Future Monte Carlo studies interfaced with a ray-tracing
and X-ray optics code Cornelius et al. [2014] should be conducted in order to validate
this hypothesis. If this is the case, one way to alleviate this problem would be to adapt
the MSC aperture to the beam divergence in order to have an angle of incidence greater
than the critical angle to prevent total external reflection to occur. Pre-treatment QA
using the SSD could thus be performed to ensure that the MSC is accurately aligned
and that the treatment beam profile is cleared from any satellite peaks.
The valley dose is very sensitive to any changes in the irradiation set-up, in partic-
ular to the alignment of the MSC. Since an increased valley dose would compromise
the sparing of the normal tissue, QA dedicated measurements to ensure patient safety
should additionally be performed with the SSD. It should be noted that the increase
in valley dose has a well defined upper limit which can be characterised as a function
of MSC alignment angle. In addition, any measured change in the intensity profile
due to slight MSC misalignment can be easily accounted for by the dose planning
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system. According to the theory the spectrum of photons in the satellite is the same
as the primary spectrum which minimises any correction required due to the energy
dependence of the SSD identified in the previous chapter.
On the horizontal scan of the 2 cm wide microbeam array acquired, the measured
c-t-c distance was in very good agreement with the values previously reported by
Bräuer-Krisch et al. [2009a]. However, an over-estimation of the microbeam width
was observed and attributed to a slight misalignment of the detector.
Indeed, the greatest limitation highlighted in this study is the degradation of spatial
resolution when the SV is not perfectly aligned with the beam axis. The angular
misalignment of the detector could be mitigated using additional positioning motor
available on the goniometer. However, using such motors requires the SSD to be
precisely positioned at the centre of rotation of the goniometer coordinate frame of
reference. Adding the alignment of the SSD on the rotation axis of the goniometer
as a step within the detector set-up would lead to a much more time-consuming task
which is not compatible with a QA procedure. A decrease in the SV length could be
considered to mitigate for the detector sensitivity to slight misalignments. However,
the dimensions of the SSD are designed to ensure that an adequate photocurrent is
able to be generated in all MRT dosimetry and QA conditions (microbeam peak and
valley regions, beam filtering, depth in water or water equivalent materials etc.). In
addition, for ideal QA measurements one need to minimise any partial volume effects
related to the sensitive volume. Therefore a trade-off exists between SSD sensitivity
and spatial resolution. A permanently mounted SSD in air, pre-aligned with the
MRT beam, would consequently be the most suitable alternative. This solution will
mean that the alignment will only need to be checked using the FReLoN imaging
technique. In the future, it could be envisaged to perform a 1D scan of the beam
using a high resolution 1D array of silicon microstrip detectors which could provide
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an instantaneous 1D fluence profile Povoli et al. [2015]. Another possible technical
improvement would be to include a modality within the RADPLOT software taking
the motor scanning speed as an input and thus allowing the SSD signal to be displayed
as a function of the distance. This would considerably facilitate and accelerate MRT
QA procedures performed using the X-Tream system.
MRT represents important challenges in QA because of the strong influence in
biological outcome from possible misalignment directly influencing the quality of the
microbeams. This also especially important in MRT which is inherently a hypofrac-
tionation technique (i.e. the number of treatment fractions is minimal). QA in radio-
therapy is required to ensure effective treatment and patient safety and an interest is
rising in conventional radiotherapy to pursue fluence-based pre-treatment plan verifi-
cation over in-phantom dosimetry measurements Boggula et al. [2010]. The SSD, or
similar technology, could be a potential candidate in the field of MRT to ensure that
fluence profiles assumed by the TPS are consistent with response profiles experimen-
tally acquired. Finally, one can consider to extend the SSD use to MRT pre-clinical
experiments where an accurate knowledge of the beam properties would contribute to
reduce experimental uncertainties between two sets of experiments.
Chapter 6
MRT Dosimetry at ESRF
Numerous pre-clinical experiments have demonstrated the efficiency of the MRT tech-
nique to treat brain tumors in small animals while preserving the non-tumourous tissue
as well as the cognitive functions. However, the MRT beneficial effect highly depends
on the delivered dose. Dilmanian et al. [2002] showed that in order to preserve the
sparing effect of MRT, the valley dose should be kept below the non-tumourous tissue
dose tolerance. On the other hand, a large peak dose is preferred in order to enhance
the tumor control. Consequently, a maximisation of the Peak to Valley Dose Ratio
(PVDR) is desired. The accurate knowledge of the PVDRs is therefore very important
and should be experimentally measured before the MRT treatment in the context of
a MRT dosimetry QA.
Up to now, PVDRs values for square fields sizes have been obtained by Monte
Carlo simulations at different depths in a solid water phantom and compared to those
obtained using HD-810 Gafchromic® films [Mart́ınez-Rovira et al., 2012]. The Treat-
ment Planning System (TPS) especially developed for MRT is based an analytical
dose kernels and has also been benchmarked against Gafchromic® films [Bartzsch,
2014]. Indeed, Gafchromic® film dosimetry currently is the most widely used means
to acquire the PVDRs because this technique exhibits high enough resolution to access
the dose within the microbeams (i.e. the peak dose). Despite their great resolution,
Gafchromic® films have some drawbacks for applications in MRT. First, the film
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reading is not direct; the recommended time between the exposure and the reading
is between 24 to 48 hours [Niroomand-Rad et al., 1998] which does not allow the use
of such detector for QA purposes right before the patient treatment. Second, the dy-
namic range of films is not sufficient to display both peak and valley doses at the same
time; either the valley dose is too low to be precisely read on the films or the peak
signal is saturated the film if the valley dose is high enough to be seen on the films.
For these reasons, a real time dosimetry allowing simultaneous acquisition of the peak
and valley signal is required.
For MRT irradiations, Output Factors (O.F) are used in order to correlate the
dose measured under reference dosimetry conditions (20 × 20 mm2 field size, at 2 cm
depth) to the so-called peak entrance dose (at 3 mm depth). An intermediate step
towards the output factor determination is the assessment of the scatter factors which
quantify the dose in a single microbeam at 2 cm depth compared to the dose measured
under reference conditions. Scatter and output factors are obtained from Monte Carlo
simulations. An experimental verification of those factors is therefore required as a
part of the MRT QA process.
In this chapter the X-Tream dosimetry system is used for the experimental vali-
dation of the PVDRs in clinically relevant field sizes and for the determination of the
scatter factors.
6.1 Material and Methods
For all experiments presented here, SSDs with a straight orientation of the SV were
used and set in the edge-on configuration in order to optimise the spatial resolution.
The SSD was set at 2 cm depth in a phantom and aligned within the central mi-
crobeams using the pink beam imaging modality available on ID17.
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6.1.1 Assessment of PVDRs
For the PVDR measurements, the MSC producing 50 µm FHWM microbeams spaced
by 400 µm c-t-c was inserted in the beam path in order to create the microbeams array.
The vertical slits aperture was set to 500 µm leading to a 520 µm beam height at the
goniometer stage. The phantom was vertically moved through the beam, at a scan
speed of 50 mm.s−1, in order to define squared shape irradiation fields. Three different
field sizes were investigated for the experiment: 1 cm × 1 cm, 2 cm × 2 cm and 3 cm ×
3 cm. The horizontal and vertical dimensions of the field were defined by the primary
slits located in the MRT optical hutch and by the vertical motion of the goniometer
respectively. For each field size, irradiations were done for different horizontal locations
of the SSD in order to acquire the signal across the central microbeam and deduce the
peak and valley signal (i.e. step and shoot mode). The peak signal was considered
as the maximum signal measured with the SSD. Conversely, the valley signal was
considered as the minimum recorded signal.
6.1.2 Assessment of scatter factors
When performing MRT irradiations, a Graphical User Interface (GUI) scales the go-
niometer speed (vz) to the desired peak entrance dose at 3 mm depth (Dpeak). The
scan speed is calculated using Eq. 6.1 which takes into account the current value in
the storage ring at the moment of the irradiation (I), the scaled dose rate measured
from the reference dosimetry (Ḋscaled), the vertical slit size selected (zbeam) and the
output factor (K0) corresponding to irradiation geometry.
vz =
ḊscaledzbeamI
D
K0 (6.1)
K0 values used are extracted from a Monte Carlo based library. In order to obtain
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this factor, one also needs to calculate the so-called scatter factors (S) which correlates
the dose at 2 cm depth in a given beam width and height (Dbeam) to the dose at 2 cm
depth in the reference 2 cm× 2 cm field size (Dreference). The scatter factors (S) are
therefore determined using the following equation:
S =
Dbeam
Dreference
(6.2)
The scatter factors were measured at 2 cm depth in a solid water phantom (defined
as Phantom C hereafter) for horizontal field sizes varying from 50 to 30 000 µm and
for three different vertical field sizes: 10, 20 and 30 mm. The vertical field sizes were
defined by scanning the phantom through the beam via the vertical motion of the
goniometer. Horizontal beam sizes between 30 and 5 mm were defined by the primary
horizontal slits located in the optical hutch. For horizontal beam sizes lower than 5
mm, the horizontal slits located in the MRT hutch were used on top of the primary
slits.
6.1.3 Phantoms
PVDR measurements were performed at the reference depth (i.e. 2 cm) into three dif-
ferent phantoms. The first phantom was a MP3-P water tank from PTW (Freiburg,
Germany) (see Figure 6.1) as water phantom remains the gold standard for dosimetry
experiments. This phantom will be referred as “Phantom A” in the rest of this chap-
ter. In order to perform measurements at different horizontal positions, the SSD was
mounted on a high resolution motor allowing horizontal motions with a resolution of
5 µm. This motor was set on two parallel aluminium rails where a series of holes were
grooved with a step of 1 cm in order to enable the mounting of the high resolution
motor at different locations along the beam axis (i.e. x axis). Consequently the de-
tector had to be moved manually in order to change the depth of the measurements
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and this position could only be changed with a resolution of 1 cm. For the PVDRs
measurements, the detector was positionned at an approximate depth between 2.2
and 2.3 cm. To ensure that the SSD would remain straight in water, the detector was
taped against a gammex support.
Figure 6.1: SSD installed in the water tank for PVDRs measurements (Phantom A).
Since full installation of the SSD within the water tank is quite a tedious time con-
suming task, two other possible configurations, without significantly compromising the
set-up, were investigated. Both of them were based on the used of a RW3 solid water
slab phantom from PTW of dimensions 30 × 12 × 30 cm3. In the first configuration
(referred as “Phantom B” hereafter), a 28 × 2 × 29 cm3 gammex plate was machined
into three different pieces which, once put back together, hold the SSD in the edge-on
orientation (see Figure 6.2). A 1 cm and a 0.5 cm thick RW3 slabs were put in front
of the detector in order to have the SV of the SSD located at 2 cm depth. The rest of
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the RW3 slabs were used as backscatter material.
Figure 6.2: SSD fixed within three gammex plates for PVDRs measurements (Phantom
B).
Figure 6.3: SSD installed in the IC in-
sert within the RW3 slab phantom.
Figure 6.4: The phantom is then closed
and the insert is filled up with water.
This configuration (Phantom C) was
used for both the PVDRs and scatter
factors acquisition.
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The last phantom consisted in the complete RW3 solid-water slab phantom where
the SSD was fixed edge-on in the insert dedicated to a Farmer-type IC (see Figure
6.3 and 6.4). As the insert was larger than the detector, the empty area was filled up
with water. This phantom, referred as “Phantom C”, was used for both PVDRs and
scatter factors measurements.
In the case of Phantom B and Phantom C, as the detector was not able to move
within the phantom, the entire phantom was moved at different horizontal locations
using the goniometer motion motors.
For each phantom configuration, pink beam images of the SSD have been acquired
in order to align the detector with the beam (see Figure 6.5-6.8). On Figure 6.5,
the SSD is installed in Phantom A and one is able to distinguish the SSD edge-on
oriented taped against the gammex support. Figure 6.6 represents the SSD within
the 3 gammex plates (Phantom B). Despite the effort carried to tailor the gammex
plates to the SSD dimensions, tight air-gaps are noticable at the junction between the
different plates. In Figure 6.7, the SSD is inside the RW3 solid-water slab phantom
(Phantom C) and the IC dedicated insert is clearly visible on this image. The insert
was then filled up with water in order to homogenise the medium. The resulting pink
beam imaging for Phantom C is presented in Figure 6.8.
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Figure 6.5: Pink beam image of the
SSD taped against a gammex support
and set in the water phantom (Phan-
tom A).
Figure 6.6: Pink beam image of the
SSD in the dedicated gammex plate
(Phantom B).
Figure 6.7: Pink beam image of the
SSD in the IC dedicated insert of the
solid water phantom (Phantom C).
Figure 6.8: Pink beam image of the
SSD in the IC dedicated insert of the
solid water phantom filled with water
(Phantom C).
6.2. Results 144
6.2 Results
6.2.1 PVDRs
The SSD signal was recorded at different horizontal (y) locations across the mi-
crobeams array in order to measure the energy deposition in the SSD in both the
valley and peak regions and to assess the PVDRs in the three different square fields.
At each horizontal location investigated the integrated counts resulting from the ac-
quired signal was calculated using the RADPLOT software. As the SR current is
constantly decreasing at the ESRF, the integrated counts have been normalised by
the current value in the storage ring at the time of the acquisition. Figure 6.9 presents
an example of the central microbeam profile thus obtained.
Figure 6.9: Example of the microbeam profile obtained with the SSD with the step
and shoot method in Phantom B for a 1 cm × 1 cm field size. The data have been
normalised by the SR current and then to 100% at the maximum value and fitted by
a Gaussian. The FHWM resulting from the Gauss fit is equal to 66 µm.
This profile was achieved in a 1 cm × 1 cm field in the Phantom B. The integrated
counts measured by the SSD and normalised by the SR current have been normalised to
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100% at the maximum value. The data have then been fitted by a Gaussian exhibited
a FWHM of 66 µm. As for the in-air study presented in the previous section, the
difference between the measured FWHM and the 50 µm expected value is most likely
coming from a slight misalignment of the SSD sensitive volume with the beam.
The ADC counts recorded by the SSD as a function of the vertical position (as
opposed to horizontal position in previous chapters when characterising the intrinsic
MRT irradiation field which is only 520 µm high typically) of the detector during
the irradiation are displayed, for the three different field sizes, in Figures 6.10- 6.15.
Figure 6.10 and Figure 6.11 represent the signal acquire in the valley and the peak
respectively when exposed in a 1cm x 1cm microbeam irradiation field. Similarly,
Figure 6.12 and Figure 6.13 represent the signal acquire in the valley and the peak when
exposed in a 2cm x 2cm microbeam irradiation field and Figure 6.14 and Figure 6.15
the signal acquire in the valley and the peak when exposed in a 3cm x 3cm microbeam
irradiation field. The horizontal location of the SSD was either at 0 mm (i.e. in the
peak, see Figure 6.9) or at 0.2 mm (i.e. in the valley). As expected, the change of field
size is more noticable in the valley region than in the peak because of the scattering
enhancement with the field size.
From the acquisitions presented in Figures 6.10- 6.15 the integrated counts in the
peak and in the valley regions can be assessed in order to calculate the PVDR. This
has been done for the three field sizes and the three phantoms investigated. The
resulting PVDRs are reported in Table 6.1 where they are compared to the PVDR
values reported in the study of Mart́ınez-Rovira et al. [2012]. In this study, the PVDRs
were obtained using both Gafchromic® HD-810 films within the RW3 solid water slab
phantom and MC simulations. The PVDRs presented in Table 6.1 for the SSD are
not corrected for the energy dependence of the detector.
The PVDR obtained in Phantom A and Phantom C are in close agreements with
6.2. Results 146
Figure 6.10: Signal acquired in a valley
with the SSD for a 1 cm × 1 cm field
(y = 0.02 mm in Phantom B).
Figure 6.11: Signal acquired in a peak
with the SSD for a 1 cm × 1 cm field
(y = 0 mm in Phantom B).
Figure 6.12: Signal acquired in a valley
with the SSD for a 2 cm × 2 cm field
(y = 0.02 mm in Phantom B).
Figure 6.13: Signal acquired in a peak
with the SSD for a 2 cm × 2 cm field
(y = 0 mm in Phantom B).
Figure 6.14: Signal acquired in a valley
with the SSD for a 3 cm × 3 cm field
(y = 0.02 mm in Phantom B)
Figure 6.15: Signal acquired in a peak
with the SSD for a 3 cm × 3 cm field
(y = 0 mm in Phantom B).
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Table 6.1: PVDR values obtained at 2 cm depth in three different phantoms and for
three field sizes. These results are compared to those reported by Mart́ınez-Rovira
et al. [2012] obtained using both MC simulations and Gafchromic® films measure-
ments.
Phantom A Phantom B Phantom C MC simulationsa Filmsb
10 × 10 mm2 53±3 68±5 54±2 51±3 47±7
20 × 20 mm2 31±1 35±2 26±3 28±2 28±4
30 × 30 mm2 21±1 25±2 20±2 20±2 18±3
a Simulated for the RW3 solid-water slab phantom.
b Obtained in the RW3 solid-water slab phantom.
the MC simulations results reported by Mart́ınez-Rovira et al. [2012]. For the 10
mm × 10 mm field size, the PVDRs measured in Phantom A and in Phantom C
with the SSD are even closer to the MC calculations than the values recorded with
Gafchromic® HD-810 films. However, the PVDRs obtained in Phantom B are higher
than expected. For the 30 mm × 30 mm and 20 mm × 20 mm field sizes, the PVDRs
measured in Phantom B are 25% higher than expected from the MC and for the 10 mm
× 10 mm field size the difference reaches 33%. These discrepancies might be coming
from the small but significant air-gap present between the gammex plates of Phantom
B noticable on the pink-beam image acquired during the alignment of the SSD (see
Figure 6.6). The presence of such air-gaps around the SSD could modify the beam
attenuation (photon streaming) and directly impact the peak and valley intensity and
thus the PVDR.
However, it is important to consider the difference in terms of composition between
the different phantom investigated as they may also play a role on the measured
PVDRs. Hill et al. [2010] observed that for low energy photon beams (below 280 kVp),
some of the so-called water equivalent materials could exhibit a behaviour different
than water. In this study, the PENELOPE MC code was used to calculate depth doses
within a 2 cm diameter field size in different phantom materials (including gammex
and RW3 phantoms). The resulting doses were compared to the corresponding doses
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calculated in a water phantom for photon beams energies ranging from 50 to 280 kVp.
They observed that, for a primary photon beam energy less than or equal to 180 kVp,
in the case of a RW3 phantom, the calculated dose was lower than the dose calculated
in the water while the doses calculated in gammex material were very close to the dose
calculated in water. In the 280 kVp photon beam energy, the depth dose in the RW3,
gammex or water phantom were equivalent. A Geant4 MC code was developed by Dr.
Iwan Cornelius (former PostDoctoral fellow at the CMRP, University of Wollongong)
in order to simulate the dose deposition in a homogeneous phantom irradiated by the
20 mm × 20 mm pre-clinical MRT broadbeam; for water, RW3, and PMMA phantom
materials commonly used in MRT. The results are presented in Figure 6.16.
Figure 6.16: Geant 4 MC simulations of the dose deposition in a homogeneous phantom
irradiated by the 20 mm × 20 mm pre-clinical MRT broadbeam for three different
compositions: water, RW3, and PMMA. The second y-axis represents the relative
difference to water profiles for the RW3 (red) and PMMA (blue). Made by Dr. Iwan
Cornelius.
The second y-axis in Figure 6.16 represents the relative difference to water profiles
for the RW3 (red) and PMMA (blue) phantom materials. No significant difference is
expected between measurements performed at 2 cm depth in water or in RW3 for the
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MRT pre-clinical beam. Following the results published by Hill et al. [2010] and the
MC simulation results obtained by Iwan Cornelius, the differences observed in terms
of PVDR in the Phantom B are more likely to be coming from the air-gaps observed
around the SSD.
Prior the measurements performed in Phantom C, dosimetry was performed with
the PinPoint 31014 reference IC at 2 cm depth in the RW3 solid water phantom in a
2 cm × 2 cm broadbeam. The SSD was irradiated at the same depth and under the
same irradiation field size in order to have the detector calibrated. This calibration
allowed the conversion of the integrated ADC counts recorded in the peak and in the
valley into doses. The estimated peak and valley doses from the SSD measurements
are reported in Table 6.2.
Table 6.2: Estimation of the peak and valley doses at 2 cm depth in the Phantom C
from the integrated ADC counts recorded by the SSD.
Scaled integrated Scaled integrated Estimated Estimated
counts in peak, counts in valley, peak dose, valley dose,
ADC counts/mA ADC counts/mA Gy Gy
10 × 10 mm2 1.83×106 3.37×104 72.7 1.34
20 × 20 mm2 1.89×106 7.23×104 75.5 2.89
30 × 30 mm2 1.85×106 9.19×104 72.7 3.62
6.2.2 Scatter factors
The assessment of the scatter factors have been performed in Phantom C as this
phantom allows an easier and quicker set-up of the SSD as well as a more precise
alignment of the SSD than in Phantom A. The experimental scatter factors obtained
are presented in Figure 6.17 (dot markers) and compared to Geant4 MC simulation
results (solid line) obtained by Stefan Bartzsch (Postdoctoral training fellow at the
Institute of Cancer Research, London). The data are given with respect to a 20 × 20
mm2 reference field at 20 mm depth.
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Figure 6.17: Scatter factors measured at 2 cm depth in a solid water phantom com-
pared to MC simulations results. Exp 10 mm, Exp 20 mm and Exp 30 mm represent the
experimental data acquired with the SSD in a 10, 20 and 30 mm high beam respec-
tively. Conversely, MC 10 mm, MC 20 mm and MC 30 mm stand for the MC simulation
results obtained in a 10, 20 and 30 mm high beam respectively.
For a beam aperture lower than ∼300 µm the maximum dose reached is dominated
by electron scattering. Decreasing the beam aperture even more leads to a larger
proportion of electrons that scatter out of the beam which results in a lower dose
in the beam. For larger beam widths, the maximum dose is dominated by photon
scattering [Bartzsch, 2014].
For beam widths between 100 µm and 30 mm, scatter factors obtained with the
SSD are in very close agreement with the simulation results as the maximum relative
difference observed in reference to the MC simulation results is equal to 3.2%. However,
for a horizontal beam aperture of 50 µm, while the scatter factors are expected to be
similar for the three beam heights, the SSD reports different scatter factors values
which are up to 15% below the expected value (i.e. 0.73). Reason for this behaviour
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could probably be attributed to a slight misalignment of the detector that would
introduce partial volume effects and lead to a higher reduction in signal than expected
at very small fields. The energy dependence of the SSD may also influence the scatter
factor measurements. Indeed, the broad-beam is made up of a large scattered photon
component, while a single 50 µm wide beam has little contribution from scattered
photons. This will lead to an underestimatedsignal in the 50 µm beam and thus an
under-estimated scattered factor with the effect less prominent at larger apertures.
Due to time constraints, scatter factors measurements have only been performed
once during the experiment, resulting in a lack of statistics. These measurements
should be repeated several times under identical conditions in order to quantify the
uncertainty bars and see if a better agreement can be reached between the experimental
and simulation results.
6.3 Discussion and Conclusion
The SSD was used for the experimental determination of the PVDR and the scatter
factors at 2 cm depth. For the PVDR, three different phantoms were considered
for the experiment; a water-based phantom (Phantom A), a RW3 solid water slab
phantom including a Gammex slab especially engineered for the SSD (Phantom B)
and the RW3 solid water slab phantom with the SSD located in the IC dedicated
insert filled up with water (Phantom C). For the three field sizes investigated, PVDR
values measured in both Phantom A and Phantom C were in close agreement with
published PVDR values obtained using both MC simulations and Gafchromic® films
measurements [Mart́ınez-Rovira et al., 2012]. Because of the small air-gaps present
in the Phantom B, higher PVDRs were measured than in the two other phantoms.
Scatter factors were measured in Phantom C and compared to MC simulation results.
A close agreement was obtained with the two techniques down to a beam horizontal
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aperture of 100 µm.
For the first time, an active detector has been able to measure both valley and
peak signals with the same accuracy leading to a direct determination of the PVDR
in agreement with published values. However, the limitations raised in the chapter
concerning the averaging effect in the 50 µm beam (and the corresponding under-
estimation) as well as the SSD energy dependence observed for broad beam irradiation
that leads to over-estimation of the measured signal should both be addressed in order
to validate those promising results. A complete Monte Carlo model of the SSD should
help us understand and quantify these effects and propose the necessary technical
improvements.
Until now, the only reliable detectors allowing PVDR measurements were Gafchromic®
films. However, for PVDR measurements, their limited dynamic range prevents the
reading of peak and valley dose on the same film. Also, the 24h time delay required
between the irradiation and the film reading [Butson et al., 2003] prevents this detector
to be used for the MRT QA tests to be performed just before the delivery of an MRT
treatment. The SSD could therefore be a dosimeter of interest for MRT applications,
especially for PVDR verification.
The scatter factor for a 50 µm large and 20 mm height beam has already been
experimentally assessed in the study of Prezado et al. [2012] using Gafchromic® films
and a PTW 34070 large area chamber (LAC). Values of 0.72 ± 0.07 and of 0.72 ±
0.10 were obtained with the films and the LAC respectively. The scatter factor value
obtained with the SSD for this beam dimensions is 0.64, which is actually within the
uncertainty bars reported by Prezado et al.. In this study, the authors also compared
the scatter factors experimentally assessed to MC simulation results using either the
PENELOPE or GEANT4 MC codes. A value of 0.68 ± 0.04 was reported with the
PENELOPE code and of 0.75 ± 0.04 with the GEANT4 code. The scatter factor
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measured with the SSD thus sits within the uncertainty bars of the scatter factor
obtained with the PENELOPE MC code. The differences in the scatter factors pre-
sented in the study of Prezado et al. depending on the method or MC simulation code
used perfectly illustrates the complexity of determining this quantity. In the PhD
work of Stefan Bartzsch [Bartzsch, 2014], scatter factors were also experimentally de-
termined using Gafchromic® films for a 20 mm beam height and a beam aperture
ranging from 20 µm to 20 mm. Experimental results were compared to MC simu-
lations and a good agreement was obtained between the two techniques. However,
measurements exhibited uncertainties in the order of 10% thus requiring further rep-
etitions of the measurements in order to show that computations and measurements
agree with smaller uncertainties.
The lack of statistics for the SSD measurements also limits the interpretation of the
results. Measurements of the scatter factors should thus be repeated under identical
conditions in order to establish error bars and see if MC simulation results and SSD
experimental results agree within the uncertainties down to a beam width of 50 µm.
The PVDRs measured with the SSD have not been corrected for the energy de-
pendence of the detector. In order to determine if the difference of energy spectrum
between the valley and peak regions impacts the experimental determination of the
PVDRs using the SSD, MC simulations of the detector response in both spectra are
required. Finally, PVDR measurements using the SSD should be performed at larger
depths in order to check if the agreement observed between the SSD, MC simulations
and Gafchromic® films remains with depth.
Despite the remaining improvements and investigations required, the SSD is the
first active device that had been able to measure PVDRs values in such a close agree-
ment with Gafchromic® films and MC simulation results and could therefore be con-
sidered as a potential candidate to perform dosimetry QA in MRT.
Chapter 7
Application of the SSD at the Imaging and
Medical Beamline at the Australian
Synchrotron
The MRT technique is also under development at the Imaging and Medical Beam Line
(IMBL) at the Australian Synchrotron. Therefore, preliminary experiments were per-
formed at IMBL using the SSD. These experiments consisted in broadbeam dosimetry
(i.e. without any spatial fractionation of the primary beam) and in the acquisition of
the horizontal microbeams 1.
Broadbeam measurements performed with the SSD were compared to those ob-
tained using a PinPoint 31014 IC as this detector is also the reference dosimeter at
IMBL. The SSD was then used to measure intensity profiles of horizontal microbeams
in hutch 1B for two MSC configurations (25 µm or 50 µm FWHM microbeams spaced
by 200 µm) at different depth in a solid water phantom.
The broadbeam measurements highlighted the high spatial resolution of the SSD
compared to the PinPoint. An over-response of the SSD compared to the PinPoint was
observed when performing measurements in a broad beam at different depths in water.
This effect was attributed to the energy dependence of the SSD. For the horizontal
microbeams intensity profiles obtained at different depths, different region of interests
1Part of the work presented in this chapter has been published in Radiation Measurements
[Fournier et al., 2017].
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(ROI) were investigated to define the valley region in order to observe its impact on
the PVDR.
7.1 Broadbeam experiments conducted in hutch 1B
7.1.1 Material and Methods
Broadbeam experiments were conducted in the MRT hutch at the Australian Syn-
chrotron also known as hutch 1B. Figure 7.1 shows the hutch 1B and the instrumen-
tation used during the experiments. The MRT dedicated hutch is located as close as
possible to the wiggler source thus maximising the dose rate [Lewis, 2005].
Figure 7.1: Instrumentation in Hutch 1B at IMBL where the measurements of the
horizontal microbeams were performed.
The clean-up slits are positioned upstream the sample stage which is located at
around 20 m from the beam source. The vertical slits can define two different beam
heights: 1 mm and 2 mm. In the lateral direction, the maximum lateral field size
is limited (by application of an acceptable beam intensity roll-off) to 30 mm at the
sample stage.
The energy spectrum used during the experiment has been calculated using the
SPECTRA program for the parameters presented in Table 7.1. In order to distribute
the heat load over a larger area, the in vacuo filters were tilted by 45◦ in regard to the
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incident synchrotron beam [Crosbie et al., 2013]. The resulting effective thickness of
each filter are also given in Table 7.1 and the resulting energy spectrum is displayed
in Figure 7.2.
Table 7.1: Parameters used for the spectra calculation.
Parameter of interest Value
Electron energy in the storage ring 3.032 GeV
Storage ring current 200 mA
Peak magnetic field 3 T
Clean up slits aperture 1 mm × 1 mm
Distance from the source 22 m
Filtration in hutch 1A 1 m air
+ 0.35 mm Be
+ 10 mm C at 45◦ (Effective thickness = 14.14 mm)
+ 1 mm Al at 45◦(Effective thickness = 1.41 mm)
+ 2 mm Cu at 45◦ (Effective thickness = 2.83 mm)
Filtration in hutch 1B 1 m air
Figure 7.2: Photon energy spectra used during the experiments performed in hutch
1B (Calculated by Andrew Stevenson from IMBL using the SPECTRA program).
At IMBL, as at the ESRF, a Pinpoint 31014 IC is used to perform the reference
dosimetry of the homogeneous beam before MRT experiments. Broadbeam experi-
ments were thus performed with both the SSD and the PinPoint.
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First, the detectors were aligned with the beam by performing horizontal and
vertical scans using a step and shoot technique; irradiations were performed at different
locations across either a 1 mm high beam for the vertical alignment or across a 1 mm
wide beam for the horizontal alignment. The detectors were centred at the location
resulting in the maximum recorded signal.
Measurements were performed with both detectors at different depths in a water
phantom (see Figure 7.3) and for the following field sizes (horizontal × vertical): 1
mm × 5 mm, 1 mm × 10 mm, 1 mm × 20 mm, 2 mm × 5 mm, 2 mm × 10 mm and
2 mm × 20 mm.
Figure 7.3: Water tank used for in-water measurements.
Additional broadbeam measurements were performed with the PinPoint at different
depths within a solid water Gammex phantom (see Figure 7.5).
During the measurements, both detectors were oriented perpendicularly to the
incoming horizontal synchrotron X-ray beam. The SSD was set edge-on with a 90◦
orientation of its sensitive volume.
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Figure 7.4: PinPoint 31014 reference
dosimeter set-up in the water tank.
Figure 7.5: PinPoint set-up in the solid
water phantom (Gammex).
7.1.2 Results
The vertical profiles obtained in a 1 mm high beam by the PinPoint and the SSD are
displayed in Figure 7.6 and Figure 7.7 respectively. For the SSD, the profiles were
obtained at 2 cm depth in water and for the PinPoint at 2 cm depth in the solid water
phantom. For both detectors, the data are normalised to 100% for the maximum
recorded signal.
In Figure 7.6, the vertical profiles measured by the PinPoint are affected by the
spatial resolution of the PinPoint limited by the dimensions of the sensitive volume
(1 mm radius and a length of 5 mm). In Figure 7.7 the high spatial resolution of
the SSD is especially highlighted. For both detectors, the lateral field size does not
look as having a strong influence on the signal recorded at the centre of the field.
However when enlarging the lateral field sizes, a higher penumbra is observed due to
the increased photon scattering.
The PinPoint signal recorded at different depths in water and for different field
sizes is displayed in Figure 7.8. The data are normalised to 100% at the maximum
recorded signal. One can see that the PinPoint is very sensitive to the beam height
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Figure 7.6: Vertical alignment of the
PinPoint chamber with a 1 mm high
beam of three lateral sizes (5, 10 and
20 mm). Data are normalised to 100%
at the maximum value obtained.
Figure 7.7: Vertical alignment of the
SSD within a 1 mm high beam of three
lateral sizes (5, 10 and 20 mm). Data
are normalised to 100% at the maxi-
mum value obtained.
as for a beam height switch from 2 mm to 1 mm, the PinPoint signal is divided by a
factor of 2. This is due to the fact that the PinPoint sensitive volume is larger than
the vertical beam size : volume averaging effects cause the signal to be smaller than it
should be i.e. the absolute dose rate measured by the IC will be smaller than reality
when measured under these conditions. The PinPoint is also sensitive to the lateral
scattering as when the horizontal beam size is reduced, the PinPoint signal decreases
due to the reduction of the Compton photon scattering. It should be noted that the
PinPoint IC is not recommended to be operated in such field sizes (20 mm ×20 mm
is the smallest field recommended by PTW) so such effects are expected.
Figure 7.9 represents the SSD integrated signal (normalised to 100% at the maxi-
mum recorded signal) obtained with the SSD for the different field sizes investigated
and at different depths in water. On the contrary to the PinPoint, the SSD is much
less sensitive to the beam dimensions as the detector sensitive volume is much smaller
(10 µm in the vertical direction) than the incident beam. However, the SSD still re-
mains sensitive to the Compton photon scattering as the amount of integrated counts
recorded with the SSD decreases when the beam area is reduced. The observed change
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Figure 7.8: PinPoint signal obtained for 1 second exposure at different depths in water
for different broadbeam field sizes (data are normalised to 100% at the maximum
recorded signal).
Figure 7.9: SSD integrated signal (normalised to 100% at the maximum recorded
signal) obtained for 1 second exposure at different depths in water and for the different
broadbeam field sizes available in hutch 1B at IMBL.
in SSD response with beam height is consistent with the definition of the dose rate for
MRT [Fournier et al., 2016b] where to a first approximation, the vertical dose profile of
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the beam is assumed to be a top-hat function. This profile is a result of the low energy
photon spectrum in MRT and of the short range of associated secondary electrons.
SSD and PinPoint measured signals at different depths in water for a 20 mm × 2
mm beam are compared in Figure 7.9. For both detectors, the signal is normalised to
100% at the reference depth of 2 cm [Fournier et al., 2016b]. The relative difference
of the SSD resulting signal relative to the PinPoint is defined as:
∆ = 100× SSD(x)− PinPoint(x)
PinPoint(x)
(7.1)
where SSD(x) and PinPoint(x) respectively are the SSD and the PinPoint normalised
signal at the depth x. ∆ is represented by the black dots in Figure 7.9. At shallow
depths, the SSD signal is lower than the PinPoint but the relative difference remains
below -2%. From 70 mm depth, the amplitude relative difference is increasing with
depth and reaches -36.3% at 250 mm depth.
Figure 7.10: Variation of both PinPoint and SSD signals with depth for a normalisation
to 100% at 20 mm depth. The second y-axis represents the relative difference of the
SSD data to the PinPoint (black dots).
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As demonstrated in Section 4.4, the SSD has a strong energy dependence for photon
beam energies below 150 keV. As a result, the SSD is expected to be more water
equivalent at deep depths where the contribution of low energy photons is less (i.e.
where the energy spectrum is harder). Since the MRT reference depth is 20 mm, so SSD
measurements at depths where significant beam hardening occurs (i.e. deeper than 50
mm) therefore appear in Figure 7.10 to under-respond compared to the PinPoint IC. In
Figure 7.11 the SSD and PinPoint signals are normalised to 100% at the deepest depth
(i.e 250 mm) in order to better highlight the impact of the SSD energy dependence.
Figure 7.11: Variation of both PinPoint and SSD signals with depth for a normalisation
to 100% at 250 mm depth. The second y-axis represents the relative difference of the
SSD data to the PinPoint (black dots).
From 250 mm depth to 70 mm, the SSD over-response goes from 0 to 47.8%. For
shallower depths, the difference remains around 55%.The constant over response, while
not ideal, implies that only a single calibration factor is required for depths between
10 and 50 mm for QA of the MRT treatment planning.
Depth dose measurements were also performed with the PinPoint within the solid
water phantom using a 20 mm × 2 mm field size. The aim was to check if a similar dose
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was measured under similar irradiation conditions between the two phantoms and thus
if the solid water phantom could be used instead of the water tank to perform reference
dosimetry before MRT experiments. This would facilitate the reference dosimetry as
the solid water phantom is easier to handle and enable quick measurements to be
performed.
In order to compare measured dose between the two phantoms, correction factors
have been applied to the PinPoint readings and are summarised in Table 7.2. At the
time of the experiments, the IMBL PinPoint was only calibrated with reference to a
60Co source, therefore a kQ factor equal to 1 was applied. Correction factors accounting
for the pressure and temperature conditions, the polarisation effect and the chamber
saturation were determined using the formulas described in Section 3.1.3. The two
voltage method for continuous beam was applied using polarisation voltages equal to
400 V and 100 V.
Table 7.2: Correction factors to be applied to the PinPoint Chamber readings in both
water and solid water phantoms
Correction factor Water Phantom Solid Water Phantom
kT,P 1.026 1.028
kQ (
60Co) 1.000 1.000
kpol 0.999 1.000
ks 1.003 1.003
kelec 1.000 1.000
General Correction Factor 1.028 1.031
Figure 7.12 presents the depth dose curves obtained with the PinPoint in both the
water and the solid water phantoms. In solid water, measurements were only performed
down to a depth of 100 mm due to the limitation of gammex plates available. The
measurements performed at 100 mm depth included a backscatter of 50 mm of solid
water.
For measurements that have been performed at the same depth in both phantom,
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Figure 7.12: Comparison of the signal recorded by the PinPoint in either water or solid
water phantom. In both case, the detector was exposed for 1 second within a 20 mm ×
2 mm field size. The second y-axis represents the relative difference of measurements
performed in solid water to those performed in water which is represented by the black
dots on the graph.
the relative difference of the measurement performed in the solid water in regards
to those performed in water has been determined and is represented by the black
dots in Figure 7.12. For depths shallower than 50 mm, the dose measured in the
solid water phantom remains close to the dose measured in the water phantom as the
relative difference remains below -2%. For larger depths, the amplitude of the relative
difference rises constantly until reaching -3.9% at 90 mm depth. According to these
results, it should be feasible to perform quality assurance procedures in the solid water
phantom rather than in the water tank phantom which would allow such procedures to
be carried out more quickly. However, the increasing dose differences measured from
50 mm depth requires further investigations. These studies are currently underway
by CMRP PhD student Matthew Cameron using Monte Carlo radiation transport
simulations.
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7.1.3 Conclusions
Broadbeam experiments were performed in the MRT hutch (hutch 1B) at the IMBL
at the Australian Synchrotron. In this study the results obtained with the reference
dosimeter at IMBL (i.e. the PinPoint 31014 IC) have been compared to the SSD.
The detectors were aligned with the beam by performing horizontal and vertical scans
using a step and shoot technique. The detectors were centred at location correspond-
ing to the maximum recorded signal. Broadbeam measurements were performed at
different depths in a water phantom for different field sizes. Additional broadbeam
measurements were performed with the PinPoint at different depths within a solid
water Gammex phantom.
The PinPoint exhibited a high sensitivity to the beam height since for a beam
height switch from 2 mm to 1 mm, the recorded signal was seen to reduce by a factor
of 2. This effect was attributed to the PinPoint’s larger sensitive volume (i.e. 5 mm
long) compared to the beam height. The PinPoint was also sensitive to the lateral
scattering. As the SSD sensitive volume was fully covered by the incident beam, the
detector was much less sensitive to the beam dimensions but remained sensitive to the
Compton photon scattering as a decrease of the ADC integrated counts was observed
with the reduction of the beam area.
The SSD energy dependence was highlighted in the measurements performed at
different depths in water when compared to the PinPoint results.
Depth dose curves were obtained with the PinPoint in both water and solid water
phantoms. Measurements in the solid water were lower than in the water phantom
but the difference seems to increase with depths from 50 to 90 mm. One possible
explaination for these discrepancies could be the solid water phantom misalignment
that can occur when switching from one depth to another as the phantom has to be
completely dismantled. Such misalignment would introduce a change in the effective
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thickness in front of the detector and thus affect the dose readings. Additional mea-
surements should be performed in both phantoms at larger depths in order to obtain
a more accurate interpretation of the results. For these measurements, a special care
should be dedicated on securing the water phantom alignment with the incident beam.
Finally, the water equivalence of Gammex at different depths and for the IMBL energy
spectrum should be checked using MC simulations.
7.2 Horizontal microbeams acquisition in hutch 1B
7.2.1 Material and Methods
The MSC available in hutch 1B creates horizontal microbeams. The MSC is made of
several tungten plates separated to each other by kapton foils of different thicknesses
which define the microbeam apertures and thus the microbeam width. This MSC
permits two microbeams setting configurations named hereafter as 25-200 and 50-200.
The 25-200 MSC configuration generates 25 µm FWHM microbeams separated by a
200 µm c-t-c distance. Accordingly, the 50-200 configuration of the MSC generates
50 µm FWHM microbeams separated by a 200 µm c-t-c distance.
The experiments consisted in the acquisition of the microbeams profiles for both
MSC configurations using the SSD. The SSD was fixed in a dedicated Gammex plate
(see Figure 7.13) and vertical profiles were aquired at different depths within the solid
water phantom.
A 10 mm × 1 mm field size was used and the vertical profiles were acquired with
5 mm.s−1 vertical scan speed. A bias of -70V was set across the SSD.
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Figure 7.13: SSD set-up in the edge-on orientation in a solid water phantom (Gammex)
for horizontal microbeams acquisition.
7.2.2 Results
The vertical profile obtained with the SSD at 20 mm in the solid water phantom for
the 25-200 MSC configuration is displayed in Figure 7.14. As the beam height was
limited to 1 mm, the scan results in an array of four microbeams. A FWHM of 59 µm
was found instead of the 25 µm expected value.
This difference is most likely to be coming from the misalignment of the SSD.
Indeed, at the time of experiments, the positioning motors of the sample stage did
not allow such a high precise alignment of the detector and no imaging modality was
available to image and align the SSD. The peak of smaller amplitude observed on the
right side of the array corresponds to the start of a fifth microbeam cut by the beam
defining slits.
Figure 7.15 shows the array using a logarithmic scale for the y-axis in order to
better illustrate the valley region. On this figure, the peak value is represented by red
crosses. As one can see, the valley dose is not flat between two microbeams. It is thus
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Figure 7.14: Horizontal microbeams measured with the SSD for the 25-200 configura-
tion.
Figure 7.15: Horizontal microbeams measured with the SSD for the 25-200 configu-
ration using semilog scale on the y-axis. Red crosses represent the peak signal. The
valley signal is presented either as the minimum value between two consecutive peak
(pink crosses) or as an average over an ROI of 25 µm (blue crosses) or 50 µm (green
crosses).
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difficult to evaluate the length of the region of interest (ROI) over which the valley
needs to be sampled. Indeed, considering only the minium value could lead to an
under-estimation of the valley which can be critical for the MRT treatment efficiency.
Therefore, three different ROIs have been investigated to determine the valley signal:
by considering only the minimum value between two peaks (pink crosses on the figure),
by averaging the signal over a 25 µm ROI (blue crosses) and by averaging the signal
over a 50 µm ROI (green crosses). On Figure 7.15 the ROIs are delimited by dashed
lines: in blue for the 25 µm ROI and in green for the 50 µm ROI.
Similar graphs than those presented in Figure 7.14 and Figure 7.15 have been
obtained for the 50-200 MSC configuration and are presented in Figure 7.16 and Fig-
ure 7.17.
Figure 7.16: Horizontal microbeams measured with the SSD for the 50-200 configura-
tion.
Because of the larger beam aperture, the peak signal is higher for the 50-200 MSC
configuration. As the c-t-c distance is the same for the two MSC configurations,
the valley signal is also higher for the 50-200 MSC configuration. At each depth
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Figure 7.17: Horizontal microbeams measured with the SSD for the 50-200 configu-
ration, semilog scale on the y-axis. Red crosses represent the peak signal. The valley
signal is presented either as the minimum value between two consecutive peak (pink
crosses) or as an average over an ROI of 25 µm (blue crosses) or 50 µm (green crosses).
investigated the four peaks values have been averaged as well as the three valley
values and the resulting data are presented as a function of depth in Figure 7.18 and
Figure 7.19.
From the peak and valley values reported in Figure 7.18 and Figure 7.19, the PV-
DRs have been determined and are presented in Figure 7.20 and Figure 7.21 for the
25-200 and 50-200 MSC configurations respectively. For both configurations the re-
sulting PVDRs remain stable with depth as the peak and valley signals decreases with
depth as the same rate. As detailed in Section 1.3.3, for squared field sizes, PVDRs
are first expected to decrease with depth before reaching a plateau and stabilise. As
the field size was 10 mm × 1 mm, and as the PVDRs are extracted from a 1D ver-
tical scans through the four horizontal microbeams, it is not relevant to compare the
PVDRs behaviour obtain in this particular configuration to the expected behaviour.
As expected though, the PVDRs are higher for the 25-200 MSC configuration as the
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Figure 7.18: Peak (left y-axis) and valley signals (right y-axis) measured at different
depths in the solid water phantom for the 25-200 configuration.
Figure 7.19: Peak (left y-axis) and valley signals (right y-axis) measured at different
depths in the solid water phantom for the 50-200 configuration.
valley signal is around 7.2 times lower than in the 50-200 MSC configuration while the
peak is only 2.5 lower.
For both MSC configurations, the PVDRs are displayed in Figure 7.20 and in
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Figure 7.20: PVDRs obtained in the 25-200 configuration for a valley either equal
to the minimum value between two consecutive peak (blue crosses) or equal to the
average signal over an ROI of 25 µm (green crosses) or 50 µm (red crosses) centred
between two consecutive peaks.
Figure 7.21: PVDRs obtained in the 50-200 configuration for a valley either equal
to the minimum value between two consecutive peak (blue crosses) or equal to the
average signal over an ROI of 25 µm (green crosses) or 50 µm (red crosses) centred
between two consecutive peaks.
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Figure 7.21 for the different ROIs investigated for the valley signal determination. At
90 mm depth, considering a ROI of 50 µm for the valley determination instead of
the minimal value beween two consecutive microbeams leads to a PVDR reduction of
22.3% for the 25-200 MSC configuration and to a PVDR reduction of 14.5% for the
50-200 MSC configuration.
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7.2.3 Conclusions
Horizontal microbeams intensity profiles have been measured at difference depths
within a solid water phantom for both the 25-200 and 50-200 MSC configurations.
For the first time at IMBL, the array of microbeams have been measured with an
active detector. Due to the lack of SSD alignment possibilities at the IMBL beam line
at the Australian Synchrotron, the measured FWHM of the microbeams were higher
than expected (59 µm and 73 µm measured FWHM instead of the 25 µm and 50 µm
expected values). However, the c-t-c distances measured (207 µm and 205 µm for the
25-200 and 50-200 MSC configuration respectively) were in agreement with the 200 µm
expected value. Nevertheless it is difficult to be sure of the expected FWHM value
as this parameter will also being influenced by volume averaging effect and electron
diffusion.
From the acquired intensity profiles, peak and valley signals were assessed and
the PVDR were deduced from the resulting values. Different ROIs were considered
for the valley definition and the effect on the resulting PVDRs was investigated. The
results showed that the valley was not uniform even in small regions right between two
consecutive peaks. Consequently, it would be important for future studies to agree
on the way to define the valley region depending on the microbeams width and their
spacing as this can have a significant effect on the PVDR and therefore on the expected
normal tissue tolerance to MRT treatment. In particular, the 25-200 and 50-200 MSC
configurations will be interesting cases to consider as electrons from the microbeams
should have a significant contribution to the valley.
Finally, the presence of several tungsten plates in the IMBL MSC, one can expect
this MSC to introduce photon reflections and potential dose deposition outside of the
MRT field. However one must consider the fact that kapton is used to separate the
plates as this will have a significant impact on the scattering conditions. An experiment
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similar to the in-air experiment performed at the ESRF and presented in chapter 5
could be performed at IMBL in order to investigate this effect.
Chapter 8
Summary and Conclusions
Microbeam Radiation Therapy (MRT) is an exciting development in the field of ra-
diation oncology. It involves the treatment of tumours using planar arrays of highly
collimated, low divergent X-ray microbeams. The underlying principle of MRT is a
fascinating radiobiological effect known as the dose-volume effect, whereby healthy
tissue demonstrates a remarkable resistance to ionising radiation when spatial frac-
tionation of the primary beam into microscopic beams is employed. Many pre-clinical
studies demonstrated the efficacy of MRT in treating gliomas and paved the way
to veterinary trials that are currently conducted at the ESRF. However, because of
the synchrotron source properties and the MRT beam geometry, dosimetry remains a
challenging task. This thesis aimed to provide some solutions for both reference and
microbeam dosimetry.
Most of the results presented in this thesis have been performed at the ID17 biomed-
ical beamline at the ESRF and preliminary measurements were carried at the Imaging
and Medical beamline (IMBL) at the Australian Synchrotron. Both beamlines instru-
mentation have been described in details in chapter 2.
Reference dosimetry is a crucial step for the accurate delivery of the treatment
as the prescribed peak dose is scaled on the reference dose. To palliate the current
lack of method and recommendations for the determination of the ion recombination
correction factor (ks) in the specific case of high photon flux from a synchrotron X-ray
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source, a new method was developed at the ESRF for this purpose and was presented
in chapter 3. This method allows the direct determination of the ion recombina-
tion correction factor using the reference dosimeter (PinPoint 31014) in the reference
dosimetry conditions. A dosimetry protocol has been established for reference dosime-
try to be performed prior to MRT irradiation. This protocol permits a determination
of the absolute dose with an accuracy better than ± 5% and will therefore be used for
future MRT pre-clinical studies and veterinary trials at the ID17 beamline. A verifica-
tion of the MRT spectrum based on Cu half value layer (HVL) measurements in both
clinical and pre-clinical conditions led to the conclusion that the TH 200 beam quality
was the closest to the MRT spectrum for both filtering configurations and therefore
the most appropriate for the MRT reference IC calibration. Having the MRT reference
IC directly calibrated at the TH 200 beam quality and performing the current ramp-
ing experiment using this calibration should further improve the reference dosimetry
precision. In the future, it is crucial to validate the current ramping method under full
veterinary beam conditions. Indeed, the current ramping method is currently limited
to filtering configurations that do not include the krypton gas filter used under the
clinical conditions as the filtration provided by the krypton is affected by the storage
ring current. Calorimetry is another independent and reliable technique that should
be investigated for absolute dosimetry in broad beam radiation fields in MRT and for
validation of the ramping method.
The dosimetry system (X-Tream) based on a high spatial resolution silicon strip
detector (SSD) was especially developed by Centre for Medical Radiation Physics
(CMRP) for MRT applications. A full description of the system was given in chapter 4
as well as the characterisation of the high and low gain X-Tream pre-amplifiers over
their full dynamic range. The low gain pre-amplifier exhibited a dynamic range of
103 which suits the MRT requirements. The conversion between counts obtained by
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the system and input current was also established. In section 4.3, a study of the
SSD radiation damage was carried out. Vertical scans of the SSD sensitive volume in
straight orientation for different accumulated doses combined to 2D response mapping
of the detector highlighted an over-response of the SSD at the junction between the
pad and the microstrip. This over-response is mainly coming from the metal-oxide-
semiconductor (MOS) capacitor generated by the pad and the silicon oxide allowing
charges collection from the pad in not pre-irradiated SSD devices. The SSD pre-
irradiation process should therefore mitigate for the SSD over-response as irradiation
damage induces a decrease in the carrier lifetime. By studying the effect of the SSD
response with accumulated dose, it was determined that pre-irradiation dose around
40 kGy had to be delivered to the SSD in order to stabilise its response (change in SSD
response is lower than 1% per 1000 Gy). For very high precision dosimetry a 70 kGy
pre-irradiation dose could be recommended in order to ensure a very stable response
from the device. However, re-calibration of pre-irradiated SSD should be performed
regularly in order to verify the constancy of the SSD response with the accumulated
dose. Similarly, a model of the SSD response with total accumulated dose should be
developed in the future. Also, a study of the SSD energy dependence was carried out
in the SSRT hutch at the ESRF using monochromatic beams of different energies. Two
different SSDs presenting different orientations of the sensitive volume (i.e. straight or
90◦) were tested in both edge-on and face-on configurations. The SSD linearity with
dose was studied at the different beam qualities by delivering three different doses
to the detectors. For all the configurations investigated, the SSDs showed a linear
behaviour with the delivered dose. A decrease of the slope of the linear fits of the
experimental data with the beam energy was observed due to the over-response of the
SSD at low energies. MC simulations should be performed to validate the experimental
results. In a longer term approach, the design of the SSD could be improved in order
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to mitigate the energy dependence effect. To this end, thinning the Si substrate and
adding a water equivalent material (PMMA) encapsulation around the device could
be considered. As additional characterisation tests, further measurements are required
to evaluate the SSD response linearity with the dose rate at ranges currently used in
MRT.
The ability of the SSD to detect minute misalignment of the MRT MSC, and its
potential use for rapid pre-treatment quality assurance in MRT was investigated in
chapter 5. This study was based on in-air measurements of the horizontal profiles of the
X-ray microbeams in order to determine the relative intensity of each microbeam and
assess the alignment of the MSC. The results showed that the SSD was able to resolve
individual microbeams which therefore provides invaluable QA of the horizontal field
size and microbeams number and shape. They also demonstrated that the SSD was
very sensitive to any small misalignment of the MSC. In order to allow as rapid QA
as possible, a fast alignment procedure of the SSD based on X-ray imaging with a low
intensity, low energy beam was developed. One of the major limitations of the SSD
highlighted in this study was the degradation of the spatial resolution of the SSD as
soon as the detector is slightly misaligned. In clinical practice a pre-aligned SSD could
be mounted permanently in air and the imaging procedure would thus confirm that no
misalignment of the detector had occurred. To even more decrease the duration of QA
procedures, one could consider including a manual entering of the scan speed as an
input in the RADPLOT software in order to directly display the microbeam intensity
as a function of distance.
The SSD has then been used for the assessment of PVDR and scatter factors at
2 cm depth and results were presented in chapter 6. Three different phantoms were
considered for the PVDR measurements; a water-based phantom (Phantom A), a RW3
solid-water slab phantom including a gammex phantom, specially engineered for the
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SSD (Phantom B) and the RW3 solid-water slab phantom with the SSD located in
the IC dedicated holder filled up with water (Phantom C). For the three field sizes
investigated, PVDRs values measured in both Phantom A and Phantom C were in
close agreement with PVDR published values obtained by both MC simulations and
Gafchromic® films measurements [Mart́ınez-Rovira et al., 2012]. Because of small air-
gaps present in the phantom B configuration, higher PVDRs were measured than in
the two other phantoms. Scatter factors were measured in Phantom C and compared
to MC simulation results. A close agreement was obtained with the two techniques
down to a beam horizontal aperture of 100 µm. For the first time, an active detector
has been able to measure both valley and peak signals with the same accuracy leading
to a direct determination of the PVDRs in agreement with published values. Due to
time constraints, the scatter factors acquired with the SSD have only been performed
once, leading to a lack of statistics. These measurements should thus be repeated
under identical conditions in order to establish error bars and see if MC simulation
results and experimental results agree within the uncertainties down to a beam width
of 50 µm. The PVDRs measured with the SSD have not been corrected for the energy
dependence of the detector. In order to determine if the difference in terms of energy
spectrum between the valley and peak regions impacts the experimental determination
of the PVDRs using the SSD, MC simulations of the detector response in both spectra
is required. Also, PVDR measurements using the SSD should be performed at larger
depths to see if results still agree with published MC and Gafchromic® films results
from Mart́ınez-Rovira et al. [2012].
Preliminary measurements performed at the Imaging and Medical Beamline at the
Australian Synchrotron were described in chapter 7. Broadbeam experiments were
performed in the MRT hutch (hutch 1B) and compared the results obtained with
to the reference PinPoint 31014 IC used at IMBL. Measurements were performed
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at different depths and an over-response of the SSD was observed compared to the
PinPoint which was attributed to the energy dependence of the SSD. For the first
time vertical intensity profiles of the horizontal microbeams were acquired with an
active detector (the SSD) in the IMBL MRT hutch. From these measurements, peak,
valley and PVDRs values have been extracted. Different ROIs were investigated to
define the valley signal. The length of the valley ROI has been proven as being a
very important parameter as it has a direct influence on the PVDR (and thus on the
expected normal tissue tolerance to MRT treatment) especially for a c-t-c distance
of 200 µm. Consequently, an agreement should be sought in order to establish the
way the valley region should be defined depending on the microbeams width and their
spacing.
As a conclusion, despite the remaining improvements and investigations required,
the ability of the SSD to perform in-air QA tests has been demonstrated. Moreover,
this is the first active device that has been able to measure PVDRs values in such a
close agreement with Gafchromic® films and MC simulation results. Therefore the
SSD, or similar technologies, should be considered as potential candidates to perform
QA tests in MRT in the future.
Appendices
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Appendix A
Characterisation of beam monitoring
chambers at the ESRF
In the context of veterinary trials at the ESRF, the characterisation of the beam
monitors intended to be used for the patient safety was required. The ramping method
was used to determine the linearity of both IC0 and IC0bis monitoring chambers with
the SR current.
Figure A.1: Signal recorded by the IC0
chamber (IC01+IC02) as a function of
the current in the storage ring.
Figure A.2: IC0 signal normalised by
the storage ring current.
In Figure A.2, one can see that the response of the IC0 remains quite flat with the
storage ring current. The average response of IC01 is 1.27 × 10−8 ± 1.13 × 10−10 (2σ)
and is thus suitable for MRT beam monitoring applications.
The same characterisation was performed for the IC0bis monitoring chamber. The
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chamber response as a function of the SR current was obtained for two different beam
heights: 520 and 51 µm.
The signal recorded by the IC0bis chamber (IC0bis1+IC0bis2) as a function of the
current in the storage ring for a 51µm beam height is displayed in Figure A.3. IC0bis
exhibits a linear behaviour with the SR current. IC0bis recorded signal has then been
divided by the SR current and normalised to 100% at the maximum value in order to
observe the IC0bis response with the SR current (see Figure A.4).
Figure A.3: Signal recorded by the
IC0bis chamber (IC0bis1+IC0bis2) as
a function of the current in the storage
ring for a 51 µm beam height.
Figure A.4: IC0bis response as a fun-
tion of the storage ring current for a 51
µm beam height.
For the 51 µm beam height, the IC0bis response remains quite stable over the full
range of current investigated (within ±2.5%).
The signal recorded by the IC0bis chamber as a function of the current in the
storage ring for a 520 µm beam height is displayed in Figure A.5. The response is first
linear with the beam current then, from 70 mA, the chamber signal saturates which
results in a decrease in the IC0bis response from 100% down to 31% (see Figure A.6).
The results presented for IC0bis have been obtained with the chamber fixed in the
beam. For the purpose of the veterinary trials, the IC0bis chamber will be set-up on
a dedicated support that will vertically move the chamber through the beam. This
support will be synchronised with the goniometer vertical motion. A characterisation
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Figure A.5: Signal recorded by the
IC0bis chamber (IC0bis1+IC0bis2) as
a function of the current in the storage
ring for a 520 µm beam height.
Figure A.6: IC0bis response as a fun-
tion of the storage ring current for a
520 µm beam height.
of the IC0bis chamber behaviour when scanned through the beam was thus perform.
The IC0bis chamber was taped against the water tank positioned on the goniometer
stage and was scanned through the beam at four different scan speed (2, 5, 20 and 100
mm/s). Measurements have been performed within a 2 cm × 2 cm field at SR current
ranging from 20 to 200 mA and two different beam heights have been investigated (51
and 520 µm). Results are presented in Figure A.7 and Figure A.8 for the 51 µm and
the 520 µm beam height respectively.
For the 51 µm beam height, IC0bis exhibits a linear behaviour over the entire range
of SR current investigated and the measured signal is proportional to the scan speed.
For the 520 µm beam height, as previously observed in the case of IC0bis fixed in the
beam, saturation occurs when the SR current reaches 75 mA. At scan speed of 100
mm/s, as the dose rate perceived by the chamber is the lower, IC0bis starts to saturate
at a beam current of 100 mA .
IC0bis can therefore not be used under broadbeam conditions if the beam height
is higher than 51 µm. However, when introducing the MSC in the beam, the effective
dose rate seen by the chamber is reduced by a factor of 8. The IC0bis chamber could
thus be suitable for microbeam monitoring when using the reference beam height of
187
Figure A.7: Signal measured by the
IC0bis in 2 cm × 2 cm broadbeam (us-
ing a the 50 µm vertical slits) as a func-
tion of the SR current. Four different
scan speeds were investigated.
Figure A.8: Signal measured by the
IC0bis in 2 cm × 2 cm broadbeam (us-
ing the 500 µm vertical slits) as a func-
tion of the SR current. Four different
scan speeds were investigated.
520 µm. The experiment with IC0bis taped on the water tank was thus repeated at
different SR currents with the MSC in the beam for three different scan speeds (5, 20
and 100 mm/s). The results are displayed in Figure A.9.
Figure A.9: Signal measured by the IC0bis in 2 cm × 2 cm microbeam field (using
the 500 µm vertical slits) as a function of the SR current. Three different scan speeds
were investigated.
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As expected, since the effective dose rate seen by IC0bis is much reduced when the
MSC is inserted in the beam, IC0bis exhibits a linear behaviour with the SR current
and the IC0bis recorded signal is proportional with the scanning speed. Therefore
the IC0bis has been evaluated as a suitable monitoring device for the MRT veterinary
trials.
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Appendix B
MRT broadbeam profiles obtained with
the PinPoint 31014 and the Semiflex
31010 ionisation chambers
As a part of the investigation of the most suitable detector to perform MRT reference
dosimetry (c.f. chapter 3), vertical and horizontal beam profiles have been performed
at 2 cm depth in a RW3 solid water slab phantom using both the PinPoint 31014 IC
and the Semiflex 31010 IC. The profiles presented have been obtained with a 520 µm
high beam and a scan speed of 20 mm.s−1.
Three different squared field sizes were considered: 10 mm × 10 mm, 20 mm × 20
mm and 30 mm × 30 mm. For the lateral beam profiles (i.e. horizontal (y) profiles),
the all phantom was horizontally moved through the beam using the goniometer lateral
motion motor. For the vertical beam profiles (z direction), as the phantom and the
IC are vertically scanned through the beam, the irradiation start and stop positions
were modified in order to simulate a vertical beam profile. For example, if the IC is
centred in the beam at a z position equal to 50 mm, the goniometer start and stop
position to be used to irradiate the chamber in the centre of a 2 cm × 2 cm field size
are 40 and 60 mm respectively. In order to simulate the vertical profile, defining the
goniometer start and stop position at 20 and 40 mm will be equivalent to moving the
IC 20 mm away from the field centre.
The horizontal and vertical beam profiles obtained with the PinPoint IC are dis-
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played in Figure B.1 and Figure B.2 respectively.
Figure B.1: MRT broadbeam horizon-
tal profiles measured with the PinPoint
31014 IC for three different field sizes (10
mm × 10 mm, 20 mm × 20 mm, 30 mm
× 30 mm).
Figure B.2: MRT broadbeam verti-
cal profiles measured with the PinPoint
31014 IC for three different field sizes (10
mm × 10 mm, 20 mm × 20 mm, 30 mm
× 30 mm).
Figure B.3: Comparison of the horizontal and vertical profiles obtained with the Pin-
Point IC for the MRT reference broadbeam field size (i.e. 20 mm × 20 mm). Data
have been normalised at 100% at the maximum measured value.
The vertical broadbeam profiles give a wider penumbra than the horizontal one.
For comparison they are both displayed Figure B.3 for the reference MRT broadbeam
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(i.e. 20 mm × 20 mm). The data have been normalised to the highest recorded signal
which corresponds to the readings obtained at the position y=0 when performing the
horizontal beam profile.
An asymmetry in the out-of-field dose profiles is observed due to polarization ef-
fects. As the polarisation is predominant in the electron orbital plane of the syn-
chrotron, the photons undergoing Compton interactions in the phantom/patient will
be preferentially scattered in the vertical direction. As a result, the out-of-field dose
is greater in the vertical direction than in the horizontal direction Hugtenburg et al.
[2010]. This assymetry on the out-of-field was previously highlighted in the work of
[Cornelius et al., 2014] and [Bartzsch et al., 2014].
The horizontal and vertical profiles obtained with the Semiflex 31010 are displayed
in Figure B.4 and Figure B.5 respectively.
Figure B.4: MRT broadbeam horizontal
profiles measured with the Semiflex 31010
IC for three different field sizes (10 mm ×
10 mm, 20 mm × 20 mm, 30 mm × 30
mm).
Figure B.5: MRT broadbeam vertical
profiles measured with the Semiflex 31010
IC for three different field sizes (10 mm ×
10 mm, 20 mm × 20 mm, 30 mm × 30
mm).
Again, when comparing the horizontal and vertical profiles in the MRT reference
broadbeam field (see Figure B.6), the assymetry in the out-of-field dose can also be
observed.
Figure B.7 and Figure B.8 respectively compare the horizontal and vertical MRT
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Figure B.6: Comparison of the horizontal and vertical profiles obtained with the Pin-
Point IC for the MRT reference broadbeam field size (i.e. 20 mm × 20 mm). Data
have been normalised at 100% at the maximum measured value.
Figure B.7: Comparison of the horizontal
profiles measured by either the PinPoint
31014 IC or the Semiflex 31010 IC in the
MRT broadbeam reference field size (i.e.
20 mm × 20 mm).
Figure B.8: Comparison of the vertical
profiles measured by either the PinPoint
31014 IC or the Semiflex 31010 IC in the
MRT broadbeam reference field size (i.e.
20 mm × 20 mm).
reference beam profiles obtained with both the PinPoint and the Semiflex chambers.
In the centre of the beam, the scaled dose rate measured by the semiflex is around
29% lower than the scaled dose rate measured by the PinPoint IC. This is attributed
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the ion recombination effect expected to be much higher in the Semiflex IC because
of the higher effective separation between electrodes in the Semiflex design compared
to the PinPoint (as detailed in subsection 3.1.4).
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E. A., Renaud, L., Khalil, E., Rémy, C., Poillot, C., et al. (2010). Preferential
effect of synchrotron microbeam radiation therapy on intracerebral 9L gliosarcoma
vascular networks. International Journal of Radiation Oncology* Biology* Physics,
78(5):1503–1512.
Bouchet, A., Sakakini, N., Atifi, M. E., Clec’h, C., Bräuer-Krisch, E., Rogalev, L.,
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